0|1|2|3
2024 Formulary(List of Covered Drugs)PLEASE READ: THIS DOCUMENT CONTAINSINFORMATION ABOUT THE DRUGS WE COVERIN THIS PLAN.HPMS Approved Formulary FileSubmission ID: 00024425 Version #: 2|||
|||
2024 Formulary(List of Covered Drugs)PLEASE READ: THIS DOCUMENT CONTAINSINFORMATION ABOUT THE DRUGS WE COVERIN THIS PLAN.HPMS Approved Formulary FileSubmission ID: 00024425 Version #: 2|||
|||
2024 Formulary(List of Covered Drugs)PLEASE READ: THIS DOCUMENT CONTAINSINFORMATION ABOUT THE DRUGS WE COVERIN THIS PLAN.HPMS Approved Formulary FileSubmission ID: 00024425 Version #: 2|||
|||
|||
|||
2024 Formulary(List of Covered Drugs)PLEASE READ: THIS DOCUMENT CONTAINSINFORMATION ABOUT THE DRUGS WE COVERIN THIS PLAN.HPMS Approved Formulary FileSubmission ID: 00024425 Version #: 2|||
|||
|||
|||
|||
|||
This formulary was updated on 10/01/2023. For more recent information or other questions, pleasecontact AmeriHealth Caritas VIP Care at 1-833-433-3767 or, for TTY users, 711, 8 a.m. – 8 p.m., Mondaythrough Friday, from April 1 to September 30, and from October 1 to March 31, 8 a.m. – 8 p.m., sevendays a week, or visit www.amerihealthcaritasvipcare.com/de.The formulary may change at any time. You will receive notice when necessary.Y0093_006_233004351_C_02|||
Part D Prescription Drugs(Standard Retail Cost-Sharing)|||
One-month supply, two-month supply, andthree-month supply|$0 copay||
Pharmacy Type|Max Days Supply||
Retail|1-30 days = 1 month supply31-60 days = 2 month supply61-100 days = 3 month supply||
Mail Order|61-100 days = 3 month supply||
Long-Term Care|0-31 days = 1 month supplyOther day supply allowed = 14-day supply||
Out of Network|1-30 days = 1 month supply||
Drug Name||Drug Tier|Requirements/Limits
Analgesics - Treatment Of Pain|||
|||
Analgesics|||
ascomp-codeine oral capsule 50-325-40-30 mg||PA; MME|
||1|
bac oral tablet 50-325-40 mg||1|PA
butalbital-acetaminophen oral tablet 50-325 mg||1|PA
butalbital-apap-caff-cod oral capsule 50-325-40-30 mg||PA; MME|
||1|
|||
butalbital-apap-caffeine oral capsule 50-325-40mg||PA|
||1|
|||
butalbital-apap-caffeine oral tablet 50-325-40 mg||1|PA
butalbital-asa-caff-codeine oral capsule 50-325-40-30 mg||PA; MME|
||1|
|||
butalbital-aspirin-caffeine oral capsule 50-325-40 mg||PA|
||1|
|||
nalbuphine hcl injection solution 10 mg/ml||1|MME
Nonsteroidal Anti-Inflammatory Drugs|||
celecoxib oral capsule 100 mg, 200 mg, 400 mg,50 mg|||
|||
||1|
|||
diclofenac potassium oral tablet 50 mg||1|
diclofenac sodium er oral tablet extended release24 hour 100 mg|||
||1|
|||
diclofenac sodium external gel 1 %, 3 %||1|
diclofenac sodium oral tablet delayed release 25mg, 50 mg, 75 mg|||
||1|
|||
diflunisal oral tablet 500 mg||1|
ec-naproxen oral tablet delayed release 375 mg,500 mg|||
||1|
|||
etodolac er oral tablet extended release 24 hour400 mg, 500 mg, 600 mg|||
||1|
|||
etodolac oral capsule 200 mg, 300 mg||1|
etodolac oral tablet 400 mg, 500 mg||1|
Drug Name||Drug Tier|Requirements/Limits
flurbiprofen oral tablet 100 mg||1|
ibu oral tablet 400 mg, 600 mg, 800 mg||1|
ibuprofen oral suspension 100 mg/5ml||1|
ibuprofen oral tablet 400 mg, 600 mg, 800 mg||1|
indomethacin er oral capsule extended release 75mg||PA|
||1|
|||
indomethacin oral capsule 25 mg, 50 mg||1|PA
ketorolac tromethamine oral tablet 10 mg||1|PA; QL (20 EA per 30 days)
meclofenamate sodium oral capsule 100 mg, 50mg|||
||1|
|||
meloxicam oral tablet 15 mg, 7.5 mg||1|
nabumetone oral tablet 500 mg, 750 mg||1|
naproxen oral suspension 125 mg/5ml||1|
naproxen oral tablet 250 mg, 375 mg, 500 mg||1|
naproxen oral tablet delayed release 375 mg, 500mg|||
||1|
|||
naproxen sodium oral tablet 275 mg, 550 mg||1|
piroxicam oral capsule 10 mg, 20 mg||1|
sulindac oral tablet 150 mg, 200 mg||1|
Opioid Analgesics, Long-Acting|||
buprenorphine transdermal patch weekly 10mcg/hr, 15 mcg/hr, 20 mcg/hr, 5 mcg/hr, 7.5mcg/hr||MME; QL (4 EA per 28 days)|
|||
||1|
|||
fentanyl transdermal patch 72 hour 100 mcg/hr||1|PA; MME
fentanyl transdermal patch 72 hour 12 mcg/hr, 25mcg/hr, 37.5 mcg/hr, 50 mcg/hr, 62.5 mcg/hr, 75mcg/hr, 87.5 mcg/hr||MME; QL (10 EA per 30 days)|
||1|
|||
methadone hcl oral solution 10 mg/5ml||1|MME; QL (1200 ML per 30 days)
methadone hcl oral solution 5 mg/5ml||1|MME; QL (2400 ML per 30 days)
methadone hcl oral tablet 10 mg||1|PA; MME
methadone hcl oral tablet 5 mg||1|MME; QL (180 EA per 30 days)
morphine sulfate er oral tablet extended release100 mg, 200 mg||PA; MME|
||1|
|||
morphine sulfate er oral tablet extended release15 mg, 30 mg, 60 mg||MME; QL (60 EA per 30 days)|
||1|
|||
oxycodone hcl er oral tablet er 12 hour abuse-deterrent 10 mg, 20 mg, 40 mg, 80 mg||PA; MME|
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
Opioid Analgesics, Short-Acting|||
acetaminophen-codeine #3 oral tablet 300-30 mg||MME|
||1|
acetaminophen-codeine oral solution 120-12mg/5ml||MME|
||1|
|||
acetaminophen-codeine oral tablet 300-15 mg,300-30 mg, 300-60 mg||MME|
||1|
|||
butorphanol tartrate nasal solution 10 mg/ml||1|MME; QL (5 ML per 30 days)
endocet oral tablet 10-325 mg, 2.5-325 mg, 5-325mg, 7.5-325 mg||MME|
||1|
|||
fentanyl citrate buccal lozenge on a handle 1200mcg, 1600 mcg, 200 mcg, 400 mcg, 600 mcg, 800mcg||PA; MME; QL (120 EA per 30days)|
||1|
|||
hydrocodone-acetaminophen oral tablet 10-325mg, 5-325 mg, 7.5-325 mg||MME|
||1|
|||
hydrocodone-ibuprofen oral tablet 10-200 mg, 5-200 mg, 7.5-200 mg||MME|
||1|
|||
hydromorphone hcl oral tablet 2 mg, 4 mg, 8 mg||1|MME; QL (120 EA per 30 days)
hydromorphone hcl pf injection solution 1 mg/ml,10 mg/ml, 4 mg/ml, 50 mg/5ml, 500 mg/50ml||MME|
||1|
|||
morphine sulfate (concentrate) oral solution 100mg/5ml, 20 mg/ml||MME; QL (240 ML per 30 days)|
||1|
|||
morphine sulfate oral tablet 15 mg, 30 mg||1|MME; QL (120 EA per 30 days)
oxycodone hcl oral solution 5 mg/5ml||1|MME; QL (5400 ML per 30 days)
oxycodone hcl oral tablet 10 mg, 15 mg, 20 mg,30 mg, 5 mg||MME; QL (120 EA per 30 days)|
||1|
|||
oxycodone-acetaminophen oral tablet 10-325 mg,2.5-325 mg, 5-325 mg, 7.5-325 mg||MME|
||1|
|||
pentazocine-naloxone hcl oral tablet 50-0.5 mg||1|PA; MME
tramadol hcl oral tablet 100 mg||1|MME; QL (120 EA per 30 days)
tramadol hcl oral tablet 50 mg||1|MME; QL (240 EA per 30 days)
tramadol-acetaminophen oral tablet 37.5-325 mg||1|MME
Anesthetics - Local Treatment Of Pain|||
|||
Local Anesthetics|||
lidocaine external ointment 5 %|||
||1|
lidocaine external patch 5 %||1|PA; QL (90 EA per 30 days)
lidocaine hcl external solution 4 %||1|
lidocaine hcl urethral/mucosal external gel 2 %||1|
Drug Name||Drug Tier|Requirements/Limits
lidocaine hcl urethral/mucosal external prefilledsyringe 2 %|||
||1|
|||
lidocaine viscous hcl mouth/throat solution 2 %||1|
lidocaine-prilocaine external cream 2.5-2.5 %||1|
ZTLIDO EXTERNAL PATCH 1.8 %||1|PA; QL (90 EA per 30 days)
Anti-Addiction/ Substance Abuse|||
Treatment Agents - Treatment Of|||
Substance Abuse Disorders|||
Alcohol Deterrents/Anti-Craving|||
acamprosate calcium oral tablet delayed release333 mg|||
|||
||1|
|||
disulfiram oral tablet 250 mg, 500 mg||1|
Opioid Dependence|||
buprenorphine hcl sublingual tablet sublingual 2mg, 8 mg||MME|
|||
||1|
|||
buprenorphine hcl-naloxone hcl sublingual film12-3 mg||MME; QL (60 EA per 30 days)|
||1|
|||
buprenorphine hcl-naloxone hcl sublingual film2-0.5 mg||MME; QL (120 EA per 30 days)|
||1|
|||
buprenorphine hcl-naloxone hcl sublingual film4-1 mg, 8-2 mg||MME; QL (90 EA per 30 days)|
||1|
|||
buprenorphine hcl-naloxone hcl sublingual tabletsublingual 2-0.5 mg, 8-2 mg||MME|
||1|
|||
LUCEMYRA ORAL TABLET 0.18 MG||1|PA; QL (224 EA per 14 days)
naltrexone hcl oral tablet 50 mg||1|
Opioid Reversal Agents|||
naloxone hcl injection solution 0.4 mg/ml, 4mg/10ml|||
|||
||1|
|||
naloxone hcl injection solution cartridge 0.4mg/ml|||
||1|
|||
naloxone hcl injection solution prefilled syringe 2mg/2ml|||
||1|
|||
naloxone hcl nasal liquid 4 mg/0.1ml||1|
Smoking Cessation Agents|||
bupropion hcl er (smoking det) oral tabletextended release 12 hour 150 mg|||
|||
||1|
|||
NICOTROL INHALATION INHALER 10 MG||1|
Drug Name||Drug Tier|Requirements/Limits
NICOTROL NS NASAL SOLUTION 10MG/ML|||
||1|
|||
varenicline tartrate (starter) oral tablet therapypack 0.5 mg x 11 & 1 mg x 42||QL (56 EA per 28 days)|
||1|
|||
varenicline tartrate oral tablet 0.5 mg, 1 mg||1|QL (56 EA per 28 days)
Antibacterials - Treatment Of Bacterial|||
Infections|||
Aminoglycosides|||
amikacin sulfate injection solution 500 mg/2ml|||
||1|
gentamicin in saline intravenous solution 0.8-0.9mg/ml-%, 1-0.9 mg/ml-%, 1.2-0.9 mg/ml-%, 1.6-0.9 mg/ml-%|||
||1|
|||
gentamicin sulfate injection solution 40 mg/ml||1|
neomycin sulfate oral tablet 500 mg||1|
paromomycin sulfate oral capsule 250 mg||1|
streptomycin sulfate intramuscular solutionreconstituted 1 gm|||
||1|
|||
tobramycin sulfate injection solution 1.2gm/30ml, 10 mg/ml, 2 gm/50ml, 80 mg/2ml|||
||1|
|||
tobramycin sulfate injection solution reconstituted1.2 gm|||
||1|
|||
Antibacterials, Other|||
aztreonam injection solution reconstituted 1 gm, 2gm|||
|||
||1|
|||
clindamycin hcl oral capsule 150 mg, 300 mg, 75mg|||
||1|
|||
clindamycin palmitate hcl oral solutionreconstituted 75 mg/5ml|||
||1|
|||
clindamycin phosphate in d5w intravenoussolution 300 mg/50ml, 600 mg/50ml, 900mg/50ml|||
||1|
|||
clindamycin phosphate in nacl intravenoussolution 300-0.9 mg/50ml-%, 600-0.9 mg/50ml-%, 900-0.9 mg/50ml-%|||
||1|
|||
clindamycin phosphate injection solution 300mg/2ml, 600 mg/4ml, 900 mg/6ml|||
||1|
|||
clindamycin phosphate vaginal cream 2 %||1|
colistimethate sodium (cba) injection solutionreconstituted 150 mg|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
daptomycin intravenous solution reconstituted350 mg, 500 mg|||
||1|
|||
linezolid in sodium chloride intravenous solution600-0.9 mg/300ml-%|||
||1|
|||
linezolid intravenous solution 600 mg/300ml||1|
linezolid oral suspension reconstituted 100mg/5ml|||
||1|
|||
linezolid oral tablet 600 mg||1|
methenamine hippurate oral tablet 1 gm||1|
metronidazole intravenous solution 500 mg/100ml||1|
metronidazole oral capsule 375 mg||1|
metronidazole oral tablet 250 mg, 500 mg||1|
metronidazole vaginal gel 0.75 %||1|
nitrofurantoin macrocrystal oral capsule 100 mg,25 mg, 50 mg|||
||1|
|||
nitrofurantoin monohyd macro oral capsule 100mg|||
||1|
|||
polymyxin b sulfate injection solutionreconstituted 500000 unit|||
||1|
|||
tinidazole oral tablet 250 mg, 500 mg||1|
trimethoprim oral tablet 100 mg||1|
vancomycin hcl intravenous solution reconstituted1 gm, 10 gm, 100 gm, 5 gm, 500 mg, 750 mg|||
||1|
|||
vancomycin hcl oral capsule 125 mg, 250 mg||1|
Beta-Lactam, Cephalosporins|||
cefaclor er oral tablet extended release 12 hour500 mg|||
|||
||1|
|||
cefaclor oral capsule 250 mg, 500 mg||1|
cefadroxil oral capsule 500 mg||1|
cefadroxil oral suspension reconstituted 250mg/5ml, 500 mg/5ml|||
||1|
|||
cefadroxil oral tablet 1 gm||1|
cefazolin sodium injection solution reconstituted1 gm, 2 gm, 500 mg|||
||1|
|||
cefazolin sodium intravenous solutionreconstituted 1 gm, 2 gm, 3 gm|||
||1|
|||
cefazolin sodium-dextrose intravenous solution 1-4 gm/50ml-%|||
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
cefazolin sodium-dextrose intravenous solutionreconstituted 1-4 gm-%(50ml)|||
|1||
|||
cefdinir oral capsule 300 mg|1||
cefdinir oral suspension reconstituted 125mg/5ml, 250 mg/5ml|||
|1||
|||
cefepime hcl injection solution reconstituted 1 gm|1||
cefepime hcl intravenous solution 1 gm/50ml, 2gm/100ml|||
|1||
|||
cefepime hcl intravenous solution reconstituted 2gm|||
|1||
|||
cefepime-dextrose intravenous solutionreconstituted 1-5 gm-%(50ml), 2-5 gm-%(50ml)|||
|1||
|||
cefixime oral capsule 400 mg|1||
cefotaxime sodium injection solution reconstituted1 gm|||
|1||
|||
cefoxitin sodium intravenous solutionreconstituted 1 gm, 10 gm, 2 gm|||
|1||
|||
cefoxitin sodium-dextrose intravenous solutionreconstituted 1-4 gm-%(50ml), 2-2.2 gm-%(50ml)|||
|1||
|||
cefpodoxime proxetil oral suspensionreconstituted 100 mg/5ml, 50 mg/5ml|||
|1||
|||
cefpodoxime proxetil oral tablet 100 mg, 200 mg|1||
cefprozil oral suspension reconstituted 125mg/5ml, 250 mg/5ml|||
|1||
|||
cefprozil oral tablet 250 mg, 500 mg|1||
ceftazidime and dextrose intravenous solutionreconstituted 1-5 gm-%(50ml), 2-5 gm-%(50ml)|||
|1||
|||
ceftazidime injection solution reconstituted 1 gm,6 gm|||
|1||
|||
ceftazidime intravenous solution reconstituted 2gm|||
|1||
|||
ceftriaxone sodium in dextrose intravenoussolution 20 mg/ml, 40 mg/ml|||
|1||
|||
ceftriaxone sodium injection solutionreconstituted 1 gm, 100 gm, 2 gm, 250 mg, 500mg|||
|1||
|||
ceftriaxone sodium intravenous solutionreconstituted 1 gm, 10 gm, 2 gm|||
1|||
|||
Drug Name||Drug Tier|Requirements/Limits
ceftriaxone sodium-dextrose intravenous solutionreconstituted 1-3.74 gm-%(50ml), 2-2.22 gm-%(50ml)|||
||1|
|||
cefuroxime axetil oral tablet 250 mg, 500 mg||1|
cefuroxime sodium injection solutionreconstituted 750 mg|||
||1|
|||
cefuroxime sodium intravenous solutionreconstituted 1.5 gm|||
||1|
|||
cephalexin oral capsule 250 mg, 500 mg||1|
cephalexin oral suspension reconstituted 125mg/5ml, 250 mg/5ml|||
||1|
|||
cephalexin oral tablet 250 mg, 500 mg||1|
TEFLARO INTRAVENOUS SOLUTIONRECONSTITUTED 400 MG, 600 MG||PA|
||1|
|||
Beta-Lactam, Penicillins|||
amoxicillin oral capsule 250 mg, 500 mg|||
||1|
amoxicillin oral suspension reconstituted 125mg/5ml, 200 mg/5ml, 250 mg/5ml, 400 mg/5ml|||
||1|
|||
amoxicillin oral tablet 500 mg, 875 mg||1|
amoxicillin oral tablet chewable 125 mg, 250 mg||1|
amoxicillin-pot clavulanate er oral tabletextended release 12 hour 1000-62.5 mg|||
||1|
|||
amoxicillin-pot clavulanate oral suspensionreconstituted 200-28.5 mg/5ml, 250-62.5 mg/5ml,400-57 mg/5ml, 600-42.9 mg/5ml|||
||1|
|||
amoxicillin-pot clavulanate oral tablet 250-125mg, 500-125 mg, 875-125 mg|||
||1|
|||
amoxicillin-pot clavulanate oral tablet chewable200-28.5 mg, 400-57 mg|||
||1|
|||
ampicillin oral capsule 500 mg||1|
ampicillin sodium injection solution reconstituted1 gm, 125 mg|||
||1|
|||
ampicillin sodium intravenous solutionreconstituted 1 gm, 10 gm|||
||1|
|||
ampicillin-sulbactam sodium injection solutionreconstituted 1.5 (1-0.5) gm, 3 (2-1) gm|||
||1|
|||
ampicillin-sulbactam sodium intravenous solutionreconstituted 1.5 (1-0.5) gm, 15 (10-5) gm, 3 (2-1)gm|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
BICILLIN L-A INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 1200000UNIT/2ML, 2400000 UNIT/4ML, 600000UNIT/ML|||
||1|
|||
dicloxacillin sodium oral capsule 250 mg, 500 mg||1|
nafcillin sodium in dextrose intravenous solution1 gm/50ml, 2 gm/100ml|||
||1|
|||
nafcillin sodium injection solution reconstituted 1gm, 2 gm|||
||1|
|||
nafcillin sodium intravenous solutionreconstituted 2 gm|||
||1|
|||
penicillin g procaine intramuscular suspension600000 unit/ml|||
||1|
|||
penicillin g sodium injection solutionreconstituted 5000000 unit|||
||1|
|||
penicillin v potassium oral solution reconstituted125 mg/5ml, 250 mg/5ml|||
||1|
|||
penicillin v potassium oral tablet 250 mg, 500 mg||1|
piperacillin sod-tazobactam so intravenoussolution reconstituted 13.5 (12-1.5) gm, 2.25 (2-0.25) gm, 3-0.375 gm, 3.375 (3-0.375) gm, 4-0.5gm, 4.5 (4-0.5) gm, 40.5 (36-4.5) gm|||
||1|
|||
Carbapenems|||
ertapenem sodium injection solution reconstituted1 gm|||
|||
||1|
|||
imipenem-cilastatin intravenous solutionreconstituted 250 mg, 500 mg|||
||1|
|||
meropenem intravenous solution reconstituted 1gm, 500 mg|||
||1|
|||
meropenem-sodium chloride intravenous solutionreconstituted 1 gm/50ml, 500 mg/50ml|||
||1|
|||
Macrolides|||
azithromycin intravenous solution reconstituted500 mg|||
|||
||1|
|||
azithromycin oral packet 1 gm||1|
azithromycin oral suspension reconstituted 100mg/5ml, 200 mg/5ml|||
||1|
|||
azithromycin oral tablet 250 mg, 250 mg (6 pack),500 mg, 500 mg (3 pack), 600 mg|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
clarithromycin er oral tablet extended release 24hour 500 mg|||
||1|
|||
clarithromycin oral suspension reconstituted 125mg/5ml, 250 mg/5ml|||
||1|
|||
clarithromycin oral tablet 250 mg, 500 mg||1|
DIFICID ORAL SUSPENSIONRECONSTITUTED 40 MG/ML||PA|
||1|
|||
DIFICID ORAL TABLET 200 MG||1|PA
ERYTHROCIN LACTOBIONATEINTRAVENOUS SOLUTIONRECONSTITUTED 500 MG|||
||1|
|||
erythrocin stearate oral tablet 250 mg||1|
erythromycin base oral tablet 250 mg, 500 mg||1|
erythromycin ethylsuccinate oral suspensionreconstituted 200 mg/5ml|||
||1|
|||
erythromycin ethylsuccinate oral tablet 400 mg||1|
Quinolones|||
ciprofloxacin hcl oral tablet 100 mg, 250 mg, 500mg, 750 mg|||
|||
||1|
|||
ciprofloxacin in d5w intravenous solution 200mg/100ml|||
||1|
|||
levofloxacin in d5w intravenous solution 500mg/100ml, 750 mg/150ml|||
||1|
|||
levofloxacin intravenous solution 25 mg/ml||1|
levofloxacin oral solution 25 mg/ml||1|
levofloxacin oral tablet 250 mg, 500 mg, 750 mg||1|
moxifloxacin hcl in nacl intravenous solution 400mg/250ml|||
||1|
|||
moxifloxacin hcl intravenous solution 400mg/250ml|||
||1|
|||
moxifloxacin hcl oral tablet 400 mg||1|
ofloxacin oral tablet 300 mg, 400 mg||1|
Sulfonamides|||
sulfacetamide sodium (acne) external lotion 10 %|||
||1|
sulfadiazine oral tablet 500 mg||1|
sulfamethoxazole-trimethoprim oral suspension200-40 mg/5ml|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
sulfamethoxazole-trimethoprim oral tablet 400-80mg, 800-160 mg|||
||1|
|||
Tetracyclines|||
doxy 100 intravenous solution reconstituted 100mg|||
|||
||1|
|||
doxycycline hyclate intravenous solutionreconstituted 100 mg|||
||1|
|||
doxycycline hyclate oral capsule 100 mg, 50 mg||1|
doxycycline hyclate oral tablet 100 mg, 20 mg||1|
doxycycline monohydrate oral capsule 100 mg,50 mg|||
||1|
|||
doxycycline monohydrate oral tablet 100 mg, 150mg, 50 mg, 75 mg|||
||1|
|||
minocycline hcl oral capsule 100 mg, 50 mg, 75mg|||
||1|
|||
minocycline hcl oral tablet 100 mg, 50 mg, 75 mg||1|
tetracycline hcl oral capsule 250 mg, 500 mg||1|
Anticonvulsants - Treatment Of|||
Seizures|||
Anticonvulsants, Other|||
BRIVIACT ORAL SOLUTION 10 MG/ML|||
||1|
BRIVIACT ORAL TABLET 10 MG, 100 MG,25 MG, 50 MG, 75 MG|||
||1|
|||
DIACOMIT ORAL CAPSULE 250 MG, 500 MG||1|PA
DIACOMIT ORAL PACKET 250 MG, 500 MG||1|PA
divalproex sodium er oral tablet extended release24 hour 250 mg, 500 mg|||
||1|
|||
divalproex sodium oral capsule delayed releasesprinkle 125 mg|||
||1|
|||
divalproex sodium oral tablet delayed release 125mg, 250 mg, 500 mg|||
||1|
|||
EPIDIOLEX ORAL SOLUTION 100 MG/ML||1|PA
EPRONTIA ORAL SOLUTION 25 MG/ML||1|PA
felbamate oral suspension 600 mg/5ml||1|
felbamate oral tablet 400 mg, 600 mg||1|
FINTEPLA ORAL SOLUTION 2.2 MG/ML||1|PA
FYCOMPA ORAL SUSPENSION 0.5 MG/ML||1|ST; QL (720 ML per 30 days)
Drug Name||Drug Tier|Requirements/Limits
FYCOMPA ORAL TABLET 10 MG, 12 MG, 2MG, 4 MG, 6 MG, 8 MG||ST; QL (30 EA per 30 days)|
||1|
|||
lamotrigine er oral tablet extended release 24hour 100 mg, 200 mg, 25 mg, 250 mg, 300 mg, 50mg|||
||1|
|||
lamotrigine oral tablet 100 mg, 150 mg, 200 mg,25 mg|||
||1|
|||
lamotrigine oral tablet chewable 25 mg, 5 mg||1|
lamotrigine starter kit-blue oral kit 35 x 25 mg||1|
lamotrigine starter kit-green oral kit 84 x 25 mg& 14x100 mg|||
||1|
|||
lamotrigine starter kit-orange oral kit 42 x 25 mg& 7 x 100 mg|||
||1|
|||
levetiracetam er oral tablet extended release 24hour 500 mg, 750 mg|||
||1|
|||
levetiracetam oral solution 100 mg/ml||1|
levetiracetam oral tablet 1000 mg, 250 mg, 500mg, 750 mg|||
||1|
|||
roweepra oral tablet 500 mg||1|
SPRITAM ORAL TABLET DISINTEGRATINGSOLUBLE 1000 MG, 250 MG, 500 MG||ST; QL (60 EA per 30 days)|
||1|
|||
SPRITAM ORAL TABLET DISINTEGRATINGSOLUBLE 750 MG||ST; QL (120 EA per 30 days)|
||1|
|||
topiramate oral capsule sprinkle 15 mg, 25 mg||1|
topiramate oral tablet 100 mg, 200 mg, 25 mg, 50mg|||
||1|
|||
valproic acid oral capsule 250 mg||1|
valproic acid oral solution 250 mg/5ml||1|
XCOPRI (250 MG DAILY DOSE) ORALTABLET THERAPY PACK 100 & 150 MG||ST|
||1|
|||
XCOPRI (350 MG DAILY DOSE) ORALTABLET THERAPY PACK 150 & 200 MG||ST|
||1|
|||
XCOPRI ORAL TABLET 100 MG, 150 MG,200 MG, 50 MG||ST|
||1|
|||
XCOPRI ORAL TABLET THERAPY PACK 14X 12.5 MG & 14 X 25 MG, 14 X 150 MG & 14X200 MG, 14 X 50 MG & 14 X100 MG||ST|
||1|
|||
Calcium Channel Modifying Agents|||
ethosuximide oral capsule 250 mg|||
|1.0||
Drug Name||Drug Tier|Requirements/Limits
ethosuximide oral solution 250 mg/5ml||1|
methsuximide oral capsule 300 mg||1|
Gamma-Aminobutyric Acid (Gaba)|||
Augmenting Agents|||
clobazam oral suspension 2.5 mg/ml||1|QL (480 ML per 30 days)
clobazam oral tablet 10 mg, 20 mg||1|QL (60 EA per 30 days)
DIASTAT ACUDIAL RECTAL GEL 10 MG, 20MG|||
||1|
|||
DIASTAT PEDIATRIC RECTAL GEL 2.5 MG||1|
diazepam rectal gel 10 mg, 2.5 mg, 20 mg||1|
gabapentin oral capsule 100 mg, 400 mg||1|QL (270 EA per 30 days)
gabapentin oral capsule 300 mg||1|QL (360 EA per 30 days)
gabapentin oral solution 250 mg/5ml, 300 mg/6ml||1|QL (2160 ML per 30 days)
gabapentin oral tablet 600 mg||1|QL (180 EA per 30 days)
gabapentin oral tablet 800 mg||1|QL (120 EA per 30 days)
NAYZILAM NASAL SOLUTION 5 MG/0.1ML||1|PA; QL (10 EA per 30 days)
phenobarbital oral elixir 20 mg/5ml||1|PA
phenobarbital oral tablet 100 mg, 15 mg, 16.2mg, 30 mg, 32.4 mg, 60 mg, 64.8 mg, 97.2 mg||PA|
||1|
|||
pregabalin oral capsule 100 mg, 150 mg, 200 mg,25 mg, 50 mg, 75 mg||QL (90 EA per 30 days)|
||1|
|||
pregabalin oral capsule 225 mg, 300 mg||1|QL (60 EA per 30 days)
pregabalin oral solution 20 mg/ml||1|QL (900 ML per 30 days)
primidone oral tablet 250 mg, 50 mg||1|
SYMPAZAN ORAL FILM 10 MG, 20 MG, 5MG||ST; QL (60 EA per 30 days)|
||1|
|||
tiagabine hcl oral tablet 12 mg, 16 mg, 2 mg, 4mg|||
||1|
|||
VALTOCO 10 MG DOSE NASAL LIQUID 10MG/0.1ML||PA; QL (10 EA per 30 days)|
||1|
|||
VALTOCO 15 MG DOSE NASAL LIQUIDTHERAPY PACK 7.5 MG/0.1ML||PA; QL (10 EA per 30 days)|
||1|
|||
VALTOCO 20 MG DOSE NASAL LIQUIDTHERAPY PACK 10 MG/0.1ML||PA; QL (10 EA per 30 days)|
||1|
|||
VALTOCO 5 MG DOSE NASAL LIQUID 5MG/0.1ML||PA; QL (10 EA per 30 days)|
||1|
|||
vigabatrin oral packet 500 mg||1|PA; QL (180 EA per 30 days)
Drug Name||Drug Tier|Requirements/Limits
vigabatrin oral tablet 500 mg||1|PA; QL (180 EA per 30 days)
ZTALMY ORAL SUSPENSION 50 MG/ML||1|PA
Sodium Channel Agents|||
APTIOM ORAL TABLET 200 MG, 400 MG||QL (30 EA per 30 days)|
||1|
APTIOM ORAL TABLET 600 MG, 800 MG||1|QL (60 EA per 30 days)
carbamazepine er oral capsule extended release12 hour 100 mg, 200 mg, 300 mg|||
||1|
|||
carbamazepine er oral tablet extended release 12hour 100 mg, 200 mg, 400 mg|||
||1|
|||
carbamazepine oral suspension 100 mg/5ml||1|
carbamazepine oral tablet 200 mg||1|
carbamazepine oral tablet chewable 100 mg||1|
DILANTIN ORAL CAPSULE 30 MG||1|
epitol oral tablet 200 mg||1|
lacosamide oral solution 10 mg/ml||1|QL (1200 ML per 30 days)
lacosamide oral tablet 100 mg, 150 mg, 200 mg,50 mg||QL (60 EA per 30 days)|
||1|
|||
oxcarbazepine oral suspension 300 mg/5ml||1|
oxcarbazepine oral tablet 150 mg, 300 mg, 600mg|||
||1|
|||
phenytoin infatabs oral tablet chewable 50 mg||1|
phenytoin oral suspension 100 mg/4ml, 125mg/5ml|||
||1|
|||
phenytoin oral tablet chewable 50 mg||1|
phenytoin sodium extended oral capsule 100 mg,200 mg, 300 mg|||
||1|
|||
rufinamide oral suspension 40 mg/ml||1|PA; QL (2400 ML per 30 days)
rufinamide oral tablet 200 mg, 400 mg||1|PA; QL (240 EA per 30 days)
ZONISADE ORAL SUSPENSION 100MG/5ML||ST|
||1|
|||
zonisamide oral capsule 100 mg, 25 mg, 50 mg||1|
Antidementia Agents - Management Of|||
Dementia|||
Cholinesterase Inhibitors|||
donepezil hcl oral tablet 10 mg, 23 mg, 5 mg|||
||1|
donepezil hcl oral tablet dispersible 10 mg, 5 mg||1|
Drug Name||Drug Tier|Requirements/Limits
galantamine hydrobromide er oral capsuleextended release 24 hour 16 mg, 24 mg, 8 mg|||
||1|
|||
galantamine hydrobromide oral tablet 12 mg, 4mg, 8 mg|||
||1|
|||
rivastigmine tartrate oral capsule 1.5 mg, 3 mg,4.5 mg, 6 mg|||
||1|
|||
rivastigmine transdermal patch 24 hour 13.3mg/24hr, 4.6 mg/24hr, 9.5 mg/24hr||ST|
||1|
|||
N-Methyl-D-Aspartate (Nmda)|||
Receptor Antagonist|||
memantine hcl er oral capsule extended release24 hour 14 mg, 21 mg, 28 mg, 7 mg||QL (30 EA per 30 days)|
||1|
|||
memantine hcl oral tablet 10 mg, 28 x 5 mg & 21x 10 mg, 5 mg|||
||1|
|||
Antidepressants - Treatment Of|||
Depression|||
Antidepressants, Other|||
AUVELITY ORAL TABLET EXTENDEDRELEASE 45-105 MG||PA|
|||
||1|
|||
bupropion hcl er (sr) oral tablet extended release12 hour 100 mg, 150 mg, 200 mg|||
||1|
|||
bupropion hcl er (xl) oral tablet extended release24 hour 150 mg, 300 mg, 450 mg|||
||1|
|||
bupropion hcl oral tablet 100 mg, 75 mg||1|
mirtazapine oral tablet 15 mg, 30 mg, 45 mg, 7.5mg|||
||1|
|||
mirtazapine oral tablet dispersible 15 mg, 30 mg,45 mg|||
||1|
|||
perphenazine-amitriptyline oral tablet 2-10 mg,2-25 mg, 4-10 mg, 4-25 mg, 4-50 mg||PA|
||1|
|||
Monoamine Oxidase Inhibitors|||
EMSAM TRANSDERMAL PATCH 24 HOUR12 MG/24HR, 6 MG/24HR, 9 MG/24HR||PA|
|||
||1|
|||
MARPLAN ORAL TABLET 10 MG||1|
phenelzine sulfate oral tablet 15 mg||1|
tranylcypromine sulfate oral tablet 10 mg||1|
Drug Name||Drug Tier|Requirements/Limits
Ssri/Snri (Selective Serotonin Reuptake|||
Inhibitor/Serotonin And|||
Norepinephrine Reuptake Inhibitor)|||
citalopram hydrobromide oral solution 10mg/5ml|||
||1|
|||
citalopram hydrobromide oral tablet 10 mg, 20mg, 40 mg|||
||1|
|||
desvenlafaxine succinate er oral tablet extendedrelease 24 hour 100 mg, 25 mg, 50 mg|||
||1|
|||
escitalopram oxalate oral solution 5 mg/5ml||1|
escitalopram oxalate oral tablet 10 mg, 20 mg, 5mg|||
||1|
|||
FETZIMA ORAL CAPSULE EXTENDEDRELEASE 24 HOUR 120 MG, 20 MG, 40 MG,80 MG||ST|
||1|
|||
FETZIMA TITRATION ORAL CAPSULE ER24 HOUR THERAPY PACK 20 & 40 MG||ST|
||1|
|||
fluoxetine hcl oral capsule 10 mg, 20 mg, 40 mg||1|
fluoxetine hcl oral capsule delayed release 90 mg||1|
fluoxetine hcl oral solution 20 mg/5ml||1|
fluoxetine hcl oral tablet 10 mg, 20 mg||1|
fluvoxamine maleate oral tablet 100 mg, 25 mg,50 mg|||
||1|
|||
nefazodone hcl oral tablet 100 mg, 150 mg, 200mg, 250 mg, 50 mg|||
||1|
|||
paroxetine hcl er oral tablet extended release 24hour 12.5 mg, 25 mg, 37.5 mg|||
||1|
|||
paroxetine hcl oral suspension 10 mg/5ml||1|
paroxetine hcl oral tablet 10 mg, 20 mg, 30 mg,40 mg|||
||1|
|||
sertraline hcl oral concentrate 20 mg/ml||1|
sertraline hcl oral tablet 100 mg, 25 mg, 50 mg||1|
trazodone hcl oral tablet 100 mg, 150 mg, 300mg, 50 mg|||
||1|
|||
TRINTELLIX ORAL TABLET 10 MG, 20 MG,5 MG|||
||1|
|||
venlafaxine hcl er oral capsule extended release24 hour 150 mg, 37.5 mg, 75 mg|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
venlafaxine hcl er oral tablet extended release 24hour 150 mg, 225 mg, 37.5 mg, 75 mg|||
||1|
|||
venlafaxine hcl oral tablet 100 mg, 25 mg, 37.5mg, 50 mg, 75 mg|||
||1|
|||
VIIBRYD STARTER PACK ORAL KIT 10 &20 MG|||
||1|
|||
vilazodone hcl oral tablet 10 mg, 20 mg, 40 mg||1|
Tricyclics|||
amitriptyline hcl oral tablet 10 mg, 100 mg, 150mg, 25 mg, 50 mg, 75 mg||PA|
|||
||1|
|||
amoxapine oral tablet 100 mg, 150 mg, 25 mg, 50mg||PA|
||1|
|||
clomipramine hcl oral capsule 25 mg, 50 mg, 75mg||PA|
||1|
|||
desipramine hcl oral tablet 10 mg, 100 mg, 150mg, 25 mg, 50 mg, 75 mg|||
||1|
|||
doxepin hcl oral capsule 10 mg, 100 mg, 150 mg,25 mg, 50 mg, 75 mg||PA|
||1|
|||
doxepin hcl oral concentrate 10 mg/ml||1|PA
imipramine hcl oral tablet 10 mg, 25 mg, 50 mg||1|PA
imipramine pamoate oral capsule 100 mg, 125mg, 150 mg, 75 mg||PA|
||1|
|||
nortriptyline hcl oral capsule 10 mg, 25 mg, 50mg, 75 mg|||
||1|
|||
nortriptyline hcl oral solution 10 mg/5ml||1|
protriptyline hcl oral tablet 10 mg, 5 mg||1|PA
trimipramine maleate oral capsule 100 mg, 25mg, 50 mg||PA|
||1|
|||
Antiemetics - Treatment Of Vomiting|||
Or Nausea|||
Antiemetics, Other|||
chlorpromazine hcl oral concentrate 100 mg/ml,30 mg/ml|||
|||
||1|
|||
chlorpromazine hcl oral tablet 10 mg, 100 mg,200 mg, 25 mg, 50 mg|||
||1|
|||
meclizine hcl oral tablet 12.5 mg, 25 mg||1|
metoclopramide hcl oral solution 10 mg/10ml, 5mg/5ml|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
metoclopramide hcl oral tablet 10 mg, 5 mg||1|
perphenazine oral tablet 16 mg, 2 mg, 4 mg, 8 mg||1|
prochlorperazine maleate oral tablet 10 mg, 5 mg||1|
prochlorperazine rectal suppository 25 mg||1|
promethazine hcl oral syrup 6.25 mg/5ml||1|PA
promethazine hcl oral tablet 12.5 mg, 25 mg, 50mg||PA|
||1|
|||
promethazine hcl rectal suppository 12.5 mg, 25mg||PA|
||1|
|||
promethegan rectal suppository 50 mg||1|PA
scopolamine transdermal patch 72 hour 1mg/3days|||
||1|
|||
trimethobenzamide hcl oral capsule 300 mg||1|
Emetogenic Therapy Adjuncts|||
aprepitant oral 80 & 125 mg||B/D|
||1|
aprepitant oral capsule 125 mg, 40 mg, 80 & 125mg, 80 mg||B/D|
||1|
|||
dronabinol oral capsule 10 mg, 2.5 mg, 5 mg||1|B/D
EMEND ORAL SUSPENSIONRECONSTITUTED 125 MG/5ML||B/D|
||1|
|||
granisetron hcl oral tablet 1 mg||1|B/D
ondansetron hcl oral solution 4 mg/5ml||1|B/D
ondansetron hcl oral tablet 4 mg, 8 mg||1|B/D
ondansetron oral tablet dispersible 4 mg, 8 mg||1|B/D
Antifungals - Treatment Of Fungal Or|||
Yeast Infections|||
Antifungals|||
ABELCET INTRAVENOUS SUSPENSION 5MG/ML||B/D|
|||
||1|
|||
amphotericin b intravenous solution reconstituted50 mg||B/D|
||1|
|||
amphotericin b liposome intravenous suspensionreconstituted 50 mg||B/D|
||1|
|||
caspofungin acetate intravenous solutionreconstituted 50 mg, 70 mg||PA|
||1|
|||
clotrimazole external cream 1 %||1|
clotrimazole external solution 1 %||1|
Drug Name||Drug Tier|Requirements/Limits
clotrimazole mouth/throat troche 10 mg||1|
econazole nitrate external cream 1 %||1|
fluconazole in sodium chloride intravenoussolution 200-0.9 mg/100ml-%, 400-0.9 mg/200ml-%|||
||1|
|||
fluconazole oral suspension reconstituted 10mg/ml, 40 mg/ml|||
||1|
|||
fluconazole oral tablet 100 mg, 150 mg, 200 mg,50 mg|||
||1|
|||
flucytosine oral capsule 250 mg, 500 mg||1|PA
griseofulvin microsize oral suspension 125mg/5ml|||
||1|
|||
itraconazole oral capsule 100 mg||1|
itraconazole oral solution 10 mg/ml||1|
ketoconazole external cream 2 %||1|
ketoconazole external shampoo 2 %||1|
ketoconazole oral tablet 200 mg||1|
micafungin sodium intravenous solutionreconstituted 100 mg, 50 mg|||
||1|
|||
nystatin external cream 100000 unit/gm||1|
nystatin external ointment 100000 unit/gm||1|
nystatin external powder 100000 unit/gm||1|
nystatin mouth/throat suspension 100000 unit/ml||1|
nystatin oral tablet 500000 unit||1|
posaconazole oral suspension 40 mg/ml||1|PA
posaconazole oral tablet delayed release 100 mg||1|PA
terbinafine hcl oral tablet 250 mg||1|
terconazole vaginal cream 0.4 %, 0.8 %||1|
terconazole vaginal suppository 80 mg||1|
voriconazole intravenous solution reconstituted200 mg||PA|
||1|
|||
voriconazole oral suspension reconstituted 40mg/ml|||
||1|
|||
voriconazole oral tablet 200 mg, 50 mg||1|
Antigout Agents - Treatment Or|||
Prevention Of Gouty Arthritis|||
Antigout Agents|||
Drug Name||Drug Tier|Requirements/Limits
allopurinol oral tablet 100 mg, 300 mg||1|
colchicine oral capsule 0.6 mg||1|
colchicine oral tablet 0.6 mg||1|
colchicine-probenecid oral tablet 0.5-500 mg||1|
febuxostat oral tablet 40 mg, 80 mg||1|ST
probenecid oral tablet 500 mg||1|
Antimigraine Agents - Treatment Of|||
Migraine Headaches|||
Antimigraine Agents|||
NURTEC ORAL TABLET DISPERSIBLE 75MG||PA; QL (18 EA per 30 days)|
|||
||1|
|||
UBRELVY ORAL TABLET 100 MG, 50 MG||1|PA; QL (16 EA per 30 days)
ZAVZPRET NASAL SOLUTION 10 MG/ACT||1|PA; QL (8 EA per 30 days)
Ergot Alkaloids|||
dihydroergotamine mesylate nasal solution 4mg/ml||QL (8 ML per 30 days)|
|||
||1|
|||
ergotamine-caffeine oral tablet 1-100 mg||1|
Prophylactic|||
AIMOVIG SUBCUTANEOUS SOLUTIONAUTO-INJECTOR 140 MG/ML, 70 MG/ML||PA|
|||
||1|
|||
EMGALITY (300 MG DOSE)SUBCUTANEOUS SOLUTION PREFILLEDSYRINGE 100 MG/ML||PA|
||1|
|||
EMGALITY SUBCUTANEOUS SOLUTIONAUTO-INJECTOR 120 MG/ML||PA|
||1|
|||
EMGALITY SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 120 MG/ML||PA|
||1|
|||
Serotonin (5-Ht) Receptor Agonist|||
rizatriptan benzoate oral tablet 10 mg, 5 mg||QL (12 EA per 30 days)|
||1|
rizatriptan benzoate oral tablet dispersible 10 mg,5 mg||QL (12 EA per 30 days)|
||1|
|||
sumatriptan nasal solution 20 mg/act, 5 mg/act||1|QL (12 EA per 30 days)
sumatriptan succinate oral tablet 100 mg, 25 mg,50 mg||QL (9 EA per 30 days)|
||1|
|||
sumatriptan succinate refill subcutaneoussolution cartridge 4 mg/0.5ml, 6 mg/0.5ml||QL (4 ML per 30 days)|
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
sumatriptan succinate subcutaneous solution 6mg/0.5ml||QL (4 ML per 30 days)|
||1|
|||
sumatriptan succinate subcutaneous solutionauto-injector 4 mg/0.5ml, 6 mg/0.5ml||QL (4 ML per 30 days)|
||1|
|||
Antimyasthenic Agents - Treatment Of|||
Myasthenia|||
Parasympathomimetics|||
pyridostigmine bromide er oral tablet extendedrelease 180 mg|||
|||
||1|
|||
pyridostigmine bromide oral tablet 60 mg||1|
Antimycobacterials - Treatment For|||
Infections By Tuberculosis-Type|||
Organisms|||
Antimycobacterials, Other|||
dapsone oral tablet 100 mg, 25 mg|||
||1|
rifabutin oral capsule 150 mg||1|
Antituberculars|||
ethambutol hcl oral tablet 100 mg, 400 mg|||
||1|
isoniazid oral tablet 100 mg, 300 mg||1|
PRETOMANID ORAL TABLET 200 MG||1|PA
PRIFTIN ORAL TABLET 150 MG||1|
pyrazinamide oral tablet 500 mg||1|
rifampin intravenous solution reconstituted 600mg|||
||1|
|||
rifampin oral capsule 150 mg, 300 mg||1|
SIRTURO ORAL TABLET 100 MG, 20 MG||1|PA
TRECATOR ORAL TABLET 250 MG||1|
Antineoplastics - Treatment Of Cancer|||
|||
Alkylating Agents|||
cyclophosphamide oral capsule 25 mg, 50 mg||B/D|
||1|
cyclophosphamide oral tablet 25 mg, 50 mg||1|B/D
GLEOSTINE ORAL CAPSULE 10 MG, 100MG, 40 MG|||
||1|
|||
LEUKERAN ORAL TABLET 2 MG||1|
MATULANE ORAL CAPSULE 50 MG||1|
VALCHLOR EXTERNAL GEL 0.016 %||1|PA
Drug Name||Drug Tier|Requirements/Limits
Antiandrogens|||
abiraterone acetate oral tablet 250 mg, 500 mg||PA|
||1|
bicalutamide oral tablet 50 mg||1|
ERLEADA ORAL TABLET 240 MG, 60 MG||1|PA
nilutamide oral tablet 150 mg||1|PA
NUBEQA ORAL TABLET 300 MG||1|PA
XTANDI ORAL CAPSULE 40 MG||1|PA
XTANDI ORAL TABLET 40 MG, 80 MG||1|PA
YONSA ORAL TABLET 125 MG||1|PA
Antiangiogenic Agents|||
lenalidomide oral capsule 10 mg, 15 mg, 2.5 mg,20 mg, 25 mg, 5 mg||PA|
|||
||1|
|||
POMALYST ORAL CAPSULE 1 MG, 2 MG, 3MG, 4 MG||PA|
||1|
|||
REVLIMID ORAL CAPSULE 10 MG, 15 MG,2.5 MG, 20 MG, 25 MG, 5 MG||PA|
||1|
|||
THALOMID ORAL CAPSULE 100 MG, 150MG, 200 MG, 50 MG||PA|
||1|
|||
Antiestrogens/Modifiers|||
EMCYT ORAL CAPSULE 140 MG|||
||1|
SOLTAMOX ORAL SOLUTION 10 MG/5ML||1|PA
tamoxifen citrate oral tablet 10 mg, 20 mg||1|
toremifene citrate oral tablet 60 mg||1|PA
Antimetabolites|||
DROXIA ORAL CAPSULE 200 MG, 300 MG,400 MG|||
|||
||1|
|||
hydroxyurea oral capsule 500 mg||1|
INQOVI ORAL TABLET 35-100 MG||1|PA
mercaptopurine oral tablet 50 mg||1|
ONUREG ORAL TABLET 200 MG, 300 MG||1|PA
PURIXAN ORAL SUSPENSION 2000MG/100ML||PA|
||1|
|||
TABLOID ORAL TABLET 40 MG||1|PA
Antineoplastics, Other|||
BESREMI SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 500 MCG/ML||PA|
|||
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
IDHIFA ORAL TABLET 100 MG, 50 MG|1|PA|
KISQALI FEMARA (200 MG DOSE) ORALTABLET THERAPY PACK 200 & 2.5 MG||PA|
|1||
|||
KISQALI FEMARA (400 MG DOSE) ORALTABLET THERAPY PACK 200 & 2.5 MG||PA|
|1||
|||
KISQALI FEMARA (600 MG DOSE) ORALTABLET THERAPY PACK 200 & 2.5 MG||PA|
|1||
|||
KRAZATI ORAL TABLET 200 MG|1|PA|
LONSURF ORAL TABLET 15-6.14 MG, 20-8.19 MG||PA|
|1||
|||
LUMAKRAS ORAL TABLET 120 MG, 320 MG|1|PA|
LYSODREN ORAL TABLET 500 MG|1||
NINLARO ORAL CAPSULE 2.3 MG, 3 MG, 4MG||PA|
|1||
|||
ORSERDU ORAL TABLET 345 MG, 86 MG|1|PA|
REZLIDHIA ORAL CAPSULE 150 MG|1|PA|
RYLAZE INTRAMUSCULAR SOLUTION 10MG/0.5ML||PA|
|1||
|||
SYNRIBO SUBCUTANEOUS SOLUTIONRECONSTITUTED 3.5 MG||PA|
|1||
|||
TIBSOVO ORAL TABLET 250 MG|1|PA|
TICE BCG INTRAVESICAL SUSPENSIONRECONSTITUTED 50 MG|||
|1||
|||
WELIREG ORAL TABLET 40 MG|1|PA|
XATMEP ORAL SOLUTION 2.5 MG/ML|1|PA|
XPOVIO (100 MG ONCE WEEKLY) ORALTABLET THERAPY PACK 20 MG, 50 MG||PA|
|1||
|||
XPOVIO (40 MG ONCE WEEKLY) ORALTABLET THERAPY PACK 20 MG, 40 MG||PA|
|1||
|||
XPOVIO (40 MG TWICE WEEKLY) ORALTABLET THERAPY PACK 20 MG, 40 MG||PA|
|1||
|||
XPOVIO (60 MG ONCE WEEKLY) ORALTABLET THERAPY PACK 20 MG, 60 MG||PA|
|1||
|||
XPOVIO (60 MG TWICE WEEKLY) ORALTABLET THERAPY PACK 20 MG||PA|
|1||
|||
XPOVIO (80 MG ONCE WEEKLY) ORALTABLET THERAPY PACK 20 MG, 40 MG||PA|
|1||
|||
XPOVIO (80 MG TWICE WEEKLY) ORALTABLET THERAPY PACK 20 MG||PA|
1|||
|||
Drug Name||Drug Tier|Requirements/Limits
ZOLINZA ORAL CAPSULE 100 MG||1|PA
Aromatase Inhibitors, 3Rd Generation|||
anastrozole oral tablet 1 mg|||
||1|
exemestane oral tablet 25 mg||1|
letrozole oral tablet 2.5 mg||1|
Molecular Target Inhibitors|||
ALECENSA ORAL CAPSULE 150 MG||PA|
||1|
ALUNBRIG ORAL TABLET 180 MG, 30 MG,90 MG||PA|
||1|
|||
ALUNBRIG ORAL TABLET THERAPY PACK90 & 180 MG||PA|
||1|
|||
AYVAKIT ORAL TABLET 100 MG, 200 MG,25 MG, 300 MG, 50 MG||PA|
||1|
|||
BALVERSA ORAL TABLET 3 MG, 4 MG, 5MG||PA|
||1|
|||
BOSULIF ORAL TABLET 100 MG, 400 MG,500 MG||PA|
||1|
|||
BRAFTOVI ORAL CAPSULE 75 MG||1|PA
BRUKINSA ORAL CAPSULE 80 MG||1|PA
CABOMETYX ORAL TABLET 20 MG, 40 MG,60 MG||PA|
||1|
|||
CALQUENCE ORAL CAPSULE 100 MG||1|PA
CALQUENCE ORAL TABLET 100 MG||1|PA
CAPRELSA ORAL TABLET 100 MG, 300 MG||1|PA
COMETRIQ (100 MG DAILY DOSE) ORALKIT 80 & 20 MG||PA|
||1|
|||
COMETRIQ (140 MG DAILY DOSE) ORALKIT 3 X 20 MG & 80 MG||PA|
||1|
|||
COMETRIQ (60 MG DAILY DOSE) ORAL KIT20 MG||PA|
||1|
|||
COPIKTRA ORAL CAPSULE 15 MG, 25 MG||1|PA
COTELLIC ORAL TABLET 20 MG||1|PA
DAURISMO ORAL TABLET 100 MG, 25 MG||1|PA
ERIVEDGE ORAL CAPSULE 150 MG||1|PA
erlotinib hcl oral tablet 100 mg, 150 mg, 25 mg||1|PA
everolimus oral tablet 10 mg, 2.5 mg, 5 mg, 7.5mg||PA|
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
everolimus oral tablet soluble 2 mg, 3 mg, 5 mg|1|PA|
EXKIVITY ORAL CAPSULE 40 MG|1|PA|
FOTIVDA ORAL CAPSULE 0.89 MG, 1.34 MG|1|PA|
GAVRETO ORAL CAPSULE 100 MG|1|PA|
gefitinib oral tablet 250 mg|1|PA|
GILOTRIF ORAL TABLET 20 MG, 30 MG, 40MG||PA|
|1||
|||
IBRANCE ORAL CAPSULE 100 MG, 125 MG,75 MG||PA|
|1||
|||
IBRANCE ORAL TABLET 100 MG, 125 MG,75 MG||PA|
|1||
|||
ICLUSIG ORAL TABLET 10 MG, 15 MG, 30MG, 45 MG||PA|
|1||
|||
imatinib mesylate oral tablet 100 mg, 400 mg|1|PA|
IMBRUVICA ORAL CAPSULE 140 MG, 70MG||PA|
|1||
|||
IMBRUVICA ORAL SUSPENSION 70 MG/ML|1|PA|
IMBRUVICA ORAL TABLET 140 MG, 280MG, 420 MG, 560 MG||PA|
|1||
|||
INLYTA ORAL TABLET 1 MG, 5 MG|1|PA|
INREBIC ORAL CAPSULE 100 MG|1|PA|
JAKAFI ORAL TABLET 10 MG, 15 MG, 20MG, 25 MG, 5 MG||PA|
|1||
|||
JAYPIRCA ORAL TABLET 100 MG, 50 MG|1|PA|
KISQALI (200 MG DOSE) ORAL TABLETTHERAPY PACK 200 MG||PA|
|1||
|||
KISQALI (400 MG DOSE) ORAL TABLETTHERAPY PACK 200 MG||PA|
|1||
|||
KISQALI (600 MG DOSE) ORAL TABLETTHERAPY PACK 200 MG||PA|
|1||
|||
KOSELUGO ORAL CAPSULE 10 MG, 25 MG|1|PA|
lapatinib ditosylate oral tablet 250 mg|1|PA|
LENVIMA (10 MG DAILY DOSE) ORALCAPSULE THERAPY PACK 10 MG||PA|
|1||
|||
LENVIMA (12 MG DAILY DOSE) ORALCAPSULE THERAPY PACK 3 X 4 MG||PA|
|1||
|||
LENVIMA (14 MG DAILY DOSE) ORALCAPSULE THERAPY PACK 10 & 4 MG||PA|
1|||
|||
Drug Name|Drug Tier|Requirements/Limits|
LENVIMA (18 MG DAILY DOSE) ORALCAPSULE THERAPY PACK 10 MG & 2 X 4MG||PA|
|1||
|||
LENVIMA (20 MG DAILY DOSE) ORALCAPSULE THERAPY PACK 2 X 10 MG||PA|
|1||
|||
LENVIMA (24 MG DAILY DOSE) ORALCAPSULE THERAPY PACK 2 X 10 MG & 4MG||PA|
|1||
|||
LENVIMA (4 MG DAILY DOSE) ORALCAPSULE THERAPY PACK 4 MG||PA|
|1||
|||
LENVIMA (8 MG DAILY DOSE) ORALCAPSULE THERAPY PACK 2 X 4 MG||PA|
|1||
|||
LORBRENA ORAL TABLET 100 MG, 25 MG|1|PA|
LYNPARZA ORAL TABLET 100 MG, 150 MG|1|PA|
LYTGOBI (12 MG DAILY DOSE) ORALTABLET THERAPY PACK 4 MG||PA|
|1||
|||
LYTGOBI (16 MG DAILY DOSE) ORALTABLET THERAPY PACK 4 MG||PA|
|1||
|||
LYTGOBI (20 MG DAILY DOSE) ORALTABLET THERAPY PACK 4 MG||PA|
|1||
|||
MEKINIST ORAL SOLUTIONRECONSTITUTED 0.05 MG/ML||PA|
|1||
|||
MEKINIST ORAL TABLET 0.5 MG, 2 MG|1|PA|
MEKTOVI ORAL TABLET 15 MG|1|PA|
NERLYNX ORAL TABLET 40 MG|1|PA|
ODOMZO ORAL CAPSULE 200 MG|1|PA|
PEMAZYRE ORAL TABLET 13.5 MG, 4.5 MG,9 MG||PA|
|1||
|||
PIQRAY (200 MG DAILY DOSE) ORALTABLET THERAPY PACK 200 MG||PA|
|1||
|||
PIQRAY (250 MG DAILY DOSE) ORALTABLET THERAPY PACK 200 & 50 MG||PA|
|1||
|||
PIQRAY (300 MG DAILY DOSE) ORALTABLET THERAPY PACK 2 X 150 MG||PA|
|1||
|||
QINLOCK ORAL TABLET 50 MG|1|PA|
RETEVMO ORAL CAPSULE 40 MG, 80 MG|1|PA|
ROZLYTREK ORAL CAPSULE 100 MG, 200MG||PA|
1|||
|||
Drug Name|Drug Tier|Requirements/Limits|
RUBRACA ORAL TABLET 200 MG, 250 MG,300 MG||PA|
|1||
|||
RYDAPT ORAL CAPSULE 25 MG|1|PA|
SCEMBLIX ORAL TABLET 20 MG, 40 MG|1|PA|
sorafenib tosylate oral tablet 200 mg|1|PA|
SPRYCEL ORAL TABLET 100 MG, 140 MG,20 MG, 50 MG, 70 MG, 80 MG||PA|
|1||
|||
STIVARGA ORAL TABLET 40 MG|1|PA|
sunitinib malate oral capsule 12.5 mg, 25 mg,37.5 mg, 50 mg||PA|
|1||
|||
TABRECTA ORAL TABLET 150 MG, 200 MG|1|PA|
TAFINLAR ORAL CAPSULE 50 MG, 75 MG|1|PA|
TAFINLAR ORAL TABLET SOLUBLE 10 MG|1|PA|
TAGRISSO ORAL TABLET 40 MG, 80 MG|1|PA|
TALZENNA ORAL CAPSULE 0.1 MG, 0.25MG, 0.35 MG, 0.5 MG, 0.75 MG, 1 MG||PA|
|1||
|||
TASIGNA ORAL CAPSULE 150 MG, 200 MG,50 MG||PA|
|1||
|||
TAZVERIK ORAL TABLET 200 MG|1|PA|
TEPMETKO ORAL TABLET 225 MG|1|PA|
TRUSELTIQ (100MG DAILY DOSE) ORALCAPSULE THERAPY PACK 100 MG||PA|
|1||
|||
TRUSELTIQ (125MG DAILY DOSE) ORALCAPSULE THERAPY PACK 100 & 25 MG||PA|
|1||
|||
TRUSELTIQ (50MG DAILY DOSE) ORALCAPSULE THERAPY PACK 25 MG||PA|
|1||
|||
TRUSELTIQ (75MG DAILY DOSE) ORALCAPSULE THERAPY PACK 25 MG||PA|
|1||
|||
TUKYSA ORAL TABLET 150 MG, 50 MG|1|PA|
TURALIO ORAL CAPSULE 125 MG, 200 MG|1|PA|
VENCLEXTA ORAL TABLET 10 MG, 100MG, 50 MG||PA|
|1||
|||
VENCLEXTA STARTING PACK ORALTABLET THERAPY PACK 10 & 50 & 100 MG||PA|
|1||
|||
VERZENIO ORAL TABLET 100 MG, 150 MG,200 MG, 50 MG||PA|
|1||
|||
VIJOICE ORAL TABLET THERAPY PACK125 MG, 200 & 50 MG, 50 MG||PA|
1|||
|||
Drug Name||Drug Tier|Requirements/Limits
VITRAKVI ORAL CAPSULE 100 MG, 25 MG||1|PA
VITRAKVI ORAL SOLUTION 20 MG/ML||1|PA
VIZIMPRO ORAL TABLET 15 MG, 30 MG, 45MG||PA|
||1|
|||
VONJO ORAL CAPSULE 100 MG||1|PA
VOTRIENT ORAL TABLET 200 MG||1|PA
XALKORI ORAL CAPSULE 200 MG, 250 MG||1|PA
XOSPATA ORAL TABLET 40 MG||1|PA
ZEJULA ORAL CAPSULE 100 MG||1|PA
ZEJULA ORAL TABLET 100 MG, 200 MG,300 MG||PA|
||1|
|||
ZELBORAF ORAL TABLET 240 MG||1|PA
ZYDELIG ORAL TABLET 100 MG, 150 MG||1|PA
ZYKADIA ORAL TABLET 150 MG||1|PA
Retinoids|||
bexarotene external gel 1 %||PA|
||1|
bexarotene oral capsule 75 mg||1|PA
PANRETIN EXTERNAL GEL 0.1 %||1|PA
tretinoin oral capsule 10 mg||1|PA
Treatment Adjuncts|||
leucovorin calcium oral tablet 10 mg, 15 mg, 25mg, 5 mg|||
|||
||1|
|||
MESNEX ORAL TABLET 400 MG||1|
Antiparasitics - Treatment Of Infections|||
From Parasites|||
Anthelmintics|||
albendazole oral tablet 200 mg|||
||1|
ivermectin oral tablet 3 mg||1|
praziquantel oral tablet 600 mg||1|
Antiprotozoals|||
atovaquone oral suspension 750 mg/5ml|||
||1|
atovaquone-proguanil hcl oral tablet 250-100 mg,62.5-25 mg|||
||1|
|||
chloroquine phosphate oral tablet 250 mg, 500mg|||
||1|
|||
COARTEM ORAL TABLET 20-120 MG||1|
Drug Name||Drug Tier|Requirements/Limits
hydroxychloroquine sulfate oral tablet 100 mg,200 mg, 300 mg, 400 mg|||
||1|
|||
mefloquine hcl oral tablet 250 mg||1|
nitazoxanide oral tablet 500 mg||1|
pentamidine isethionate inhalation solutionreconstituted 300 mg||B/D|
||1|
|||
pentamidine isethionate injection solutionreconstituted 300 mg||PA|
||1|
|||
primaquine phosphate oral tablet 26.3 (15 base)mg|||
||1|
|||
pyrimethamine oral tablet 25 mg||1|QL (90 EA per 30 days)
quinine sulfate oral capsule 324 mg||1|
Antiparkinson Agents - Treatment Of|||
Parkinson's Disease|||
Anticholinergics|||
benztropine mesylate oral tablet 0.5 mg, 1 mg, 2mg|||
|||
||1|
|||
trihexyphenidyl hcl oral solution 0.4 mg/ml||1|PA
trihexyphenidyl hcl oral tablet 2 mg, 5 mg||1|PA
Antiparkinson Agents, Other|||
amantadine hcl oral capsule 100 mg|||
||1|
amantadine hcl oral solution 50 mg/5ml||1|
amantadine hcl oral tablet 100 mg||1|
carbidopa-levodopa-entacapone oral tablet 12.5-50-200 mg, 18.75-75-200 mg, 25-100-200 mg,31.25-125-200 mg, 37.5-150-200 mg, 50-200-200mg|||
||1|
|||
entacapone oral tablet 200 mg||1|
GOCOVRI ORAL CAPSULE EXTENDEDRELEASE 24 HOUR 137 MG, 68.5 MG||PA|
||1|
|||
ONGENTYS ORAL CAPSULE 25 MG, 50 MG||1|ST
Dopamine Agonists|||
apomorphine hcl subcutaneous solution cartridge30 mg/3ml||PA|
|||
||1|
|||
bromocriptine mesylate oral capsule 5 mg||1|
bromocriptine mesylate oral tablet 2.5 mg||1|
Drug Name||Drug Tier|Requirements/Limits
NEUPRO TRANSDERMAL PATCH 24 HOUR1 MG/24HR, 2 MG/24HR, 3 MG/24HR, 4MG/24HR, 6 MG/24HR, 8 MG/24HR|||
||1|
|||
pramipexole dihydrochloride er oral tabletextended release 24 hour 0.375 mg, 0.75 mg, 1.5mg, 2.25 mg, 3 mg, 3.75 mg, 4.5 mg|||
||1|
|||
pramipexole dihydrochloride oral tablet 0.125mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg|||
||1|
|||
ropinirole hcl er oral tablet extended release 24hour 12 mg, 2 mg, 4 mg, 6 mg, 8 mg|||
||1|
|||
ropinirole hcl oral tablet 0.25 mg, 0.5 mg, 1 mg, 2mg, 3 mg, 4 mg, 5 mg|||
||1|
|||
Dopamine Precursors And/Or L-Amino|||
Acid Decarboxylase Inhibitors|||
carbidopa oral tablet 25 mg||1|
carbidopa-levodopa er oral tablet extendedrelease 25-100 mg, 50-200 mg|||
||1|
|||
carbidopa-levodopa oral tablet 10-100 mg, 25-100 mg, 25-250 mg|||
||1|
|||
carbidopa-levodopa oral tablet dispersible 10-100 mg, 25-100 mg, 25-250 mg|||
||1|
|||
Monoamine Oxidase B (Mao-B)|||
Inhibitors|||
rasagiline mesylate oral tablet 0.5 mg, 1 mg||1|
selegiline hcl oral capsule 5 mg||1|
selegiline hcl oral tablet 5 mg||1|
Antipsychotics - Treatment Of|||
Behavioral And Emotional Disorders|||
1St Generation/Typical|||
fluphenazine decanoate injection solution 25mg/ml|||
|||
||1|
|||
fluphenazine hcl injection solution 2.5 mg/ml||1|
fluphenazine hcl oral concentrate 5 mg/ml||1|
fluphenazine hcl oral elixir 2.5 mg/5ml||1|
fluphenazine hcl oral tablet 1 mg, 10 mg, 2.5 mg,5 mg|||
||1|
|||
haloperidol decanoate intramuscular solution 100mg/ml, 100 mg/ml 1 ml, 50 mg/ml, 50 mg/ml(1ml)|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
haloperidol lactate injection solution 5 mg/ml||1|
haloperidol lactate oral concentrate 2 mg/ml||1|
haloperidol oral tablet 0.5 mg, 1 mg, 10 mg, 2mg, 20 mg, 5 mg|||
||1|
|||
loxapine succinate oral capsule 10 mg, 25 mg, 5mg, 50 mg|||
||1|
|||
molindone hcl oral tablet 10 mg, 25 mg, 5 mg||1|
pimozide oral tablet 1 mg, 2 mg||1|
thioridazine hcl oral tablet 10 mg, 100 mg, 25 mg,50 mg|||
||1|
|||
thiothixene oral capsule 1 mg, 10 mg, 2 mg, 5 mg||1|
trifluoperazine hcl oral tablet 1 mg, 10 mg, 2 mg,5 mg|||
||1|
|||
2Nd Generation/Atypical|||
ABILIFY ASIMTUFII INTRAMUSCULARPREFILLED SYRINGE 720 MG/2.4ML, 960MG/3.2ML||PA|
|||
||1|
|||
ABILIFY MAINTENA INTRAMUSCULARPREFILLED SYRINGE 300 MG, 400 MG||QL (1 EA per 28 days)|
||1|
|||
ABILIFY MAINTENA INTRAMUSCULARSUSPENSION RECONSTITUTED ER 300 MG,400 MG||QL (1 EA per 28 days)|
||1|
|||
aripiprazole oral solution 1 mg/ml||1|QL (750 ML per 30 days)
aripiprazole oral tablet 10 mg, 15 mg, 2 mg, 20mg, 30 mg, 5 mg||QL (30 EA per 30 days)|
||1|
|||
aripiprazole oral tablet dispersible 10 mg, 15 mg||1|QL (60 EA per 30 days)
ARISTADA INITIO INTRAMUSCULARPREFILLED SYRINGE 675 MG/2.4ML||PA|
||1|
|||
ARISTADA INTRAMUSCULAR PREFILLEDSYRINGE 1064 MG/3.9ML||PA; QL (3.9 ML per 56 days)|
||1|
|||
ARISTADA INTRAMUSCULAR PREFILLEDSYRINGE 441 MG/1.6ML||PA; QL (1.6 ML per 28 days)|
||1|
|||
ARISTADA INTRAMUSCULAR PREFILLEDSYRINGE 662 MG/2.4ML||PA; QL (2.4 ML per 28 days)|
||1|
|||
ARISTADA INTRAMUSCULAR PREFILLEDSYRINGE 882 MG/3.2ML||PA; QL (3.2 ML per 28 days)|
||1|
|||
asenapine maleate sublingual tablet sublingual10 mg, 2.5 mg, 5 mg||QL (60 EA per 30 days)|
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
CAPLYTA ORAL CAPSULE 10.5 MG, 21 MG,42 MG||PA|
|1||
|||
FANAPT ORAL TABLET 1 MG, 10 MG, 12MG, 2 MG, 4 MG, 6 MG, 8 MG||PA; QL (60 EA per 30 days)|
|1||
|||
FANAPT TITRATION PACK ORAL TABLET1 & 2 & 4 & 6 MG||PA|
|1||
|||
INVEGA SUSTENNA INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 117MG/0.75ML||PA; QL (0.75 ML per 28 days)|
|1||
|||
INVEGA SUSTENNA INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 156MG/ML||PA; QL (1 ML per 28 days)|
|1||
|||
INVEGA SUSTENNA INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 234MG/1.5ML||PA; QL (1.5 ML per 28 days)|
|1||
|||
INVEGA SUSTENNA INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 39MG/0.25ML||PA; QL (0.25 ML per 28 days)|
|1||
|||
INVEGA SUSTENNA INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 78MG/0.5ML||PA; QL (0.5 ML per 28 days)|
|1||
|||
INVEGA TRINZA INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 273MG/0.88ML||PA; QL (0.88 ML per 84 days)|
|1||
|||
INVEGA TRINZA INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 410MG/1.32ML||PA; QL (1.32 ML per 84 days)|
|1||
|||
INVEGA TRINZA INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 546MG/1.75ML||PA; QL (1.75 ML per 84 days)|
|1||
|||
INVEGA TRINZA INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 819MG/2.63ML||PA; QL (2.63 ML per 84 days)|
|1||
|||
lurasidone hcl oral tablet 120 mg, 20 mg, 40 mg,60 mg||QL (30 EA per 30 days)|
|1||
|||
lurasidone hcl oral tablet 80 mg|1|QL (60 EA per 30 days)|
LYBALVI ORAL TABLET 10-10 MG, 15-10MG, 20-10 MG, 5-10 MG||PA|
|1||
|||
NUPLAZID ORAL CAPSULE 34 MG|1|PA; QL (30 EA per 30 days)|
NUPLAZID ORAL TABLET 10 MG|1|PA; QL (30 EA per 30 days)|
Drug Name|Drug Tier|Requirements/Limits|
olanzapine intramuscular solution reconstituted10 mg||QL (90 EA per 30 days)|
|1||
|||
olanzapine oral tablet 10 mg, 15 mg, 2.5 mg, 20mg, 5 mg, 7.5 mg||QL (30 EA per 30 days)|
|1||
|||
olanzapine oral tablet dispersible 10 mg, 15 mg,20 mg, 5 mg||QL (30 EA per 30 days)|
|1||
|||
paliperidone er oral tablet extended release 24hour 1.5 mg, 3 mg, 9 mg||PA; QL (30 EA per 30 days)|
|1||
|||
paliperidone er oral tablet extended release 24hour 6 mg||PA; QL (60 EA per 30 days)|
|1||
|||
PERSERIS SUBCUTANEOUS PREFILLEDSYRINGE 120 MG, 90 MG||PA; QL (1 EA per 28 days)|
|1||
|||
quetiapine fumarate er oral tablet extendedrelease 24 hour 150 mg, 200 mg||QL (30 EA per 30 days)|
|1||
|||
quetiapine fumarate er oral tablet extendedrelease 24 hour 300 mg, 400 mg, 50 mg||QL (60 EA per 30 days)|
|1||
|||
quetiapine fumarate oral tablet 100 mg, 150 mg,200 mg, 300 mg, 400 mg||QL (60 EA per 30 days)|
|1||
|||
quetiapine fumarate oral tablet 25 mg, 50 mg|1|QL (90 EA per 30 days)|
REXULTI ORAL TABLET 0.25 MG, 0.5 MG, 1MG, 2 MG, 3 MG, 4 MG||PA; QL (30 EA per 30 days)|
|1||
|||
RISPERDAL CONSTA INTRAMUSCULARSUSPENSION RECONSTITUTED ER 12.5 MG,25 MG, 37.5 MG, 50 MG||PA; QL (2 EA per 28 days)|
|1||
|||
risperidone oral solution 1 mg/ml|1|QL (480 ML per 30 days)|
risperidone oral tablet 0.25 mg, 0.5 mg, 1 mg, 2mg||QL (60 EA per 30 days)|
|1||
|||
risperidone oral tablet 3 mg, 4 mg|1|QL (120 EA per 30 days)|
risperidone oral tablet dispersible 0.25 mg, 0.5mg, 1 mg, 2 mg||QL (60 EA per 30 days)|
|1||
|||
risperidone oral tablet dispersible 3 mg, 4 mg|1|QL (120 EA per 30 days)|
SECUADO TRANSDERMAL PATCH 24HOUR 3.8 MG/24HR, 5.7 MG/24HR, 7.6MG/24HR||PA; QL (30 EA per 30 days)|
|1||
|||
UZEDY SUBCUTANEOUS SUSPENSIONPREFILLED SYRINGE 100 MG/0.28ML, 125MG/0.35ML, 150 MG/0.42ML, 200MG/0.56ML, 250 MG/0.7ML, 50 MG/0.14ML,75 MG/0.21ML||PA|
1|||
|||
Drug Name||Drug Tier|Requirements/Limits
VRAYLAR ORAL CAPSULE 1.5 MG, 3 MG,4.5 MG, 6 MG||PA; QL (30 EA per 30 days)|
||1|
|||
VRAYLAR ORAL CAPSULE THERAPYPACK 1.5 & 3 MG||PA; QL (14 EA per 365 days)|
||1|
|||
ziprasidone hcl oral capsule 20 mg, 40 mg, 60mg, 80 mg||QL (60 EA per 30 days)|
||1|
|||
ziprasidone mesylate intramuscular solutionreconstituted 20 mg||QL (6 EA per 3 days)|
||1|
|||
ZYPREXA RELPREVV INTRAMUSCULARSUSPENSION RECONSTITUTED 210 MG, 300MG||PA; QL (2 EA per 28 days)|
||1|
|||
ZYPREXA RELPREVV INTRAMUSCULARSUSPENSION RECONSTITUTED 405 MG||PA; QL (1 EA per 28 days)|
||1|
|||
Treatment-Resistant|||
clozapine oral tablet 100 mg||QL (270 EA per 30 days)|
||1|
clozapine oral tablet 200 mg||1|QL (120 EA per 30 days)
clozapine oral tablet 25 mg, 50 mg||1|QL (90 EA per 30 days)
clozapine oral tablet dispersible 100 mg||1|QL (270 EA per 30 days)
clozapine oral tablet dispersible 12.5 mg||1|
clozapine oral tablet dispersible 150 mg||1|QL (180 EA per 30 days)
clozapine oral tablet dispersible 200 mg||1|QL (120 EA per 30 days)
clozapine oral tablet dispersible 25 mg||1|QL (90 EA per 30 days)
VERSACLOZ ORAL SUSPENSION 50 MG/ML||1|QL (540 ML per 30 days)
Antispasticity Agents - Treatment Of|||
Muscle Spasms|||
Antispasticity Agents|||
baclofen oral tablet 10 mg, 20 mg, 5 mg|||
||1|
dantrolene sodium oral capsule 100 mg, 25 mg,50 mg|||
||1|
|||
tizanidine hcl oral tablet 2 mg, 4 mg||1|
Antivirals - Treatment Of Infections By|||
Viruses|||
Anti-Cytomegalovirus (Cmv) Agents|||
PREVYMIS ORAL TABLET 240 MG, 480 MG||PA|
||1|
valganciclovir hcl oral solution reconstituted 50mg/ml|||
||1|
|||
valganciclovir hcl oral tablet 450 mg||1|
Drug Name||Drug Tier|Requirements/Limits
Anti-Hepatitis B (Hbv) Agents|||
adefovir dipivoxil oral tablet 10 mg||QL (30 EA per 30 days)|
||1|
BARACLUDE ORAL SOLUTION 0.05 MG/ML||1|
entecavir oral tablet 0.5 mg, 1 mg||1|
EPIVIR HBV ORAL SOLUTION 5 MG/ML||1|
lamivudine oral solution 10 mg/ml||1|QL (960 ML per 30 days)
lamivudine oral tablet 100 mg, 300 mg||1|QL (30 EA per 30 days)
lamivudine oral tablet 150 mg||1|QL (60 EA per 30 days)
tenofovir disoproxil fumarate oral tablet 300 mg||1|QL (30 EA per 30 days)
VEMLIDY ORAL TABLET 25 MG||1|PA
VIREAD ORAL POWDER 40 MG/GM||1|QL (240 GM per 30 days)
VIREAD ORAL TABLET 150 MG, 200 MG,250 MG||QL (30 EA per 30 days)|
||1|
|||
Anti-Hepatitis C (Hcv) Agents|||
MAVYRET ORAL PACKET 50-20 MG||PA|
||1|
MAVYRET ORAL TABLET 100-40 MG||1|PA
ribavirin oral capsule 200 mg||1|
ribavirin oral tablet 200 mg||1|
SOFOSBUVIR-VELPATASVIR ORALTABLET 400-100 MG||PA|
||1|
|||
VOSEVI ORAL TABLET 400-100-100 MG||1|PA
Antiherpetic Agents|||
acyclovir oral capsule 200 mg|||
||1|
acyclovir oral suspension 200 mg/5ml||1|
acyclovir oral tablet 400 mg, 800 mg||1|
acyclovir sodium intravenous solution 50 mg/ml||1|B/D
famciclovir oral tablet 125 mg, 250 mg, 500 mg||1|
trifluridine ophthalmic solution 1 %||1|
valacyclovir hcl oral tablet 1 gm, 500 mg||1|
Anti-Hiv Agents, Integrase Inhibitors|||
(Insti)|||
ISENTRESS HD ORAL TABLET 600 MG||1|QL (60 EA per 30 days)
ISENTRESS ORAL PACKET 100 MG||1|QL (60 EA per 30 days)
ISENTRESS ORAL TABLET 400 MG||1|QL (120 EA per 30 days)
Drug Name||Drug Tier|Requirements/Limits
ISENTRESS ORAL TABLET CHEWABLE 100MG, 25 MG||QL (180 EA per 30 days)|
||1|
|||
TIVICAY ORAL TABLET 10 MG||1|QL (120 EA per 30 days)
TIVICAY ORAL TABLET 25 MG||1|QL (30 EA per 30 days)
TIVICAY ORAL TABLET 50 MG||1|QL (60 EA per 30 days)
TIVICAY PD ORAL TABLET SOLUBLE 5 MG||1|QL (180 EA per 30 days)
VOCABRIA ORAL TABLET 30 MG||1|QL (30 EA per 30 days)
Anti-Hiv Agents, Non-Nucleoside|||
Reverse Transcriptase Inhibitors|||
(Nnrti)|||
EDURANT ORAL TABLET 25 MG||1|QL (60 EA per 30 days)
efavirenz oral capsule 200 mg||1|QL (120 EA per 30 days)
efavirenz oral capsule 50 mg||1|QL (180 EA per 30 days)
efavirenz oral tablet 600 mg||1|QL (30 EA per 30 days)
etravirine oral tablet 100 mg||1|QL (120 EA per 30 days)
etravirine oral tablet 200 mg||1|QL (60 EA per 30 days)
INTELENCE ORAL TABLET 25 MG||1|QL (120 EA per 30 days)
nevirapine er oral tablet extended release 24 hour100 mg||QL (120 EA per 30 days)|
||1|
|||
nevirapine er oral tablet extended release 24 hour400 mg||QL (30 EA per 30 days)|
||1|
|||
nevirapine oral suspension 50 mg/5ml||1|QL (1200 ML per 30 days)
nevirapine oral tablet 200 mg||1|QL (60 EA per 30 days)
PIFELTRO ORAL TABLET 100 MG||1|QL (30 EA per 30 days)
Anti-Hiv Agents, Nucleoside And|||
Nucleotide Reverse Transcriptase|||
Inhibitors (Nrti)|||
abacavir sulfate oral solution 20 mg/ml||1|QL (960 ML per 30 days)
abacavir sulfate oral tablet 300 mg||1|QL (60 EA per 30 days)
abacavir sulfate-lamivudine oral tablet 600-300mg||QL (30 EA per 30 days)|
||1|
|||
CIMDUO ORAL TABLET 300-300 MG||1|QL (30 EA per 30 days)
DESCOVY ORAL TABLET 120-15 MG, 200-25MG||QL (30 EA per 30 days)|
||1|
|||
emtricitabine oral capsule 200 mg||1|QL (30 EA per 30 days)
emtricitabine-tenofovir df oral tablet 100-150 mg,133-200 mg, 167-250 mg, 200-300 mg||QL (30 EA per 30 days)|
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
EMTRIVA ORAL SOLUTION 10 MG/ML||1|
lamivudine-zidovudine oral tablet 150-300 mg||1|QL (60 EA per 30 days)
TEMIXYS ORAL TABLET 300-300 MG||1|QL (30 EA per 30 days)
TRIZIVIR ORAL TABLET 300-150-300 MG||1|QL (60 EA per 30 days)
zidovudine oral capsule 100 mg||1|QL (180 EA per 30 days)
zidovudine oral syrup 50 mg/5ml||1|QL (1920 ML per 30 days)
zidovudine oral tablet 300 mg||1|QL (60 EA per 30 days)
Anti-Hiv Agents, Other|||
BIKTARVY ORAL TABLET 30-120-15 MG,50-200-25 MG||QL (30 EA per 30 days)|
|||
||1|
|||
COMPLERA ORAL TABLET 200-25-300 MG||1|QL (30 EA per 30 days)
DELSTRIGO ORAL TABLET 100-300-300 MG||1|QL (30 EA per 30 days)
DOVATO ORAL TABLET 50-300 MG||1|QL (30 EA per 30 days)
efavirenz-emtricitab-tenofo df oral tablet 600-200-300 mg||QL (30 EA per 30 days)|
||1|
|||
efavirenz-lamivudine-tenofovir oral tablet 400-300-300 mg, 600-300-300 mg||QL (30 EA per 30 days)|
||1|
|||
EVOTAZ ORAL TABLET 300-150 MG||1|QL (30 EA per 30 days)
FUZEON SUBCUTANEOUS SOLUTIONRECONSTITUTED 90 MG|||
||1|
|||
GENVOYA ORAL TABLET 150-150-200-10MG||QL (30 EA per 30 days)|
||1|
|||
JULUCA ORAL TABLET 50-25 MG||1|QL (30 EA per 30 days)
maraviroc oral tablet 150 mg||1|QL (60 EA per 30 days)
maraviroc oral tablet 300 mg||1|QL (120 EA per 30 days)
ODEFSEY ORAL TABLET 200-25-25 MG||1|QL (30 EA per 30 days)
PREZCOBIX ORAL TABLET 800-150 MG||1|QL (30 EA per 30 days)
RUKOBIA ORAL TABLET EXTENDEDRELEASE 12 HOUR 600 MG||QL (60 EA per 30 days)|
||1|
|||
SELZENTRY ORAL SOLUTION 20 MG/ML||1|QL (1840 ML per 30 days)
SELZENTRY ORAL TABLET 25 MG||1|QL (240 EA per 30 days)
SELZENTRY ORAL TABLET 75 MG||1|QL (120 EA per 30 days)
STRIBILD ORAL TABLET 150-150-200-300MG||QL (30 EA per 30 days)|
||1|
|||
SUNLENCA ORAL TABLET THERAPYPACK 4 X 300 MG||QL (8 EA per 365 days)|
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
SUNLENCA ORAL TABLET THERAPYPACK 5 X 300 MG||QL (10 EA per 365 days)|
||1|
|||
SUNLENCA SUBCUTANEOUS SOLUTION463.5 MG/1.5ML||QL (6 ML per 365 days)|
||1|
|||
SYMTUZA ORAL TABLET 800-150-200-10MG||QL (30 EA per 30 days)|
||1|
|||
TRIUMEQ ORAL TABLET 600-50-300 MG||1|QL (30 EA per 30 days)
TRIUMEQ PD ORAL TABLET SOLUBLE 60-5-30 MG||QL (180 EA per 30 days)|
||1|
|||
TYBOST ORAL TABLET 150 MG||1|QL (30 EA per 30 days)
Anti-Hiv Agents, Protease Inhibitors|||
(Pi)|||
APTIVUS ORAL CAPSULE 250 MG||1|QL (120 EA per 30 days)
atazanavir sulfate oral capsule 150 mg, 300 mg||1|QL (30 EA per 30 days)
atazanavir sulfate oral capsule 200 mg||1|QL (60 EA per 30 days)
CRIXIVAN ORAL CAPSULE 200 MG||1|QL (360 EA per 30 days)
CRIXIVAN ORAL CAPSULE 400 MG||1|QL (180 EA per 30 days)
darunavir oral tablet 600 mg||1|QL (60 EA per 30 days)
darunavir oral tablet 800 mg||1|QL (30 EA per 30 days)
fosamprenavir calcium oral tablet 700 mg||1|QL (120 EA per 30 days)
INVIRASE ORAL TABLET 500 MG||1|QL (120 EA per 30 days)
LEXIVA ORAL SUSPENSION 50 MG/ML||1|
lopinavir-ritonavir oral solution 400-100 mg/5ml||1|QL (390 ML per 30 days)
lopinavir-ritonavir oral tablet 100-25 mg||1|QL (300 EA per 30 days)
lopinavir-ritonavir oral tablet 200-50 mg||1|QL (120 EA per 30 days)
NORVIR ORAL PACKET 100 MG||1|QL (360 EA per 30 days)
PREZISTA ORAL SUSPENSION 100 MG/ML||1|QL (400 ML per 30 days)
PREZISTA ORAL TABLET 150 MG||1|QL (180 EA per 30 days)
PREZISTA ORAL TABLET 75 MG||1|QL (300 EA per 30 days)
REYATAZ ORAL PACKET 50 MG||1|
ritonavir oral tablet 100 mg||1|QL (360 EA per 30 days)
VIRACEPT ORAL TABLET 250 MG||1|QL (300 EA per 30 days)
VIRACEPT ORAL TABLET 625 MG||1|QL (120 EA per 30 days)
Anti-Influenza Agents|||
oseltamivir phosphate oral capsule 30 mg||QL (84 EA per 180 days)|
||1|
oseltamivir phosphate oral capsule 45 mg, 75 mg||1|QL (42 EA per 180 days)
Drug Name||Drug Tier|Requirements/Limits
oseltamivir phosphate oral suspensionreconstituted 6 mg/ml||QL (540 ML per 180 days)|
||1|
|||
RELENZA DISKHALER INHALATIONAEROSOL POWDER BREATH ACTIVATED 5MG/ACT||QL (60 EA per 180 days)|
||1|
|||
rimantadine hcl oral tablet 100 mg||1|
Antivirals|||
lagevrio oral capsule 200 mg||QL (40 EA per 5 days)|
||1|
paxlovid (150/100) oral tablet therapy pack 10 x150 mg & 10 x 100mg||QL (20 EA per 5 days)|
||1|
|||
paxlovid (300/100) oral tablet therapy pack 20 x150 mg & 10 x 100mg||QL (30 EA per 5 days)|
||1|
|||
Anxiolytics - Treatment Of Anxiety Or|||
Nervousness|||
Anxiolytics, Other|||
buspirone hcl oral tablet 10 mg, 15 mg, 30 mg, 5mg, 7.5 mg|||
|||
||1|
|||
hydroxyzine pamoate oral capsule 100 mg, 25mg, 50 mg||PA|
||1|
|||
Benzodiazepines|||
alprazolam intensol oral concentrate 1 mg/ml||QL (300 ML per 30 days)|
||1|
alprazolam oral tablet 0.25 mg, 0.5 mg, 1 mg||1|QL (120 EA per 30 days)
alprazolam oral tablet 2 mg||1|QL (150 EA per 30 days)
clonazepam oral tablet 0.5 mg, 1 mg||1|QL (90 EA per 30 days)
clonazepam oral tablet 2 mg||1|QL (300 EA per 30 days)
clonazepam oral tablet dispersible 0.125 mg, 0.25mg, 0.5 mg, 1 mg||QL (90 EA per 30 days)|
||1|
|||
clonazepam oral tablet dispersible 2 mg||1|QL (300 EA per 30 days)
clorazepate dipotassium oral tablet 15 mg||1|QL (180 EA per 30 days)
clorazepate dipotassium oral tablet 3.75 mg, 7.5mg||QL (90 EA per 30 days)|
||1|
|||
diazepam intensol oral concentrate 5 mg/ml||1|QL (240 ML per 30 days)
diazepam oral concentrate 5 mg/ml||1|QL (240 ML per 30 days)
diazepam oral solution 5 mg/5ml||1|QL (1200 ML per 30 days)
diazepam oral tablet 10 mg, 2 mg, 5 mg||1|QL (120 EA per 30 days)
lorazepam intensol oral concentrate 2 mg/ml||1|QL (150 ML per 30 days)
lorazepam oral concentrate 2 mg/ml||1|QL (150 ML per 30 days)
Drug Name||Drug Tier|Requirements/Limits
lorazepam oral tablet 0.5 mg, 1 mg||1|QL (90 EA per 30 days)
lorazepam oral tablet 2 mg||1|QL (150 EA per 30 days)
Bipolar Agents - Treatment For Bipolar|||
Illnesses|||
Mood Stabilizers|||
EQUETRO ORAL CAPSULE EXTENDEDRELEASE 12 HOUR 100 MG, 200 MG, 300 MG|||
|||
||1|
|||
lithium carbonate er oral tablet extended release300 mg, 450 mg|||
||1|
|||
lithium carbonate oral capsule 150 mg, 300 mg,600 mg|||
||1|
|||
lithium carbonate oral tablet 300 mg||1|
Blood Glucose Regulators - Control Of|||
Diabetes|||
Antidiabetic Agents|||
acarbose oral tablet 100 mg, 25 mg, 50 mg||QL (90 EA per 30 days)|
||1|
FARXIGA ORAL TABLET 10 MG, 5 MG||1|QL (30 EA per 30 days)
glimepiride oral tablet 1 mg||1|QL (240 EA per 30 days)
glimepiride oral tablet 2 mg||1|QL (120 EA per 30 days)
glimepiride oral tablet 4 mg||1|QL (60 EA per 30 days)
glipizide er oral tablet extended release 24 hour10 mg||QL (60 EA per 30 days)|
||1|
|||
glipizide er oral tablet extended release 24 hour2.5 mg||QL (240 EA per 30 days)|
||1|
|||
glipizide er oral tablet extended release 24 hour 5mg||QL (120 EA per 30 days)|
||1|
|||
glipizide oral tablet 10 mg||1|QL (120 EA per 30 days)
glipizide oral tablet 5 mg||1|QL (240 EA per 30 days)
glipizide xl oral tablet extended release 24 hour10 mg||QL (60 EA per 30 days)|
||1|
|||
glipizide xl oral tablet extended release 24 hour2.5 mg||QL (240 EA per 30 days)|
||1|
|||
glipizide xl oral tablet extended release 24 hour 5mg||QL (120 EA per 30 days)|
||1|
|||
glipizide-metformin hcl oral tablet 2.5-250 mg||1|QL (240 EA per 30 days)
glipizide-metformin hcl oral tablet 2.5-500 mg, 5-500 mg||QL (120 EA per 30 days)|
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
glyburide micronized oral tablet 1.5 mg, 3 mg|1|PA; QL (90 EA per 30 days)|
glyburide micronized oral tablet 6 mg|1|PA; QL (60 EA per 30 days)|
glyburide oral tablet 1.25 mg, 2.5 mg|1|PA; QL (60 EA per 30 days)|
glyburide oral tablet 5 mg|1|PA; QL (120 EA per 30 days)|
glyburide-metformin oral tablet 1.25-250 mg|1|PA; QL (240 EA per 30 days)|
glyburide-metformin oral tablet 2.5-500 mg, 5-500 mg||PA; QL (120 EA per 30 days)|
|1||
|||
GLYXAMBI ORAL TABLET 10-5 MG, 25-5MG||QL (30 EA per 30 days)|
|1||
|||
JANUMET ORAL TABLET 50-1000 MG, 50-500 MG||QL (60 EA per 30 days)|
|1||
|||
JANUMET XR ORAL TABLET EXTENDEDRELEASE 24 HOUR 100-1000 MG||QL (30 EA per 30 days)|
|1||
|||
JANUMET XR ORAL TABLET EXTENDEDRELEASE 24 HOUR 50-1000 MG, 50-500 MG||QL (60 EA per 30 days)|
|1||
|||
JANUVIA ORAL TABLET 100 MG, 25 MG, 50MG||QL (30 EA per 30 days)|
|1||
|||
JARDIANCE ORAL TABLET 10 MG, 25 MG|1|QL (30 EA per 30 days)|
JENTADUETO ORAL TABLET 2.5-1000 MG,2.5-500 MG, 2.5-850 MG||QL (60 EA per 30 days)|
|1||
|||
JENTADUETO XR ORAL TABLETEXTENDED RELEASE 24 HOUR 2.5-1000 MG||QL (60 EA per 30 days)|
|1||
|||
JENTADUETO XR ORAL TABLETEXTENDED RELEASE 24 HOUR 5-1000 MG||QL (30 EA per 30 days)|
|1||
|||
metformin hcl er oral tablet extended release 24hour 500 mg||QL (120 EA per 30 days)|
|1||
|||
metformin hcl er oral tablet extended release 24hour 750 mg||QL (60 EA per 30 days)|
|1||
|||
metformin hcl oral tablet 1000 mg|1|QL (75 EA per 30 days)|
metformin hcl oral tablet 500 mg|1|QL (150 EA per 30 days)|
metformin hcl oral tablet 850 mg|1|QL (90 EA per 30 days)|
MOUNJARO SUBCUTANEOUS SOLUTIONPEN-INJECTOR 10 MG/0.5ML, 12.5MG/0.5ML, 15 MG/0.5ML, 2.5 MG/0.5ML, 5MG/0.5ML, 7.5 MG/0.5ML||ST; QL (2 ML per 28 days)|
|1||
|||
nateglinide oral tablet 120 mg, 60 mg|1|QL (90 EA per 30 days)|
OZEMPIC (0.25 OR 0.5 MG/DOSE)SUBCUTANEOUS SOLUTION PEN-INJECTOR 2 MG/1.5ML||ST; QL (1.5 ML per 28 days)|
1|||
|||
Drug Name||Drug Tier|Requirements/Limits
OZEMPIC (0.25 OR 0.5 MG/DOSE)SUBCUTANEOUS SOLUTION PEN-INJECTOR 2 MG/3ML||ST; QL (3 ML per 28 days)|
||1|
|||
OZEMPIC (1 MG/DOSE) SUBCUTANEOUSSOLUTION PEN-INJECTOR 4 MG/3ML||ST; QL (3 ML per 28 days)|
||1|
|||
OZEMPIC (2 MG/DOSE) SUBCUTANEOUSSOLUTION PEN-INJECTOR 8 MG/3ML||ST; QL (3 ML per 28 days)|
||1|
|||
pioglitazone hcl oral tablet 15 mg, 30 mg, 45 mg||1|QL (30 EA per 30 days)
pioglitazone hcl-metformin hcl oral tablet 15-500mg, 15-850 mg||QL (90 EA per 30 days)|
||1|
|||
repaglinide oral tablet 0.5 mg, 1 mg||1|QL (120 EA per 30 days)
repaglinide oral tablet 2 mg||1|QL (240 EA per 30 days)
RYBELSUS ORAL TABLET 14 MG, 3 MG, 7MG||ST; QL (30 EA per 30 days)|
||1|
|||
SYMLINPEN 120 SUBCUTANEOUSSOLUTION PEN-INJECTOR 2700 MCG/2.7ML||PA|
||1|
|||
SYMLINPEN 60 SUBCUTANEOUSSOLUTION PEN-INJECTOR 1500 MCG/1.5ML||PA|
||1|
|||
SYNJARDY ORAL TABLET 12.5-1000 MG,12.5-500 MG, 5-1000 MG, 5-500 MG||QL (60 EA per 30 days)|
||1|
|||
SYNJARDY XR ORAL TABLET EXTENDEDRELEASE 24 HOUR 10-1000 MG, 12.5-1000MG, 5-1000 MG||QL (60 EA per 30 days)|
||1|
|||
SYNJARDY XR ORAL TABLET EXTENDEDRELEASE 24 HOUR 25-1000 MG||QL (30 EA per 30 days)|
||1|
|||
TRADJENTA ORAL TABLET 5 MG||1|QL (30 EA per 30 days)
TRULICITY SUBCUTANEOUS SOLUTIONPEN-INJECTOR 0.75 MG/0.5ML, 1.5MG/0.5ML, 3 MG/0.5ML, 4.5 MG/0.5ML||ST; QL (2 ML per 28 days)|
||1|
|||
VICTOZA SUBCUTANEOUS SOLUTIONPEN-INJECTOR 18 MG/3ML||ST; QL (9 ML per 30 days)|
||1|
|||
XIGDUO XR ORAL TABLET EXTENDEDRELEASE 24 HOUR 10-1000 MG, 10-500 MG,5-500 MG||QL (30 EA per 30 days)|
||1|
|||
XIGDUO XR ORAL TABLET EXTENDEDRELEASE 24 HOUR 2.5-1000 MG, 5-1000 MG||QL (60 EA per 30 days)|
||1|
|||
Glycemic Agents|||
BAQSIMI ONE PACK NASAL POWDER 3MG/DOSE||QL (4 EA per 30 days)|
|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
BAQSIMI TWO PACK NASAL POWDER 3MG/DOSE||QL (4 EA per 30 days)|
||1|
|||
diazoxide oral suspension 50 mg/ml||1|
GLUCAGEN HYPOKIT INJECTIONSOLUTION RECONSTITUTED 1 MG||QL (4 EA per 30 days)|
||1|
|||
glucagon emergency injection kit 1 mg||1|QL (4 EA per 30 days)
glucagon emergency injection solutionreconstituted 1 mg/ml||QL (4 EA per 30 days)|
||1|
|||
KORLYM ORAL TABLET 300 MG||1|PA
Insulins|||
"gauze pad 2""x2"""|||
||1|
HUMALOG INJECTION SOLUTION 100UNIT/ML|||
||1|
|||
HUMALOG JUNIOR KWIKPENSUBCUTANEOUS SOLUTION PEN-INJECTOR 100 UNIT/ML|||
||1|
|||
HUMALOG KWIKPEN SUBCUTANEOUSSOLUTION PEN-INJECTOR 100 UNIT/ML,200 UNIT/ML|||
||1|
|||
HUMALOG MIX 50/50 KWIKPENSUBCUTANEOUS SUSPENSION PEN-INJECTOR (50-50) 100 UNIT/ML|||
||1|
|||
HUMALOG MIX 50/50 SUBCUTANEOUSSUSPENSION (50-50) 100 UNIT/ML|||
||1|
|||
HUMALOG MIX 75/25 KWIKPENSUBCUTANEOUS SUSPENSION PEN-INJECTOR (75-25) 100 UNIT/ML|||
||1|
|||
HUMALOG MIX 75/25 SUBCUTANEOUSSUSPENSION (75-25) 100 UNIT/ML|||
||1|
|||
HUMALOG SUBCUTANEOUS SOLUTIONCARTRIDGE 100 UNIT/ML|||
||1|
|||
HUMULIN 70/30 KWIKPENSUBCUTANEOUS SUSPENSION PEN-INJECTOR (70-30) 100 UNIT/ML|||
||1|
|||
HUMULIN 70/30 SUBCUTANEOUSSUSPENSION (70-30) 100 UNIT/ML|||
||1|
|||
HUMULIN N KWIKPEN SUBCUTANEOUSSUSPENSION PEN-INJECTOR 100 UNIT/ML|||
||1|
|||
HUMULIN N SUBCUTANEOUSSUSPENSION 100 UNIT/ML|||
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
HUMULIN R INJECTION SOLUTION 100UNIT/ML|||
|1||
|||
HUMULIN R U-500 (CONCENTRATED)SUBCUTANEOUS SOLUTION 500 UNIT/ML|||
|1||
|||
HUMULIN R U-500 KWIKPENSUBCUTANEOUS SOLUTION PEN-INJECTOR 500 UNIT/ML|||
|1||
|||
insulin aspart flexpen subcutaneous solution pen-injector 100 unit/ml|||
|1||
|||
insulin aspart injection solution 100 unit/ml|1||
insulin aspart prot & aspart subcutaneoussuspension (70-30) 100 unit/ml|||
|1||
|||
insulin lispro (1 unit dial) subcutaneous solutionpen-injector 100 unit/ml|||
|1||
|||
insulin lispro injection solution 100 unit/ml|1||
insulin lispro junior kwikpen subcutaneoussolution pen-injector 100 unit/ml|||
|1||
|||
insulin lispro prot & lispro subcutaneoussuspension pen-injector (75-25) 100 unit/ml|||
|1||
|||
"insulin syringe 27g x 1/2"" 0.5 ml, 27g x 1/2"" 1 ml,27g x 5/8"" 1 ml, 28g x 1/2"" 0.5 ml, 28g x 1/2"" 1ml, 29g 0.3 ml, 29g x 1/2"" 0.3 ml, 29g x 1/2"" 0.5ml, 29g x 1/2"" 1 ml, 30g x 1/2"" 0.3 ml, 30g x 1/2""0.5 ml, 30g x 1/2"" 1 ml, 30g x 5/16"" 0.3 ml, 30g x5/16"" 0.5 ml, 30g x 5/16"" 1 ml, 31g x 1/4"" 0.3 ml,31g x 1/4"" 0.5 ml, 31g x 1/4"" 1 ml, 31g x 15/64""0.3 ml, 31g x 15/64"" 0.5 ml, 31g x 15/64"" 1 ml,31g x 5/16"" 0.3 ml, 31g x 5/16"" 0.5 ml, 31g x5/16"" 1 ml, 31g x 6mm 0.5 ml, u-100 1 ml"|||
|1||
|||
LANTUS SOLOSTAR SUBCUTANEOUSSOLUTION PEN-INJECTOR 100 UNIT/ML|||
|1||
|||
LANTUS SUBCUTANEOUS SOLUTION 100UNIT/ML|||
|1||
|||
LEVEMIR FLEXPEN SUBCUTANEOUSSOLUTION PEN-INJECTOR 100 UNIT/ML|||
|1||
|||
LEVEMIR FLEXTOUCH SUBCUTANEOUSSOLUTION PEN-INJECTOR 100 UNIT/ML|||
|1||
|||
LEVEMIR SUBCUTANEOUS SOLUTION 100UNIT/ML|||
1|||
|||
Drug Name|Drug Tier|Requirements/Limits|
NOVOLIN 70/30 FLEXPEN SUBCUTANEOUSSUSPENSION PEN-INJECTOR (70-30) 100UNIT/ML|||
|1||
|||
NOVOLIN 70/30 SUBCUTANEOUSSUSPENSION (70-30) 100 UNIT/ML|||
|1||
|||
NOVOLIN N FLEXPEN SUBCUTANEOUSSUSPENSION PEN-INJECTOR 100 UNIT/ML|||
|1||
|||
NOVOLIN N SUBCUTANEOUS SUSPENSION100 UNIT/ML|||
|1||
|||
NOVOLIN R FLEXPEN INJECTIONSOLUTION PEN-INJECTOR 100 UNIT/ML|||
|1||
|||
NOVOLIN R INJECTION SOLUTION 100UNIT/ML|||
|1||
|||
NOVOLOG FLEXPEN SUBCUTANEOUSSOLUTION PEN-INJECTOR 100 UNIT/ML|||
|1||
|||
NOVOLOG INJECTION SOLUTION 100UNIT/ML|||
|1||
|||
NOVOLOG MIX 70/30 FLEXPENSUBCUTANEOUS SUSPENSION PEN-INJECTOR (70-30) 100 UNIT/ML|||
|1||
|||
NOVOLOG MIX 70/30 SUBCUTANEOUSSUSPENSION (70-30) 100 UNIT/ML|||
|1||
|||
OMNIPOD 5 G6 INTRO (GEN 5) KIT|1||
OMNIPOD 5 G6 POD (GEN 5)|1||
OMNIPOD DASH INTRO (GEN 4) KIT|1||
OMNIPOD DASH PDM (GEN 4) KIT|1||
OMNIPOD DASH PODS (GEN 4)|1||
OMNIPOD GO KIT 10 UNIT/24HR, 15UNIT/24HR, 20 UNIT/24HR, 25 UNIT/24HR, 30UNIT/24HR, 35 UNIT/24HR, 40 UNIT/24HR|||
|1||
|||
pen needles 29g x 12mm , 30g x 5 mm , 30g x 8mm , 31g x 4 mm , 31g x 5 mm , 31g x 6 mm , 31gx 8 mm , 32g x 4 mm , 32g x 5 mm , 32g x 6 mm|||
|1||
|||
SOLIQUA SUBCUTANEOUS SOLUTIONPEN-INJECTOR 100-33 UNT-MCG/ML||QL (30 ML per 30 days)|
|1||
|||
V-GO 20 KIT 20 UNIT/24HR|1||
V-GO 30 KIT 30 UNIT/24HR|1||
V-GO 40 KIT 40 UNIT/24HR|1||
Drug Name||Drug Tier|Requirements/Limits
Blood Products And Modifiers -|||
Prevention Of Clotting And Increasing|||
Blood Cell Production|||
Anticoagulants|||
ELIQUIS DVT/PE STARTER PACK ORALTABLET THERAPY PACK 5 MG||QL (74 EA per 30 days)|
|||
||1|
|||
ELIQUIS ORAL TABLET 2.5 MG||1|QL (60 EA per 30 days)
ELIQUIS ORAL TABLET 5 MG||1|QL (74 EA per 30 days)
enoxaparin sodium injection solution 300 mg/3ml||1|
enoxaparin sodium injection solution prefilledsyringe 100 mg/ml, 120 mg/0.8ml, 150 mg/ml, 30mg/0.3ml, 40 mg/0.4ml, 60 mg/0.6ml, 80mg/0.8ml|||
||1|
|||
fondaparinux sodium subcutaneous solution 10mg/0.8ml, 2.5 mg/0.5ml, 5 mg/0.4ml, 7.5mg/0.6ml|||
||1|
|||
FRAGMIN SUBCUTANEOUS SOLUTION95000 UNIT/3.8ML|||
||1|
|||
FRAGMIN SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 10000 UNIT/ML, 12500UNIT/0.5ML, 15000 UNIT/0.6ML, 18000UNT/0.72ML, 2500 UNIT/0.2ML, 5000UNIT/0.2ML, 7500 UNIT/0.3ML|||
||1|
|||
heparin sodium (porcine) injection solution 1000unit/ml, 10000 unit/ml, 5000 unit/ml|||
||1|
|||
jantoven oral tablet 1 mg, 10 mg, 2 mg, 2.5 mg, 3mg, 4 mg, 5 mg, 6 mg, 7.5 mg|||
||1|
|||
warfarin sodium oral tablet 1 mg, 10 mg, 2 mg,2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg|||
||1|
|||
XARELTO ORAL TABLET 10 MG, 20 MG||1|QL (30 EA per 30 days)
XARELTO ORAL TABLET 15 MG||1|QL (60 EA per 30 days)
XARELTO ORAL TABLET 2.5 MG||1|QL (120 EA per 30 days)
XARELTO STARTER PACK ORAL TABLETTHERAPY PACK 15 & 20 MG||QL (51 EA per 30 days)|
||1|
|||
Blood Products And Modifiers, Other|||
anagrelide hcl oral capsule 0.5 mg, 1 mg|||
||1|
ARANESP (ALBUMIN FREE) INJECTIONSOLUTION 100 MCG/ML, 200 MCG/ML, 25MCG/ML, 40 MCG/ML, 60 MCG/ML||PA|
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
ARANESP (ALBUMIN FREE) INJECTIONSOLUTION PREFILLED SYRINGE 10MCG/0.4ML, 100 MCG/0.5ML, 150MCG/0.3ML, 200 MCG/0.4ML, 25MCG/0.42ML, 300 MCG/0.6ML, 40MCG/0.4ML, 500 MCG/ML, 60 MCG/0.3ML||PA|
|1||
|||
EPOGEN INJECTION SOLUTION 10000UNIT/ML, 2000 UNIT/ML, 20000 UNIT/ML,3000 UNIT/ML, 4000 UNIT/ML||PA|
|1||
|||
FULPHILA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 6 MG/0.6ML||PA|
|1||
|||
FYLNETRA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 6 MG/0.6ML||PA|
|1||
|||
LEUKINE INJECTION SOLUTIONRECONSTITUTED 250 MCG||PA|
|1||
|||
NEULASTA ONPRO SUBCUTANEOUSPREFILLED SYRINGE KIT 6 MG/0.6ML||PA|
|1||
|||
NEULASTA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 6 MG/0.6ML||PA|
|1||
|||
NYVEPRIA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 6 MG/0.6ML||PA|
|1||
|||
OXBRYTA ORAL TABLET 300 MG, 500 MG|1|PA|
OXBRYTA ORAL TABLET SOLUBLE 300MG||PA|
|1||
|||
PROCRIT INJECTION SOLUTION 10000UNIT/ML, 2000 UNIT/ML, 20000 UNIT/ML,3000 UNIT/ML, 4000 UNIT/ML, 40000UNIT/ML||PA|
|1||
|||
PROMACTA ORAL PACKET 12.5 MG|1|PA; QL (360 EA per 30 days)|
PROMACTA ORAL PACKET 25 MG|1|PA; QL (180 EA per 30 days)|
PROMACTA ORAL TABLET 12.5 MG, 25 MG|1|PA; QL (30 EA per 30 days)|
PROMACTA ORAL TABLET 50 MG, 75 MG|1|PA; QL (60 EA per 30 days)|
PYRUKYND ORAL TABLET 20 MG, 5 MG, 50MG||PA|
|1||
|||
PYRUKYND TAPER PACK ORAL TABLETTHERAPY PACK 5 MG, 7 X 20 MG & 7 X 5MG, 7 X 50 MG & 7 X 20 MG||PA|
|1||
|||
RETACRIT INJECTION SOLUTION 10000UNIT/ML, 10000 UNIT/ML(1ML), 2000UNIT/ML, 20000 UNIT/ML, 3000 UNIT/ML,4000 UNIT/ML, 40000 UNIT/ML||PA|
1|||
|||
Drug Name||Drug Tier|Requirements/Limits
ROLVEDON SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 13.2 MG/0.6ML||PA|
||1|
|||
STIMUFEND SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 6 MG/0.6ML||PA|
||1|
|||
TAVNEOS ORAL CAPSULE 10 MG||1|PA
tranexamic acid oral tablet 650 mg||1|
UDENYCA SUBCUTANEOUS SOLUTIONAUTO-INJECTOR 6 MG/0.6ML||PA|
||1|
|||
UDENYCA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 6 MG/0.6ML||PA|
||1|
|||
ZARXIO INJECTION SOLUTION PREFILLEDSYRINGE 300 MCG/0.5ML, 480 MCG/0.8ML||PA|
||1|
|||
ZIEXTENZO SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 6 MG/0.6ML||PA|
||1|
|||
Platelet Modifying Agents|||
aspirin-dipyridamole er oral capsule extendedrelease 12 hour 25-200 mg|||
|||
||1|
|||
BRILINTA ORAL TABLET 60 MG, 90 MG||1|
cilostazol oral tablet 100 mg, 50 mg||1|
clopidogrel bisulfate oral tablet 75 mg||1|
dipyridamole oral tablet 25 mg, 50 mg, 75 mg||1|PA
DOPTELET ORAL TABLET 20 MG, 20 MG (10PACK), 20 MG(15 PACK)||PA|
||1|
|||
prasugrel hcl oral tablet 10 mg, 5 mg||1|
Cardiovascular Agents - Treatment Of|||
Conditions Affecting The Heart And|||
Blood Vessels|||
Alpha-Adrenergic Agonists|||
clonidine hcl oral tablet 0.1 mg, 0.2 mg, 0.3 mg|||
||1|
clonidine transdermal patch weekly 0.1 mg/24hr,0.2 mg/24hr, 0.3 mg/24hr|||
||1|
|||
droxidopa oral capsule 100 mg, 200 mg, 300 mg||1|
guanfacine hcl oral tablet 1 mg, 2 mg||1|PA
midodrine hcl oral tablet 10 mg, 2.5 mg, 5 mg||1|
Alpha-Adrenergic Blocking Agents|||
doxazosin mesylate oral tablet 1 mg, 2 mg, 4 mg,8 mg|||
|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
phenoxybenzamine hcl oral capsule 10 mg||1|PA
prazosin hcl oral capsule 1 mg, 2 mg, 5 mg||1|
terazosin hcl oral capsule 1 mg, 10 mg, 2 mg, 5mg|||
||1|
|||
Angiotensin Ii Receptor Antagonists|||
candesartan cilexetil oral tablet 16 mg, 32 mg, 4mg, 8 mg|||
|||
||1|
|||
irbesartan oral tablet 150 mg, 300 mg, 75 mg||1|
losartan potassium oral tablet 100 mg, 25 mg, 50mg|||
||1|
|||
olmesartan medoxomil oral tablet 20 mg, 40 mg,5 mg|||
||1|
|||
telmisartan oral tablet 20 mg, 40 mg, 80 mg||1|
valsartan oral tablet 160 mg, 320 mg, 40 mg, 80mg|||
||1|
|||
Angiotensin-Converting Enzyme (Ace)|||
Inhibitors|||
benazepril hcl oral tablet 10 mg, 20 mg, 40 mg, 5mg|||
||1|
|||
captopril oral tablet 100 mg, 12.5 mg, 25 mg, 50mg|||
||1|
|||
enalapril maleate oral tablet 10 mg, 2.5 mg, 20mg, 5 mg|||
||1|
|||
fosinopril sodium oral tablet 10 mg, 20 mg, 40 mg||1|
lisinopril oral tablet 10 mg, 2.5 mg, 20 mg, 30mg, 40 mg, 5 mg|||
||1|
|||
moexipril hcl oral tablet 15 mg, 7.5 mg||1|
perindopril erbumine oral tablet 2 mg, 4 mg, 8mg|||
||1|
|||
quinapril hcl oral tablet 10 mg, 20 mg, 40 mg, 5mg|||
||1|
|||
ramipril oral capsule 1.25 mg, 10 mg, 2.5 mg, 5mg|||
||1|
|||
trandolapril oral tablet 1 mg, 2 mg, 4 mg||1|
Antiarrhythmics|||
amiodarone hcl oral tablet 100 mg, 200 mg, 400mg|||
|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
disopyramide phosphate oral capsule 100 mg,150 mg||PA|
||1|
|||
dofetilide oral capsule 125 mcg, 250 mcg, 500mcg|||
||1|
|||
flecainide acetate oral tablet 100 mg, 150 mg, 50mg|||
||1|
|||
mexiletine hcl oral capsule 150 mg, 200 mg, 250mg|||
||1|
|||
MULTAQ ORAL TABLET 400 MG||1|
NORPACE CR ORAL CAPSULE EXTENDEDRELEASE 12 HOUR 100 MG, 150 MG||PA|
||1|
|||
propafenone hcl oral tablet 150 mg, 225 mg, 300mg|||
||1|
|||
quinidine gluconate er oral tablet extendedrelease 324 mg|||
||1|
|||
quinidine sulfate oral tablet 200 mg, 300 mg||1|
sotalol hcl (af) oral tablet 120 mg, 160 mg, 80 mg||1|
sotalol hcl oral tablet 120 mg, 160 mg, 240 mg,80 mg|||
||1|
|||
Beta-Adrenergic Blocking Agents|||
acebutolol hcl oral capsule 200 mg, 400 mg|||
||1|
atenolol oral tablet 100 mg, 25 mg, 50 mg||1|
betaxolol hcl oral tablet 10 mg, 20 mg||1|
bisoprolol fumarate oral tablet 10 mg, 5 mg||1|
carvedilol oral tablet 12.5 mg, 25 mg, 3.125 mg,6.25 mg|||
||1|
|||
labetalol hcl oral tablet 100 mg, 200 mg, 300 mg||1|
metoprolol succinate er oral tablet extendedrelease 24 hour 100 mg, 200 mg, 25 mg, 50 mg|||
||1|
|||
metoprolol tartrate oral tablet 100 mg, 25 mg, 50mg|||
||1|
|||
nadolol oral tablet 20 mg, 40 mg, 80 mg||1|
nebivolol hcl oral tablet 10 mg, 2.5 mg, 20 mg, 5mg|||
||1|
|||
pindolol oral tablet 10 mg, 5 mg||1|
propranolol hcl er oral capsule extended release24 hour 120 mg, 160 mg, 60 mg, 80 mg|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
propranolol hcl oral solution 20 mg/5ml, 40mg/5ml|||
||1|
|||
propranolol hcl oral tablet 10 mg, 20 mg, 40 mg,60 mg, 80 mg|||
||1|
|||
timolol maleate oral tablet 10 mg, 20 mg, 5 mg||1|
Calcium Channel Blocking Agents,|||
Dihydropyridines|||
amlodipine besylate oral tablet 10 mg, 2.5 mg, 5mg|||
||1|
|||
felodipine er oral tablet extended release 24 hour10 mg, 2.5 mg, 5 mg|||
||1|
|||
isradipine oral capsule 2.5 mg, 5 mg||1|
nifedipine er oral tablet extended release 24 hour30 mg, 60 mg, 90 mg|||
||1|
|||
nifedipine er osmotic release oral tablet extendedrelease 24 hour 30 mg, 60 mg, 90 mg|||
||1|
|||
nifedipine oral capsule 10 mg, 20 mg||1|PA
nimodipine oral capsule 30 mg||1|
Calcium Channel Blocking Agents,|||
Nondihydropyridines|||
cartia xt oral capsule extended release 24 hour120 mg, 180 mg, 240 mg, 300 mg|||
||1|
|||
diltiazem hcl er beads oral capsule extendedrelease 24 hour 120 mg, 180 mg, 240 mg, 300 mg,360 mg, 420 mg|||
||1|
|||
diltiazem hcl er coated beads oral capsuleextended release 24 hour 120 mg, 180 mg, 240mg, 300 mg, 360 mg|||
||1|
|||
diltiazem hcl er oral capsule extended release 12hour 120 mg, 60 mg, 90 mg|||
||1|
|||
diltiazem hcl er oral capsule extended release 24hour 120 mg, 180 mg, 240 mg|||
||1|
|||
diltiazem hcl oral tablet 120 mg, 30 mg, 60 mg,90 mg|||
||1|
|||
dilt-xr oral capsule extended release 24 hour 120mg, 180 mg, 240 mg|||
||1|
|||
verapamil hcl er oral capsule extended release 24hour 100 mg, 120 mg, 180 mg, 200 mg, 240 mg,300 mg, 360 mg|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
verapamil hcl er oral tablet extended release 120mg, 180 mg, 240 mg|||
||1|
|||
verapamil hcl oral tablet 120 mg, 40 mg, 80 mg||1|
Cardiovascular Agents, Other|||
acetazolamide oral tablet 125 mg, 250 mg|||
||1|
aliskiren fumarate oral tablet 150 mg, 300 mg||1|
amiloride-hydrochlorothiazide oral tablet 5-50mg|||
||1|
|||
amlodipine besy-benazepril hcl oral capsule 10-20 mg, 10-40 mg, 2.5-10 mg, 5-10 mg, 5-20 mg,5-40 mg|||
||1|
|||
amlodipine besylate-valsartan oral tablet 10-160mg, 10-320 mg, 5-160 mg, 5-320 mg|||
||1|
|||
amlodipine-olmesartan oral tablet 10-20 mg, 10-40 mg, 5-20 mg, 5-40 mg|||
||1|
|||
amlodipine-valsartan-hctz oral tablet 10-160-12.5mg, 10-160-25 mg, 10-320-25 mg, 5-160-12.5 mg,5-160-25 mg|||
||1|
|||
atenolol-chlorthalidone oral tablet 100-25 mg,50-25 mg|||
||1|
|||
benazepril-hydrochlorothiazide oral tablet 10-12.5 mg, 20-12.5 mg, 20-25 mg, 5-6.25 mg|||
||1|
|||
bisoprolol-hydrochlorothiazide oral tablet 10-6.25 mg, 2.5-6.25 mg, 5-6.25 mg|||
||1|
|||
CAMZYOS ORAL CAPSULE 10 MG, 15 MG,2.5 MG, 5 MG||PA; QL (30 EA per 30 days)|
||1|
|||
candesartan cilexetil-hctz oral tablet 16-12.5 mg,32-12.5 mg, 32-25 mg|||
||1|
|||
CORLANOR ORAL SOLUTION 5 MG/5ML||1|PA
CORLANOR ORAL TABLET 5 MG, 7.5 MG||1|PA
digoxin oral solution 0.05 mg/ml||1|QL (150 ML per 30 days)
digoxin oral tablet 125 mcg, 250 mcg||1|QL (30 EA per 30 days)
enalapril-hydrochlorothiazide oral tablet 10-25mg, 5-12.5 mg|||
||1|
|||
ENTRESTO ORAL TABLET 24-26 MG, 49-51MG, 97-103 MG||QL (60 EA per 30 days)|
||1|
|||
fosinopril sodium-hctz oral tablet 10-12.5 mg, 20-12.5 mg|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
irbesartan-hydrochlorothiazide oral tablet 150-12.5 mg, 300-12.5 mg|||
||1|
|||
KERENDIA ORAL TABLET 10 MG, 20 MG||1|PA; QL (30 EA per 30 days)
lisinopril-hydrochlorothiazide oral tablet 10-12.5mg, 20-12.5 mg, 20-25 mg|||
||1|
|||
losartan potassium-hctz oral tablet 100-12.5 mg,100-25 mg, 50-12.5 mg|||
||1|
|||
metoprolol-hydrochlorothiazide oral tablet 100-25 mg, 100-50 mg, 50-25 mg|||
||1|
|||
metyrosine oral capsule 250 mg||1|PA
NEXLETOL ORAL TABLET 180 MG||1|PA
NEXLIZET ORAL TABLET 180-10 MG||1|PA
olmesartan medoxomil-hctz oral tablet 20-12.5mg, 40-12.5 mg, 40-25 mg|||
||1|
|||
olmesartan-amlodipine-hctz oral tablet 20-5-12.5mg, 40-10-12.5 mg, 40-10-25 mg, 40-5-12.5 mg,40-5-25 mg|||
||1|
|||
pentoxifylline er oral tablet extended release 400mg|||
||1|
|||
quinapril-hydrochlorothiazide oral tablet 10-12.5mg, 20-12.5 mg, 20-25 mg|||
||1|
|||
ranolazine er oral tablet extended release 12 hour1000 mg, 500 mg|||
||1|
|||
spironolactone-hctz oral tablet 25-25 mg||1|
telmisartan-hctz oral tablet 40-12.5 mg, 80-12.5mg, 80-25 mg|||
||1|
|||
triamterene-hctz oral capsule 37.5-25 mg||1|
triamterene-hctz oral tablet 37.5-25 mg, 75-50 mg||1|
valsartan-hydrochlorothiazide oral tablet 160-12.5 mg, 160-25 mg, 320-12.5 mg, 320-25 mg,80-12.5 mg|||
||1|
|||
VERQUVO ORAL TABLET 10 MG, 2.5 MG, 5MG||QL (30 EA per 30 days)|
||1|
|||
Diuretics, Loop|||
bumetanide oral tablet 0.5 mg, 1 mg, 2 mg|||
||1|
furosemide injection solution 10 mg/ml||1|
furosemide oral solution 10 mg/ml, 8 mg/ml||1|
furosemide oral tablet 20 mg, 40 mg, 80 mg||1|
Drug Name||Drug Tier|Requirements/Limits
torsemide oral tablet 10 mg, 100 mg, 20 mg, 5 mg||1|
Diuretics, Potassium-Sparing|||
amiloride hcl oral tablet 5 mg|||
||1|
eplerenone oral tablet 25 mg, 50 mg||1|
spironolactone oral tablet 100 mg, 25 mg, 50 mg||1|
Diuretics, Thiazide|||
chlorthalidone oral tablet 25 mg, 50 mg|||
||1|
hydrochlorothiazide oral capsule 12.5 mg||1|
hydrochlorothiazide oral tablet 12.5 mg, 25 mg,50 mg|||
||1|
|||
indapamide oral tablet 1.25 mg, 2.5 mg||1|
metolazone oral tablet 10 mg, 2.5 mg, 5 mg||1|
Dyslipidemics, Fibric Acid Derivatives|||
fenofibrate micronized oral capsule 134 mg, 200mg, 43 mg, 67 mg|||
|||
||1|
|||
fenofibrate oral capsule 134 mg, 200 mg, 67 mg||1|
fenofibrate oral tablet 145 mg, 160 mg, 48 mg, 54mg|||
||1|
|||
fenofibric acid oral capsule delayed release 135mg, 45 mg|||
||1|
|||
fenofibric acid oral tablet 35 mg||1|
gemfibrozil oral tablet 600 mg||1|
Dyslipidemics, Hmg Coa Reductase|||
Inhibitors|||
atorvastatin calcium oral tablet 10 mg, 20 mg, 40mg, 80 mg|||
||1|
|||
lovastatin oral tablet 10 mg, 20 mg, 40 mg||1|
pravastatin sodium oral tablet 10 mg, 20 mg, 40mg, 80 mg|||
||1|
|||
rosuvastatin calcium oral tablet 10 mg, 20 mg, 40mg, 5 mg|||
||1|
|||
simvastatin oral tablet 10 mg, 20 mg, 40 mg, 5mg, 80 mg|||
||1|
|||
Dyslipidemics, Other|||
cholestyramine light oral packet 4 gm|||
||1|
cholestyramine light oral powder 4 gm/dose||1|
Drug Name||Drug Tier|Requirements/Limits
cholestyramine oral packet 4 gm||1|
cholestyramine oral powder 4 gm/dose||1|
colesevelam hcl oral packet 3.75 gm||1|
colesevelam hcl oral tablet 625 mg||1|
colestipol hcl oral granules 5 gm||1|
colestipol hcl oral packet 5 gm||1|
colestipol hcl oral tablet 1 gm||1|
ezetimibe oral tablet 10 mg||1|
ezetimibe-rosuvastatin oral tablet 10-10 mg, 10-20 mg, 10-40 mg, 10-5 mg|||
||1|
|||
ezetimibe-simvastatin oral tablet 10-10 mg, 10-20mg, 10-40 mg, 10-80 mg|||
||1|
|||
icosapent ethyl oral capsule 0.5 gm, 1 gm||1|PA
niacin er (antihyperlipidemic) oral tabletextended release 1000 mg, 500 mg, 750 mg|||
||1|
|||
omega-3-acid ethyl esters oral capsule 1 gm||1|
PRALUENT SUBCUTANEOUS SOLUTIONAUTO-INJECTOR 150 MG/ML, 75 MG/ML||PA|
||1|
|||
prevalite oral packet 4 gm||1|
prevalite oral powder 4 gm/dose||1|
REPATHA PUSHTRONEX SYSTEMSUBCUTANEOUS SOLUTION CARTRIDGE420 MG/3.5ML||PA|
||1|
|||
REPATHA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 140 MG/ML||PA|
||1|
|||
REPATHA SURECLICK SUBCUTANEOUSSOLUTION AUTO-INJECTOR 140 MG/ML||PA|
||1|
|||
Vasodilators, Direct-Acting Arterial|||
hydralazine hcl oral tablet 10 mg, 100 mg, 25 mg,50 mg|||
|||
||1|
|||
isosorb dinitrate-hydralazine oral tablet 20-37.5mg|||
||1|
|||
minoxidil oral tablet 10 mg, 2.5 mg||1|
Vasodilators, Direct-Acting Arterial/|||
Venous|||
isosorbide dinitrate oral tablet 10 mg, 20 mg, 30mg, 5 mg|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
isosorbide mononitrate er oral tablet extendedrelease 24 hour 120 mg, 30 mg, 60 mg|||
||1|
|||
isosorbide mononitrate oral tablet 10 mg, 20 mg||1|
NITRO-BID TRANSDERMAL OINTMENT 2 %||1|
NITRO-DUR TRANSDERMAL PATCH 24HOUR 0.3 MG/HR, 0.8 MG/HR|||
||1|
|||
nitroglycerin sublingual tablet sublingual 0.3 mg,0.4 mg, 0.6 mg|||
||1|
|||
nitroglycerin transdermal patch 24 hour 0.1mg/hr, 0.2 mg/hr, 0.4 mg/hr, 0.6 mg/hr|||
||1|
|||
nitroglycerin translingual solution 0.4 mg/spray||1|
RECTIV RECTAL OINTMENT 0.4 %||1|
Central Nervous System Agents -|||
Treatment Of Disorders Of The Brain|||
And Spinal Column|||
Attention Deficit Hyperactivity|||
Disorder Agents, Amphetamines|||
amphetamine-dextroamphet er oral capsuleextended release 24 hour 10 mg, 15 mg, 20 mg,25 mg, 30 mg, 5 mg||QL (30 EA per 30 days)|
||1|
|||
amphetamine-dextroamphetamine oral tablet 10mg, 20 mg, 30 mg, 5 mg, 7.5 mg||QL (60 EA per 30 days)|
||1|
|||
amphetamine-dextroamphetamine oral tablet 12.5mg||QL (120 EA per 30 days)|
||1|
|||
amphetamine-dextroamphetamine oral tablet 15mg||QL (90 EA per 30 days)|
||1|
|||
dextroamphetamine sulfate er oral capsuleextended release 24 hour 10 mg||QL (150 EA per 30 days)|
||1|
|||
dextroamphetamine sulfate er oral capsuleextended release 24 hour 15 mg||QL (120 EA per 30 days)|
||1|
|||
dextroamphetamine sulfate er oral capsuleextended release 24 hour 5 mg||QL (90 EA per 30 days)|
||1|
|||
dextroamphetamine sulfate oral tablet 10 mg, 5mg||QL (180 EA per 30 days)|
||1|
|||
Attention Deficit Hyperactivity|||
Disorder Agents, Non-Amphetamines|||
atomoxetine hcl oral capsule 10 mg, 100 mg, 18mg, 25 mg, 40 mg, 60 mg, 80 mg|||
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
clonidine hcl er oral tablet extended release 12hour 0.1 mg||QL (120 EA per 30 days)|
|1||
|||
dexmethylphenidate hcl er oral capsule extendedrelease 24 hour 10 mg, 15 mg, 20 mg, 25 mg, 30mg, 35 mg, 40 mg, 5 mg||QL (30 EA per 30 days)|
|1||
|||
dexmethylphenidate hcl oral tablet 10 mg|1|QL (60 EA per 30 days)|
dexmethylphenidate hcl oral tablet 2.5 mg, 5 mg|1|QL (90 EA per 30 days)|
guanfacine hcl er oral tablet extended release 24hour 1 mg, 2 mg, 3 mg, 4 mg||PA|
|1||
|||
methylphenidate hcl er (cd) oral capsule extendedrelease 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60mg||QL (30 EA per 30 days)|
|1||
|||
methylphenidate hcl er (la) oral capsule extendedrelease 24 hour 10 mg, 20 mg, 30 mg, 40 mg, 60mg||QL (30 EA per 30 days)|
|1||
|||
methylphenidate hcl er (osm) oral tablet extendedrelease 18 mg||QL (120 EA per 30 days)|
|1||
|||
methylphenidate hcl er (osm) oral tablet extendedrelease 27 mg, 54 mg, 72 mg||QL (30 EA per 30 days)|
|1||
|||
methylphenidate hcl er (osm) oral tablet extendedrelease 36 mg||QL (60 EA per 30 days)|
|1||
|||
methylphenidate hcl er (xr) oral capsule extendedrelease 24 hour 10 mg, 15 mg, 20 mg, 30 mg, 40mg, 50 mg, 60 mg||QL (30 EA per 30 days)|
|1||
|||
methylphenidate hcl er oral tablet extendedrelease 10 mg||QL (30 EA per 30 days)|
|1||
|||
methylphenidate hcl er oral tablet extendedrelease 20 mg||QL (90 EA per 30 days)|
|1||
|||
methylphenidate hcl er oral tablet extendedrelease 24 hour 18 mg||QL (120 EA per 30 days)|
|1||
|||
methylphenidate hcl er oral tablet extendedrelease 24 hour 27 mg, 54 mg||QL (30 EA per 30 days)|
|1||
|||
methylphenidate hcl er oral tablet extendedrelease 24 hour 36 mg||QL (60 EA per 30 days)|
|1||
|||
methylphenidate hcl oral solution 10 mg/5ml|1|QL (900 ML per 30 days)|
methylphenidate hcl oral solution 5 mg/5ml|1|QL (1800 ML per 30 days)|
methylphenidate hcl oral tablet 10 mg, 20 mg, 5mg||QL (90 EA per 30 days)|
|1||
|||
methylphenidate hcl oral tablet chewable 10 mg|1|QL (180 EA per 30 days)|
Drug Name||Drug Tier|Requirements/Limits
methylphenidate hcl oral tablet chewable 2.5 mg,5 mg||QL (90 EA per 30 days)|
||1|
|||
Central Nervous System, Other|||
AUSTEDO ORAL TABLET 12 MG, 6 MG, 9MG||PA|
|||
||1|
|||
AUSTEDO PATIENT TITRATION KIT ORALTABLET THERAPY PACK 6 & 9 & 12 MG||PA|
||1|
|||
EVRYSDI ORAL SOLUTIONRECONSTITUTED 0.75 MG/ML||PA|
||1|
|||
FIRDAPSE ORAL TABLET 10 MG||1|PA
INGREZZA ORAL CAPSULE 40 MG, 60 MG,80 MG||PA; QL (30 EA per 30 days)|
||1|
|||
INGREZZA ORAL CAPSULE THERAPYPACK 40 & 80 MG||PA; QL (56 EA per 365 days)|
||1|
|||
NUEDEXTA ORAL CAPSULE 20-10 MG||1|PA
RADICAVA ORS ORAL SUSPENSION 105MG/5ML||PA|
||1|
|||
RADICAVA ORS STARTER KIT ORALSUSPENSION 105 MG/5ML||PA|
||1|
|||
RELYVRIO ORAL PACKET 3-1 GM||1|PA
riluzole oral tablet 50 mg||1|
tetrabenazine oral tablet 12.5 mg, 25 mg||1|PA
Fibromyalgia Agents|||
duloxetine hcl oral capsule delayed releaseparticles 20 mg, 30 mg, 60 mg|||
|||
||1|
|||
SAVELLA ORAL TABLET 100 MG, 12.5 MG,25 MG, 50 MG||ST|
||1|
|||
SAVELLA TITRATION PACK ORAL 12.5 &25 & 50 MG||ST|
||1|
|||
Multiple Sclerosis Agents|||
BAFIERTAM ORAL CAPSULE DELAYEDRELEASE 95 MG||PA|
|||
||1|
|||
BETASERON SUBCUTANEOUS KIT 0.3 MG||1|PA
dalfampridine er oral tablet extended release 12hour 10 mg||PA|
||1|
|||
dimethyl fumarate oral capsule delayed release120 mg, 240 mg||PA|
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
dimethyl fumarate starter pack oral 120 & 240mg||PA|
|1||
|||
EXTAVIA SUBCUTANEOUS KIT 0.3 MG|1|PA|
fingolimod hcl oral capsule 0.5 mg|1|PA|
glatiramer acetate subcutaneous solutionprefilled syringe 20 mg/ml, 40 mg/ml||PA|
|1||
|||
glatopa subcutaneous solution prefilled syringe20 mg/ml, 40 mg/ml||PA|
|1||
|||
KESIMPTA SUBCUTANEOUS SOLUTIONAUTO-INJECTOR 20 MG/0.4ML||PA|
|1||
|||
MAVENCLAD (10 TABS) ORAL TABLETTHERAPY PACK 10 MG||PA|
|1||
|||
MAVENCLAD (4 TABS) ORAL TABLETTHERAPY PACK 10 MG||PA|
|1||
|||
MAVENCLAD (5 TABS) ORAL TABLETTHERAPY PACK 10 MG||PA|
|1||
|||
MAVENCLAD (6 TABS) ORAL TABLETTHERAPY PACK 10 MG||PA|
|1||
|||
MAVENCLAD (7 TABS) ORAL TABLETTHERAPY PACK 10 MG||PA|
|1||
|||
MAVENCLAD (8 TABS) ORAL TABLETTHERAPY PACK 10 MG||PA|
|1||
|||
MAVENCLAD (9 TABS) ORAL TABLETTHERAPY PACK 10 MG||PA|
|1||
|||
MAYZENT ORAL TABLET 0.25 MG, 1 MG, 2MG||PA|
|1||
|||
MAYZENT STARTER PACK ORAL TABLETTHERAPY PACK 12 X 0.25 MG, 7 X 0.25 MG||PA|
|1||
|||
PONVORY ORAL TABLET 20 MG|1|PA|
PONVORY STARTER PACK ORAL TABLETTHERAPY PACK 2-3-4-5-6-7-8-9 & 10 MG||PA|
|1||
|||
REBIF REBIDOSE SUBCUTANEOUSSOLUTION AUTO-INJECTOR 22 MCG/0.5ML,44 MCG/0.5ML||PA|
|1||
|||
REBIF REBIDOSE TITRATION PACKSUBCUTANEOUS SOLUTION AUTO-INJECTOR 6X8.8 & 6X22 MCG||PA|
|1||
|||
REBIF SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 22 MCG/0.5ML, 44MCG/0.5ML||PA|
1|||
|||
Drug Name||Drug Tier|Requirements/Limits
REBIF TITRATION PACK SUBCUTANEOUSSOLUTION PREFILLED SYRINGE 6X8.8 &6X22 MCG||PA|
||1|
|||
TASCENSO ODT ORAL TABLETDISPERSIBLE 0.25 MG, 0.5 MG||PA|
||1|
|||
teriflunomide oral tablet 14 mg, 7 mg||1|PA
ZEPOSIA 7-DAY STARTER PACK ORALCAPSULE THERAPY PACK 4 X 0.23MG & 3X 0.46MG||PA|
||1|
|||
ZEPOSIA ORAL CAPSULE 0.92 MG||1|PA
ZEPOSIA STARTER KIT ORAL CAPSULETHERAPY PACK 0.23MG &0.46MG0.92MG(21)||PA|
||1|
|||
Dental And Oral Agents - Treatment Of|||
Mouth And Gum Disorders|||
Dental And Oral Agents|||
cevimeline hcl oral capsule 30 mg|||
||1|
chlorhexidine gluconate mouth/throat solution0.12 %|||
||1|
|||
pilocarpine hcl oral tablet 5 mg, 7.5 mg||1|
triamcinolone acetonide mouth/throat paste 0.1 %||1|
Dermatological Agents - Treatment Of|||
Skin Conditions|||
Acne And Rosacea Agents|||
acitretin oral capsule 10 mg, 17.5 mg, 25 mg||PA|
||1|
adapalene external gel 0.1 %||1|
adapalene-benzoyl peroxide external gel 0.1-2.5%|||
||1|
|||
amnesteem oral capsule 10 mg, 20 mg, 40 mg||1|
benzoyl peroxide-erythromycin external gel 5-3 %||1|
claravis oral capsule 10 mg, 20 mg, 30 mg, 40 mg||1|
clindamycin phos-benzoyl perox external gel 1-5%, 1.2-2.5 %, 1.2-5 %|||
||1|
|||
isotretinoin oral capsule 10 mg, 20 mg, 30 mg, 40mg|||
||1|
|||
myorisan oral capsule 10 mg, 20 mg, 30 mg, 40mg|||
||1|
|||
tazarotene external cream 0.1 %||1|
Drug Name||Drug Tier|Requirements/Limits
tazarotene external gel 0.05 %, 0.1 %||1|
TAZORAC EXTERNAL CREAM 0.05 %||1|
tretinoin external cream 0.025 %, 0.05 %, 0.1 %||1|
tretinoin external gel 0.01 %, 0.025 %||1|
zenatane oral capsule 10 mg, 20 mg, 30 mg, 40mg|||
||1|
|||
Dermatitis And Pruritus Agents|||
alclometasone dipropionate external cream 0.05%|||
|||
||1|
|||
alclometasone dipropionate external ointment0.05 %|||
||1|
|||
ammonium lactate external cream 12 %||1|
ammonium lactate external lotion 12 %||1|
betamethasone dipropionate aug external cream0.05 %|||
||1|
|||
betamethasone dipropionate aug external gel 0.05%|||
||1|
|||
betamethasone dipropionate aug external lotion0.05 %|||
||1|
|||
betamethasone dipropionate aug externalointment 0.05 %|||
||1|
|||
betamethasone dipropionate external cream 0.05%|||
||1|
|||
betamethasone dipropionate external lotion 0.05%|||
||1|
|||
betamethasone dipropionate external ointment0.05 %|||
||1|
|||
betamethasone valerate external cream 0.1 %||1|
betamethasone valerate external lotion 0.1 %||1|
betamethasone valerate external ointment 0.1 %||1|
clobetasol prop emollient base external cream0.05 %|||
||1|
|||
clobetasol propionate e external cream 0.05 %||1|
clobetasol propionate external cream 0.05 %||1|
clobetasol propionate external gel 0.05 %||1|
clobetasol propionate external ointment 0.05 %||1|
clobetasol propionate external solution 0.05 %||1|
Drug Name|Drug Tier|Requirements/Limits|
desonide external cream 0.05 %|1||
desonide external lotion 0.05 %|1||
desonide external ointment 0.05 %|1||
desoximetasone external cream 0.05 %, 0.25 %|1||
desoximetasone external gel 0.05 %|1||
desoximetasone external ointment 0.05 %, 0.25 %|1||
doxepin hcl external cream 5 %|1|PA; QL (45 GM per 30 days)|
EUCRISA EXTERNAL OINTMENT 2 %|1|PA|
fluocinolone acetonide external cream 0.01 %,0.025 %|||
|1||
|||
fluocinolone acetonide external ointment 0.025 %|1||
fluocinolone acetonide external solution 0.01 %|1||
fluocinonide emulsified base external cream 0.05%|||
|1||
|||
fluocinonide external cream 0.05 %|1||
fluocinonide external gel 0.05 %|1||
fluocinonide external ointment 0.05 %|1||
fluocinonide external solution 0.05 %|1||
fluticasone propionate external cream 0.05 %|1||
fluticasone propionate external lotion 0.05 %|1||
fluticasone propionate external ointment 0.005 %|1||
halobetasol propionate external cream 0.05 %|1||
halobetasol propionate external ointment 0.05 %|1||
hydrocortisone (perianal) external cream 1 %,2.5 %|||
|1||
|||
hydrocortisone butyr lipo base external cream 0.1%|||
|1||
|||
hydrocortisone butyrate external cream 0.1 %|1||
hydrocortisone butyrate external ointment 0.1 %|1||
hydrocortisone butyrate external solution 0.1 %|1||
hydrocortisone external cream 1 %, 2.5 %|1||
hydrocortisone external lotion 2.5 %|1||
hydrocortisone external ointment 1 %, 2.5 %|1||
hydrocortisone valerate external cream 0.2 %|1||
hydrocortisone valerate external ointment 0.2 %|1||
HYFTOR EXTERNAL GEL 0.2 %|1|PA|
Drug Name||Drug Tier|Requirements/Limits
mometasone furoate external cream 0.1 %||1|
mometasone furoate external ointment 0.1 %||1|
mometasone furoate external solution 0.1 %||1|
pimecrolimus external cream 1 %||1|ST
prednicarbate external ointment 0.1 %||1|
selenium sulfide external lotion 2.5 %||1|
tacrolimus external ointment 0.03 %, 0.1 %||1|ST
triamcinolone acetonide external cream 0.025 %,0.1 %, 0.5 %|||
||1|
|||
triamcinolone acetonide external lotion 0.025 %,0.1 %|||
||1|
|||
triamcinolone acetonide external ointment 0.025%, 0.05 %, 0.1 %, 0.5 %|||
||1|
|||
triamcinolone in absorbase external ointment0.05 %|||
||1|
|||
Dermatological Agents, Other|||
alcohol pad  , 70 %|||
||1|
alcohol sheet  , 70 %||1|
calcipotriene external cream 0.005 %||1|
calcipotriene external ointment 0.005 %||1|
calcipotriene external solution 0.005 %||1|
calcitriol external ointment 3 mcg/gm||1|
clotrimazole-betamethasone external cream 1-0.05 %|||
||1|
|||
clotrimazole-betamethasone external lotion 1-0.05 %|||
||1|
|||
fluorouracil external cream 0.5 %||1|PA
fluorouracil external cream 5 %||1|
fluorouracil external solution 2 %, 5 %||1|
imiquimod external cream 5 %||1|
methoxsalen rapid oral capsule 10 mg||1|
nystatin-triamcinolone external cream 100000-0.1 unit/gm-%|||
||1|
|||
nystatin-triamcinolone external ointment 100000-0.1 unit/gm-%|||
||1|
|||
OTEZLA ORAL TABLET 30 MG||1|PA
Drug Name||Drug Tier|Requirements/Limits
OTEZLA ORAL TABLET THERAPY PACK 10& 20 & 30 MG||PA|
||1|
|||
podofilox external solution 0.5 %||1|
REGRANEX EXTERNAL GEL 0.01 %||1|PA; QL (15 GM per 30 days)
SANTYL EXTERNAL OINTMENT 250UNIT/GM||QL (90 GM per 30 days)|
||1|
|||
silver sulfadiazine external cream 1 %||1|
sodium chloride irrigation solution 0.9 %||1|
Pediculicides/Scabicides|||
lindane external shampoo 1 %|||
||1|
malathion external lotion 0.5 %||1|
permethrin external cream 5 %||1|
Topical Anti-Infectives|||
acyclovir external cream 5 %|||
||1|
acyclovir external ointment 5 %||1|
ciclopirox external solution 8 %||1|
ciclopirox olamine external cream 0.77 %||1|
ciclopirox olamine external suspension 0.77 %||1|
clindamycin phosphate external gel 1 %||1|
clindamycin phosphate external lotion 1 %||1|
clindamycin phosphate external solution 1 %||1|
clindamycin phosphate external swab 1 %||1|
ery external pad 2 %||1|
erythromycin external gel 2 %||1|
erythromycin external solution 2 %||1|
gentamicin sulfate external cream 0.1 %||1|
gentamicin sulfate external ointment 0.1 %||1|
metronidazole external cream 0.75 %||1|
metronidazole external gel 0.75 %, 1 %||1|
metronidazole external lotion 0.75 %||1|
mupirocin external ointment 2 %||1|QL (88 GM per 30 days)
penciclovir external cream 1 %||1|
Drug Name||Drug Tier|Requirements/Limits
Electrolytes/Minerals/ Metals/ Vitamins|||
- Products That Supplement Or Replace|||
Electrolytes, Minerals, Metals Or|||
Vitamins|||
Electrolyte/ Mineral Replacement|||
carglumic acid oral tablet soluble 200 mg||PA|
||1|
ISOLYTE-S INTRAVENOUS SOLUTION||1|
ISOLYTE-S PH 7.4 INTRAVENOUSSOLUTION|||
||1|
|||
kcl in dextrose-nacl intravenous solution 20-5-0.45 meq/l-%-%|||
||1|
|||
KLOR-CON 10 ORAL TABLET EXTENDEDRELEASE 10 MEQ|||
||1|
|||
klor-con m10 oral tablet extended release 10 meq||1|
klor-con m15 oral tablet extended release 15 meq||1|
klor-con m20 oral tablet extended release 20 meq||1|
KLOR-CON ORAL TABLET EXTENDEDRELEASE 8 MEQ|||
||1|
|||
magnesium sulfate injection solution 50 %, 50 %(10ml syringe)|||
||1|
|||
potassium chloride crys er oral tablet extendedrelease 10 meq, 15 meq, 20 meq|||
||1|
|||
potassium chloride er oral capsule extendedrelease 10 meq, 8 meq|||
||1|
|||
potassium chloride er oral tablet extended release10 meq, 20 meq, 8 meq|||
||1|
|||
potassium chloride intravenous solution 2meq/ml, 2 meq/ml (20 ml), 40 meq/100ml|||
||1|
|||
potassium chloride oral solution 10 %, 20meq/15ml (10%), 40 meq/15ml (20%)|||
||1|
|||
potassium citrate er oral tablet extended release10 meq (1080 mg), 15 meq (1620 mg), 5 meq (540mg)|||
||1|
|||
sodium chloride (pf) injection solution 0.9 %||1|
sodium chloride intravenous solution 0.45 %, 0.9%, 3 %|||
||1|
|||
sodium fluoride oral tablet 2.2 (1 f) mg||1|
Electrolyte/Mineral/Metal Modifiers|||
Drug Name||Drug Tier|Requirements/Limits
CUVRIOR ORAL TABLET 300 MG||1|PA
deferasirox granules oral packet 180 mg, 360 mg,90 mg||PA|
||1|
|||
deferasirox oral packet 180 mg, 360 mg, 90 mg||1|PA
deferasirox oral tablet 180 mg, 360 mg, 90 mg||1|PA
deferasirox oral tablet soluble 125 mg, 250 mg,500 mg||PA|
||1|
|||
deferiprone oral tablet 1000 mg, 500 mg||1|PA
penicillamine oral tablet 250 mg||1|PA
tolvaptan oral tablet 15 mg, 30 mg||1|PA
trientine hcl oral capsule 250 mg||1|PA
Electrolytes/Minerals/Metals/Vitamins|||
clinisol sf intravenous solution 15 %||B/D|
||1|
dextrose intravenous solution 10 %, 5 %||1|
dextrose-nacl intravenous solution 10-0.2 %, 10-0.45 %, 2.5-0.45 %, 5-0.2 %, 5-0.33 %, 5-0.45 %,5-0.9 %|||
||1|
|||
dextrose-sodium chloride intravenous solution2.5-0.45 %, 5-0.45 %, 5-0.9 %|||
||1|
|||
INTRALIPID INTRAVENOUS EMULSION 20%, 30 %||B/D|
||1|
|||
ISOLYTE-P IN D5W INTRAVENOUSSOLUTION|||
||1|
|||
levocarnitine oral solution 1 gm/10ml||1|
levocarnitine oral tablet 330 mg||1|
levocarnitine sf oral solution 1 gm/10ml||1|
NUTRILIPID INTRAVENOUS EMULSION 20%||B/D|
||1|
|||
plenamine intravenous solution 15 %||1|B/D
prenatal oral tablet 27-1 mg||1|
Phosphate Binders|||
calcium acetate (phos binder) oral capsule 667mg|||
|||
||1|
|||
lanthanum carbonate oral tablet chewable 1000mg, 500 mg, 750 mg|||
||1|
|||
sevelamer carbonate oral packet 0.8 gm, 2.4 gm||1|
sevelamer carbonate oral tablet 800 mg||1|
Drug Name||Drug Tier|Requirements/Limits
Potassium Binders|||
LOKELMA ORAL PACKET 10 GM, 5 GM|||
||1|
sodium polystyrene sulfonate oral powder||1|
sps oral suspension 15 gm/60ml||1|
Vitamins|||
m-natal plus oral tablet 27-1 mg|||
||1|
trinatal rx 1 oral tablet 60-1 mg||1|
Gastrointestinal Agents - Treatment Of|||
Stomach And Intestinal Conditions|||
Anti-Constipation Agents|||
constulose oral solution 10 gm/15ml|||
||1|
enulose oral solution 10 gm/15ml||1|
gavilyte-c oral solution reconstituted 240 gm||1|
gavilyte-g oral solution reconstituted 236 gm||1|
generlac oral solution 10 gm/15ml||1|
lactulose encephalopathy oral solution 10gm/15ml|||
||1|
|||
lactulose oral solution 10 gm/15ml, 20 gm/30ml||1|
LINZESS ORAL CAPSULE 145 MCG, 290MCG, 72 MCG||QL (30 EA per 30 days)|
||1|
|||
lubiprostone oral capsule 24 mcg, 8 mcg||1|QL (60 EA per 30 days)
MOVANTIK ORAL TABLET 12.5 MG, 25 MG||1|QL (30 EA per 30 days)
peg 3350-kcl-na bicarb-nacl oral solutionreconstituted 420 gm|||
||1|
|||
peg-3350/electrolytes oral solution reconstituted236 gm|||
||1|
|||
RELISTOR ORAL TABLET 150 MG||1|PA
RELISTOR SUBCUTANEOUS SOLUTION 12MG/0.6ML, 12 MG/0.6ML (0.6ML SYRINGE),8 MG/0.4ML||PA|
||1|
|||
Anti-Diarrheal Agents|||
alosetron hcl oral tablet 0.5 mg, 1 mg||QL (60 EA per 30 days)|
||1|
diphenoxylate-atropine oral liquid 2.5-0.025mg/5ml|||
||1|
|||
diphenoxylate-atropine oral tablet 2.5-0.025 mg||1|
loperamide hcl oral capsule 2 mg||1|
Drug Name||Drug Tier|Requirements/Limits
XERMELO ORAL TABLET 250 MG||1|PA
XIFAXAN ORAL TABLET 200 MG, 550 MG||1|PA
Antispasmodics, Gastrointestinal|||
dicyclomine hcl oral capsule 10 mg|||
||1|
dicyclomine hcl oral solution 10 mg/5ml||1|
dicyclomine hcl oral tablet 20 mg||1|
glycopyrrolate oral solution 1 mg/5ml||1|
glycopyrrolate oral tablet 1 mg, 2 mg||1|
Gastrointestinal Agents, Other|||
GATTEX SUBCUTANEOUS KIT 5 MG||PA|
||1|
LIVMARLI ORAL SOLUTION 9.5 MG/ML||1|PA
OCALIVA ORAL TABLET 10 MG, 5 MG||1|PA
ursodiol oral capsule 300 mg||1|
ursodiol oral tablet 250 mg, 500 mg||1|
VOWST ORAL CAPSULE||1|PA
Histamine2 (H2) Receptor Antagonists|||
cimetidine hcl oral solution 300 mg/5ml, 400mg/6.67ml|||
|||
||1|
|||
cimetidine oral tablet 200 mg, 300 mg, 400 mg,800 mg|||
||1|
|||
famotidine oral tablet 20 mg, 40 mg||1|
Protectants|||
misoprostol oral tablet 100 mcg, 200 mcg|||
||1|
sucralfate oral tablet 1 gm||1|
Proton Pump Inhibitors|||
esomeprazole magnesium oral capsule delayedrelease 20 mg, 40 mg|||
|||
||1|
|||
lansoprazole oral capsule delayed release 15 mg,30 mg|||
||1|
|||
omeprazole oral capsule delayed release 10 mg,20 mg, 40 mg|||
||1|
|||
pantoprazole sodium oral tablet delayed release20 mg, 40 mg|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
Genetic Or Enzyme Or Protein|||
Disorder: Replacement, Modifiers,|||
Treatment - Products That Replace,|||
Modify, Or Treat Genetic Or Enzyme|||
Disorders|||
Genetic Or Enzyme Or Protein|||
Disorder: Replacement, Modifiers,|||
Treatment|||
ARALAST NP INTRAVENOUS SOLUTIONRECONSTITUTED 1000 MG, 500 MG||PA|
||1|
|||
betaine oral powder||1|
CERDELGA ORAL CAPSULE 84 MG||1|PA
CHOLBAM ORAL CAPSULE 250 MG, 50 MG||1|PA
CREON ORAL CAPSULE DELAYEDRELEASE PARTICLES 12000-38000 UNIT,24000-76000 UNIT, 3000-9500 UNIT, 36000-114000 UNIT, 6000-19000 UNIT|||
||1|
|||
CYSTAGON ORAL CAPSULE 150 MG, 50 MG||1|PA
dichlorphenamide oral tablet 50 mg||1|PA
ENDARI ORAL PACKET 5 GM||1|PA
GALAFOLD ORAL CAPSULE 123 MG||1|PA
GLASSIA INTRAVENOUS SOLUTION 1000MG/50ML||PA|
||1|
|||
miglustat oral capsule 100 mg||1|PA
nitisinone oral capsule 10 mg, 2 mg, 20 mg, 5 mg||1|PA
ORFADIN ORAL SUSPENSION 4 MG/ML||1|PA
PROLASTIN-C INTRAVENOUS SOLUTION1000 MG/20ML||PA|
||1|
|||
PROLASTIN-C INTRAVENOUS SOLUTIONRECONSTITUTED 1000 MG||PA|
||1|
|||
RAVICTI ORAL LIQUID 1.1 GM/ML||1|PA
sapropterin dihydrochloride oral packet 100 mg,500 mg||PA|
||1|
|||
sapropterin dihydrochloride oral tablet 100 mg||1|PA
sodium phenylbutyrate oral powder 3 gm/tsp||1|PA
sodium phenylbutyrate oral tablet 500 mg||1|PA
SUCRAID ORAL SOLUTION 8500 UNIT/ML||1|PA
Drug Name||Drug Tier|Requirements/Limits
XURIDEN ORAL PACKET 2 GM||1|PA
ZEMAIRA INTRAVENOUS SOLUTIONRECONSTITUTED 1000 MG||PA|
||1|
|||
ZENPEP ORAL CAPSULE DELAYEDRELEASE PARTICLES 10000-32000 UNIT,15000-47000 UNIT, 20000-63000 UNIT, 25000-79000 UNIT, 3000-10000 UNIT, 40000-126000UNIT, 5000-24000 UNIT|||
||1|
|||
Genitourinary Agents - Treatment Of|||
Urinary Tract And Prostate Conditions|||
Antispasmodics, Urinary|||
darifenacin hydrobromide er oral tablet extendedrelease 24 hour 15 mg, 7.5 mg||ST|
|||
||1|
|||
fesoterodine fumarate er oral tablet extendedrelease 24 hour 4 mg, 8 mg||ST|
||1|
|||
flavoxate hcl oral tablet 100 mg||1|
MYRBETRIQ ORAL SUSPENSIONRECONSTITUTED ER 8 MG/ML||QL (300 ML per 30 days)|
||1|
|||
MYRBETRIQ ORAL TABLET EXTENDEDRELEASE 24 HOUR 25 MG, 50 MG||QL (30 EA per 30 days)|
||1|
|||
oxybutynin chloride er oral tablet extendedrelease 24 hour 10 mg, 15 mg, 5 mg|||
||1|
|||
oxybutynin chloride oral syrup 5 mg/5ml||1|
oxybutynin chloride oral tablet 5 mg||1|
solifenacin succinate oral tablet 10 mg, 5 mg||1|
tolterodine tartrate er oral capsule extendedrelease 24 hour 2 mg, 4 mg|||
||1|
|||
tolterodine tartrate oral tablet 1 mg, 2 mg||1|
trospium chloride er oral capsule extendedrelease 24 hour 60 mg||ST|
||1|
|||
trospium chloride oral tablet 20 mg||1|
Benign Prostatic Hypertrophy Agents|||
alfuzosin hcl er oral tablet extended release 24hour 10 mg|||
|||
||1|
|||
dutasteride oral capsule 0.5 mg||1|
finasteride oral tablet 5 mg||1|
tamsulosin hcl oral capsule 0.4 mg||1|
Genitourinary Agents, Other|||
Drug Name||Drug Tier|Requirements/Limits
bethanechol chloride oral tablet 10 mg, 25 mg, 5mg, 50 mg|||
||1|
|||
ELMIRON ORAL CAPSULE 100 MG||1|
FILSPARI ORAL TABLET 200 MG, 400 MG||1|PA
THIOLA EC ORAL TABLET DELAYEDRELEASE 100 MG, 300 MG||PA|
||1|
|||
tiopronin oral tablet 100 mg||1|PA
Hormonal Agents, Stimulant/|||
Replacement/ Modifying (Adrenal) -|||
Treatment Of Conditions Requiring|||
Steroids|||
Hormonal Agents, Stimulant/|||
Replacement/ Modifying (Adrenal)|||
ACTHAR INJECTION GEL 80 UNIT/ML||1|PA
CORTROPHIN INJECTION GEL 80 UNIT/ML||1|PA
dexamethasone oral solution 0.5 mg/5ml||1|
dexamethasone oral tablet 0.5 mg, 0.75 mg, 1 mg,1.5 mg, 2 mg, 4 mg, 6 mg|||
||1|
|||
fludrocortisone acetate oral tablet 0.1 mg||1|
hydrocortisone oral tablet 10 mg, 20 mg, 5 mg||1|
methylprednisolone oral tablet 16 mg, 32 mg, 4mg, 8 mg|||
||1|
|||
methylprednisolone oral tablet therapy pack 4 mg||1|
prednisolone oral solution 15 mg/5ml||1|
prednisolone sodium phosphate oral solution 25mg/5ml, 6.7 (5 base) mg/5ml|||
||1|
|||
Hormonal Agents, Stimulant/|||
Replacement/ Modifying (Pituitary) -|||
Treatment Of Pituitary Gland|||
Conditions|||
Hormonal Agents, Stimulant/|||
Replacement/ Modifying (Pituitary)|||
desmopressin ace spray refrig nasal solution 0.01%|||
||1|
|||
desmopressin acetate oral tablet 0.1 mg, 0.2 mg||1|
EGRIFTA SV SUBCUTANEOUS SOLUTIONRECONSTITUTED 2 MG||PA|
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
GENOTROPIN MINIQUICKSUBCUTANEOUS PREFILLED SYRINGE 0.2MG, 0.4 MG, 0.6 MG, 0.8 MG, 1 MG, 1.2 MG,1.4 MG, 1.6 MG, 1.8 MG, 2 MG||PA|
||1|
|||
GENOTROPIN SUBCUTANEOUSCARTRIDGE 12 MG, 5 MG||PA|
||1|
|||
HUMATROPE INJECTION CARTRIDGE 12MG, 24 MG, 6 MG||PA|
||1|
|||
INCRELEX SUBCUTANEOUS SOLUTION 40MG/4ML||PA|
||1|
|||
NORDITROPIN FLEXPRO SUBCUTANEOUSSOLUTION PEN-INJECTOR 10 MG/1.5ML, 15MG/1.5ML, 30 MG/3ML, 5 MG/1.5ML||PA|
||1|
|||
NUTROPIN AQ NUSPIN 10 SUBCUTANEOUSSOLUTION PEN-INJECTOR 10 MG/2ML||PA|
||1|
|||
NUTROPIN AQ NUSPIN 20 SUBCUTANEOUSSOLUTION PEN-INJECTOR 20 MG/2ML||PA|
||1|
|||
NUTROPIN AQ NUSPIN 5 SUBCUTANEOUSSOLUTION PEN-INJECTOR 5 MG/2ML||PA|
||1|
|||
OMNITROPE SUBCUTANEOUS SOLUTIONCARTRIDGE 10 MG/1.5ML, 5 MG/1.5ML||PA|
||1|
|||
OMNITROPE SUBCUTANEOUS SOLUTIONRECONSTITUTED 5.8 MG||PA|
||1|
|||
SEROSTIM SUBCUTANEOUS SOLUTIONRECONSTITUTED 4 MG, 5 MG, 6 MG||PA|
||1|
|||
SKYTROFA SUBCUTANEOUS CARTRIDGE11 MG, 13.3 MG, 3 MG, 3.6 MG, 4.3 MG, 5.2MG, 6.3 MG, 7.6 MG, 9.1 MG||PA|
||1|
|||
Hormonal Agents, Stimulant/|||
Replacement/ Modifying (Sex|||
Hormones/ Modifiers) - For The|||
Replacement Or Modification Of Sex|||
Hormones|||
Anabolic Steroids|||
oxandrolone oral tablet 10 mg, 2.5 mg|||
||1|
Androgens|||
danazol oral capsule 100 mg, 200 mg, 50 mg|||
||1|
methyltestosterone oral capsule 10 mg||1|PA
Drug Name||Drug Tier|Requirements/Limits
testosterone cypionate injection solution 200mg/ml|||
||1|
|||
testosterone cypionate intramuscular solution 100mg/ml, 200 mg/ml, 200 mg/ml (1 ml)|||
||1|
|||
testosterone enanthate intramuscular solution 200mg/ml|||
||1|
|||
testosterone transdermal gel 1.62 %, 12.5 mg/act(1%), 20.25 mg/1.25gm (1.62%), 20.25 mg/act(1.62%), 25 mg/2.5gm (1%), 40.5 mg/2.5gm(1.62%), 50 mg/5gm (1%)||PA|
||1|
|||
testosterone transdermal solution 30 mg/act||1|PA
Estrogens|||
estradiol oral tablet 0.5 mg, 1 mg, 2 mg|||
||1|
estradiol transdermal patch twice weekly 0.025mg/24hr, 0.0375 mg/24hr, 0.05 mg/24hr, 0.075mg/24hr, 0.1 mg/24hr|||
||1|
|||
estradiol transdermal patch weekly 0.025mg/24hr, 0.0375 mg/24hr, 0.05 mg/24hr, 0.06mg/24hr, 0.075 mg/24hr, 0.1 mg/24hr|||
||1|
|||
estradiol vaginal cream 0.1 mg/gm||1|
estradiol vaginal tablet 10 mcg||1|
estradiol valerate intramuscular oil 10 mg/ml, 20mg/ml, 40 mg/ml|||
||1|
|||
MENEST ORAL TABLET 0.3 MG, 0.625 MG,1.25 MG, 2.5 MG||PA|
||1|
|||
PREMARIN ORAL TABLET 0.3 MG, 0.45 MG,0.625 MG, 0.9 MG, 1.25 MG|||
||1|
|||
PREMARIN VAGINAL CREAM 0.625 MG/GM||1|
yuvafem vaginal tablet 10 mcg||1|
Hormonal Agents, Stimulant/|||
Replacement/ Modifying (Sex|||
Hormones/ Modifiers)|||
afirmelle oral tablet 0.1-20 mg-mcg||1|
altavera oral tablet 0.15-30 mg-mcg||1|
alyacen 1/35 oral tablet 1-35 mg-mcg||1|
alyacen 7/7/7 oral tablet 0.5/0.75/1-35 mg-mcg||1|
amabelz oral tablet 0.5-0.1 mg, 1-0.5 mg||1|
apri oral tablet 0.15-30 mg-mcg||1|
Drug Name|Drug Tier|Requirements/Limits|
aranelle oral tablet 0.5/1/0.5-35 mg-mcg|1||
aubra eq oral tablet 0.1-20 mg-mcg|1||
aurovela 1.5/30 oral tablet 1.5-30 mg-mcg|1||
aurovela fe 1.5/30 oral tablet 1.5-30 mg-mcg|1||
aurovela fe 1/20 oral tablet 1-20 mg-mcg|1||
aviane oral tablet 0.1-20 mg-mcg|1||
ayuna oral tablet 0.15-30 mg-mcg|1||
balziva oral tablet 0.4-35 mg-mcg|1||
blisovi fe 1.5/30 oral tablet 1.5-30 mg-mcg|1||
blisovi fe 1/20 oral tablet 1-20 mg-mcg|1||
briellyn oral tablet 0.4-35 mg-mcg|1||
chateal eq oral tablet 0.15-30 mg-mcg|1||
COMBIPATCH TRANSDERMAL PATCHTWICE WEEKLY 0.05-0.14 MG/DAY, 0.05-0.25 MG/DAY|||
|1||
|||
cryselle-28 oral tablet 0.3-30 mg-mcg|1||
cyred eq oral tablet 0.15-30 mg-mcg|1||
desogestrel-ethinyl estradiol oral tablet 0.15-0.02/0.01 mg (21/5), 0.15-30 mg-mcg|||
|1||
|||
drospirenone-ethinyl estradiol oral tablet 3-0.02mg, 3-0.03 mg|||
|1||
|||
eluryng vaginal ring 0.12-0.015 mg/24hr|1||
enpresse-28 oral tablet 50-30/75-40/ 125-30 mcg|1||
enskyce oral tablet 0.15-30 mg-mcg|1||
estarylla oral tablet 0.25-35 mg-mcg|1||
estradiol-norethindrone acet oral tablet 0.5-0.1mg, 1-0.5 mg|||
|1||
|||
ethynodiol diac-eth estradiol oral tablet 1-35 mg-mcg, 1-50 mg-mcg|||
|1||
|||
etonogestrel-ethinyl estradiol vaginal ring 0.12-0.015 mg/24hr|||
|1||
|||
falmina oral tablet 0.1-20 mg-mcg|1||
femynor oral tablet 0.25-35 mg-mcg|1||
fyavolv oral tablet 0.5-2.5 mg-mcg, 1-5 mg-mcg|1||
hailey 24 fe oral tablet 1-20 mg-mcg(24)|1||
hailey fe 1.5/30 oral tablet 1.5-30 mg-mcg|1||
hailey fe 1/20 oral tablet 1-20 mg-mcg|1||
Drug Name|Drug Tier|Requirements/Limits|
introvale oral tablet 0.15-0.03 mg|1||
isibloom oral tablet 0.15-30 mg-mcg|1||
jinteli oral tablet 1-5 mg-mcg|1||
juleber oral tablet 0.15-30 mg-mcg|1||
junel 1.5/30 oral tablet 1.5-30 mg-mcg|1||
junel 1/20 oral tablet 1-20 mg-mcg|1||
junel fe 1.5/30 oral tablet 1.5-30 mg-mcg|1||
junel fe 1/20 oral tablet 1-20 mg-mcg|1||
kariva oral tablet 0.15-0.02/0.01 mg (21/5)|1||
kelnor 1/35 oral tablet 1-35 mg-mcg|1||
kelnor 1/50 oral tablet 1-50 mg-mcg|1||
kurvelo oral tablet 0.15-30 mg-mcg|1||
larin 1.5/30 oral tablet 1.5-30 mg-mcg|1||
larin 1/20 oral tablet 1-20 mg-mcg|1||
larin fe 1.5/30 oral tablet 1.5-30 mg-mcg|1||
larin fe 1/20 oral tablet 1-20 mg-mcg|1||
leena oral tablet 0.5/1/0.5-35 mg-mcg|1||
lessina oral tablet 0.1-20 mg-mcg|1||
levonest oral tablet 50-30/75-40/ 125-30 mcg|1||
levonorgest-eth estrad 91-day oral tablet 0.1-0.02& 0.01 mg, 0.15-0.03 &0.01 mg, 0.15-0.03 mg|||
|1||
|||
levonorgestrel-ethinyl estrad oral tablet 0.1-20mg-mcg, 0.15-30 mg-mcg|||
|1||
|||
levonorg-eth estrad triphasic oral tablet 50-30/75-40/ 125-30 mcg|||
|1||
|||
levora 0.15/30 (28) oral tablet 0.15-30 mg-mcg|1||
low-ogestrel oral tablet 0.3-30 mg-mcg|1||
lutera oral tablet 0.1-20 mg-mcg|1||
marlissa oral tablet 0.15-30 mg-mcg|1||
microgestin 1.5/30 oral tablet 1.5-30 mg-mcg|1||
microgestin 1/20 oral tablet 1-20 mg-mcg|1||
microgestin 24 fe oral tablet 1-20 mg-mcg|1||
microgestin fe 1.5/30 oral tablet 1.5-30 mg-mcg|1||
microgestin fe 1/20 oral tablet 1-20 mg-mcg|1||
mili oral tablet 0.25-35 mg-mcg|1||
mimvey oral tablet 1-0.5 mg|1||
Drug Name|Drug Tier|Requirements/Limits|
necon 0.5/35 (28) oral tablet 0.5-35 mg-mcg|1||
norethin ace-eth estrad-fe oral tablet 1-20 mg-mcg, 1.5-30 mg-mcg|||
|1||
|||
norethindrone acet-ethinyl est oral tablet 1-20mg-mcg, 1.5-30 mg-mcg|||
|1||
|||
norethindrone-eth estradiol oral tablet 0.5-2.5mg-mcg, 1-5 mg-mcg|||
|1||
|||
norethindron-ethinyl estrad-fe oral tablet 1-20/1-30/1-35 mg-mcg|||
|1||
|||
norgestimate-eth estradiol oral tablet 0.25-35 mg-mcg|||
|1||
|||
norgestim-eth estrad triphasic oral tablet0.18/0.215/0.25 mg-35 mcg|||
|1||
|||
nortrel 0.5/35 (28) oral tablet 0.5-35 mg-mcg|1||
nortrel 1/35 (21) oral tablet 1-35 mg-mcg|1||
nortrel 1/35 (28) oral tablet 1-35 mg-mcg|1||
nortrel 7/7/7 oral tablet 0.5/0.75/1-35 mg-mcg|1||
nylia 1/35 oral tablet 1-35 mg-mcg|1||
nylia 7/7/7 oral tablet 0.5/0.75/1-35 mg-mcg|1||
ocella oral tablet 3-0.03 mg|1||
pimtrea oral tablet 0.15-0.02/0.01 mg (21/5)|1||
pirmella 1/35 oral tablet 1-35 mg-mcg|1||
portia-28 oral tablet 0.15-30 mg-mcg|1||
PREMPHASE ORAL TABLET 0.625-5 MG|1||
PREMPRO ORAL TABLET 0.3-1.5 MG, 0.45-1.5 MG, 0.625-2.5 MG, 0.625-5 MG|||
|1||
|||
reclipsen oral tablet 0.15-30 mg-mcg|1||
setlakin oral tablet 0.15-0.03 mg|1||
sprintec 28 oral tablet 0.25-35 mg-mcg|1||
sronyx oral tablet 0.1-20 mg-mcg|1||
tarina fe 1/20 eq oral tablet 1-20 mg-mcg|1||
tri femynor oral tablet 0.18/0.215/0.25 mg-35mcg|||
|1||
|||
tri-estarylla oral tablet 0.18/0.215/0.25 mg-35mcg|||
|1||
|||
tri-legest fe oral tablet 1-20/1-30/1-35 mg-mcg|1||
tri-mili oral tablet 0.18/0.215/0.25 mg-35 mcg|1||
Drug Name||Drug Tier|Requirements/Limits
tri-sprintec oral tablet 0.18/0.215/0.25 mg-35mcg|||
||1|
|||
trivora (28) oral tablet 50-30/75-40/ 125-30 mcg||1|
tri-vylibra oral tablet 0.18/0.215/0.25 mg-35 mcg||1|
velivet oral tablet 0.1/0.125/0.15 -0.025 mg||1|
vienva oral tablet 0.1-20 mg-mcg||1|
vyfemla oral tablet 0.4-35 mg-mcg||1|
vylibra oral tablet 0.25-35 mg-mcg||1|
xulane transdermal patch weekly 150-35mcg/24hr|||
||1|
|||
zafemy transdermal patch weekly 150-35mcg/24hr|||
||1|
|||
zovia 1/35 (28) oral tablet 1-35 mg-mcg||1|
Progestins|||
camila oral tablet 0.35 mg|||
||1|
deblitane oral tablet 0.35 mg||1|
DEPO-SUBQ PROVERA 104SUBCUTANEOUS SUSPENSION PREFILLEDSYRINGE 104 MG/0.65ML|||
||1|
|||
errin oral tablet 0.35 mg||1|
incassia oral tablet 0.35 mg||1|
lyza oral tablet 0.35 mg||1|
medroxyprogesterone acetate intramuscularsuspension 150 mg/ml|||
||1|
|||
medroxyprogesterone acetate intramuscularsuspension prefilled syringe 150 mg/ml|||
||1|
|||
medroxyprogesterone acetate oral tablet 10 mg,2.5 mg, 5 mg|||
||1|
|||
megestrol acetate oral suspension 40 mg/ml, 400mg/10ml, 625 mg/5ml, 800 mg/20ml||PA|
||1|
|||
megestrol acetate oral tablet 20 mg, 40 mg||1|PA
nora-be oral tablet 0.35 mg||1|
norethindrone acetate oral tablet 5 mg||1|
norethindrone oral tablet 0.35 mg||1|
norlyroc oral tablet 0.35 mg||1|
progesterone oral capsule 100 mg, 200 mg||1|
sharobel oral tablet 0.35 mg||1|
Drug Name||Drug Tier|Requirements/Limits
Selective Estrogen Receptor Modifying|||
Agents|||
DUAVEE ORAL TABLET 0.45-20 MG||1|
raloxifene hcl oral tablet 60 mg||1|
Hormonal Agents, Stimulant/|||
Replacement/ Modifying (Thyroid) -|||
Treatment Of Thyroid Conditions|||
Hormonal Agents, Stimulant/|||
Replacement/ Modifying (Thyroid)|||
EUTHYROX ORAL TABLET 100 MCG, 112MCG, 125 MCG, 137 MCG, 150 MCG, 175MCG, 200 MCG, 25 MCG, 50 MCG, 75 MCG,88 MCG|1.0||
|1.0||
LEVO-T ORAL TABLET 100 MCG, 112 MCG,125 MCG, 137 MCG, 150 MCG, 175 MCG, 200MCG, 25 MCG, 300 MCG, 50 MCG, 75 MCG,88 MCG|1.0||
|1.0||
levothyroxine sodium oral tablet 100 mcg, 112mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 200mcg, 25 mcg, 300 mcg, 50 mcg, 75 mcg, 88 mcg|1.0||
|1.0||
LEVOXYL ORAL TABLET 100 MCG, 112MCG, 125 MCG, 137 MCG, 150 MCG, 175MCG, 200 MCG, 25 MCG, 50 MCG, 75 MCG,88 MCG|1.0||
|1.0||
liothyronine sodium oral tablet 25 mcg, 5 mcg, 50mcg|1.0||
|1.0||
SYNTHROID ORAL TABLET 100 MCG, 112MCG, 125 MCG, 137 MCG, 150 MCG, 175MCG, 200 MCG, 25 MCG, 300 MCG, 50 MCG,75 MCG, 88 MCG|1.0||
|1.0||
UNITHROID ORAL TABLET 100 MCG, 112MCG, 125 MCG, 137 MCG, 150 MCG, 175MCG, 200 MCG, 25 MCG, 300 MCG, 50 MCG,75 MCG, 88 MCG|1.0||
|1.0||
Hormonal Agents, Suppressant|||
(Pituitary) - Treatment Of Or|||
Modification Of Pituitary Hormone|||
Secretion|||
Hormonal Agents, Suppressant|||
(Pituitary)|||
1|||
1|||
1|||
1|||
1|||
1|||
1|||
1|||
1|||
1|||
1|||
1|||
1|||
1|||
Drug Name|Drug Tier|Requirements/Limits|
cabergoline oral tablet 0.5 mg|1||
CAMCEVI SUBCUTANEOUS PREFILLEDSYRINGE 42 MG||PA|
|1||
|||
ELIGARD SUBCUTANEOUS KIT 22.5 MG, 30MG, 45 MG, 7.5 MG||PA|
|1||
|||
FIRMAGON (240 MG DOSE)SUBCUTANEOUS SOLUTIONRECONSTITUTED 120 MG/VIAL||PA|
|1||
|||
FIRMAGON SUBCUTANEOUS SOLUTIONRECONSTITUTED 80 MG||PA|
|1||
|||
leuprolide acetate (3 month) intramuscularinjectable 22.5 mg||PA|
|1||
|||
leuprolide acetate injection kit 1 mg/0.2ml|1||
LUPRON DEPOT (1-MONTH)INTRAMUSCULAR KIT 3.75 MG, 7.5 MG||PA|
|1||
|||
LUPRON DEPOT (3-MONTH)INTRAMUSCULAR KIT 11.25 MG, 22.5 MG||PA|
|1||
|||
LUPRON DEPOT (4-MONTH)INTRAMUSCULAR KIT 30 MG||PA|
|1||
|||
LUPRON DEPOT (6-MONTH)INTRAMUSCULAR KIT 45 MG||PA|
|1||
|||
MYFEMBREE ORAL TABLET 40-1-0.5 MG|1|PA|
octreotide acetate injection solution 100 mcg/ml,1000 mcg/ml, 200 mcg/ml, 50 mcg/ml, 500mcg/ml||PA|
|1||
|||
octreotide acetate subcutaneous solution prefilledsyringe 100 mcg/ml, 50 mcg/ml, 500 mcg/ml|||
|1||
|||
ORGOVYX ORAL TABLET 120 MG|1|PA|
ORIAHNN ORAL CAPSULE THERAPY PACK300-1-0.5 & 300 MG||PA|
|1||
|||
ORILISSA ORAL TABLET 150 MG, 200 MG|1|PA|
RECORLEV ORAL TABLET 150 MG|1|PA|
SIGNIFOR SUBCUTANEOUS SOLUTION 0.3MG/ML, 0.6 MG/ML, 0.9 MG/ML||PA|
|1||
|||
SOMAVERT SUBCUTANEOUS SOLUTIONRECONSTITUTED 10 MG, 15 MG, 20 MG, 25MG, 30 MG||PA|
|1||
|||
SYNAREL NASAL SOLUTION 2 MG/ML|1|PA|
Drug Name||Drug Tier|Requirements/Limits
TARPEYO ORAL CAPSULE DELAYEDRELEASE 4 MG||PA|
||1|
|||
TRELSTAR MIXJECT INTRAMUSCULARSUSPENSION RECONSTITUTED 11.25 MG,22.5 MG, 3.75 MG||PA|
||1|
|||
Hormonal Agents, Suppressant|||
(Thyroid) - Treatment For Overactive|||
Thyroid|||
Antithyroid Agents|||
methimazole oral tablet 10 mg, 5 mg|||
||1|
propylthiouracil oral tablet 50 mg||1|
Immunological Agents - Medications|||
That Alter The Immune System|||
Including Vaccinations|||
Angioedema Agents|||
CINRYZE INTRAVENOUS SOLUTIONRECONSTITUTED 500 UNIT||PA|
|||
||1|
|||
HAEGARDA SUBCUTANEOUS SOLUTIONRECONSTITUTED 2000 UNIT, 3000 UNIT||PA|
||1|
|||
icatibant acetate subcutaneous solution prefilledsyringe 30 mg/3ml||PA|
||1|
|||
ORLADEYO ORAL CAPSULE 110 MG, 150MG||PA|
||1|
|||
Immunoglobulins|||
FLEBOGAMMA DIF INTRAVENOUSSOLUTION 5 GM/50ML||B/D|
|||
||1|
|||
GAMMAGARD INJECTION SOLUTION 1GM/10ML, 10 GM/100ML, 2.5 GM/25ML, 20GM/200ML, 30 GM/300ML, 5 GM/50ML||B/D|
||1|
|||
GAMMAGARD S/D LESS IGAINTRAVENOUS SOLUTIONRECONSTITUTED 10 GM, 5 GM||B/D|
||1|
|||
GAMMAKED INJECTION SOLUTION 1GM/10ML||B/D|
||1|
|||
GAMMAPLEX INTRAVENOUS SOLUTION10 GM/100ML, 10 GM/200ML, 20 GM/200ML,5 GM/50ML||B/D|
||1|
|||
GAMUNEX-C INJECTION SOLUTION 1GM/10ML||B/D|
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
PRIVIGEN INTRAVENOUS SOLUTION 10GM/100ML, 20 GM/200ML, 40 GM/400ML, 5GM/50ML||B/D|
||1|
|||
Immunological Agents, Other|||
ACTEMRA ACTPEN SUBCUTANEOUSSOLUTION AUTO-INJECTOR 162 MG/0.9ML||PA|
|||
||1|
|||
ACTEMRA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 162 MG/0.9ML||PA|
||1|
|||
ARCALYST SUBCUTANEOUS SOLUTIONRECONSTITUTED 220 MG||PA|
||1|
|||
BENLYSTA SUBCUTANEOUS SOLUTIONAUTO-INJECTOR 200 MG/ML||PA|
||1|
|||
BENLYSTA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 200 MG/ML||PA|
||1|
|||
CIBINQO ORAL TABLET 100 MG, 200 MG,50 MG||PA|
||1|
|||
COSENTYX (300 MG DOSE)SUBCUTANEOUS SOLUTION PREFILLEDSYRINGE 150 MG/ML||PA|
||1|
|||
COSENTYX SENSOREADY (300 MG)SUBCUTANEOUS SOLUTION AUTO-INJECTOR 150 MG/ML||PA|
||1|
|||
COSENTYX SENSOREADY PENSUBCUTANEOUS SOLUTION AUTO-INJECTOR 150 MG/ML||PA|
||1|
|||
COSENTYX SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 150 MG/ML, 75MG/0.5ML||PA|
||1|
|||
COSENTYX UNOREADY SUBCUTANEOUSSOLUTION AUTO-INJECTOR 300 MG/2ML||PA|
||1|
|||
ILARIS SUBCUTANEOUS SOLUTION 150MG/ML||PA|
||1|
|||
ILUMYA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 100 MG/ML||PA|
||1|
|||
KEVZARA SUBCUTANEOUS SOLUTIONAUTO-INJECTOR 150 MG/1.14ML, 200MG/1.14ML||PA|
||1|
|||
KEVZARA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 150 MG/1.14ML, 200MG/1.14ML||PA|
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
KINERET SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 100 MG/0.67ML||PA|
|1||
|||
OLUMIANT ORAL TABLET 1 MG, 2 MG, 4MG||PA|
|1||
|||
ORENCIA CLICKJECT SUBCUTANEOUSSOLUTION AUTO-INJECTOR 125 MG/ML||PA|
|1||
|||
ORENCIA INTRAVENOUS SOLUTIONRECONSTITUTED 250 MG||PA|
|1||
|||
ORENCIA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 125 MG/ML, 50MG/0.4ML, 87.5 MG/0.7ML||PA|
|1||
|||
RINVOQ ORAL TABLET EXTENDEDRELEASE 24 HOUR 15 MG, 30 MG, 45 MG||PA|
|1||
|||
SILIQ SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 210 MG/1.5ML||PA|
|1||
|||
SKYRIZI INTRAVENOUS SOLUTION 600MG/10ML||PA|
|1||
|||
SKYRIZI PEN SUBCUTANEOUS SOLUTIONAUTO-INJECTOR 150 MG/ML||PA|
|1||
|||
SKYRIZI SUBCUTANEOUS SOLUTIONCARTRIDGE 180 MG/1.2ML, 360 MG/2.4ML||PA|
|1||
|||
SKYRIZI SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 150 MG/ML||PA|
|1||
|||
SOTYKTU ORAL TABLET 6 MG|1|PA|
STELARA INTRAVENOUS SOLUTION 130MG/26ML||PA|
|1||
|||
STELARA SUBCUTANEOUS SOLUTION 45MG/0.5ML||PA|
|1||
|||
STELARA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 45 MG/0.5ML, 90MG/ML||PA|
|1||
|||
TALTZ SUBCUTANEOUS SOLUTION AUTO-INJECTOR 80 MG/ML||PA|
|1||
|||
TALTZ SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 80 MG/ML||PA|
|1||
|||
TREMFYA SUBCUTANEOUS SOLUTIONPEN-INJECTOR 100 MG/ML||PA|
|1||
|||
TREMFYA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 100 MG/ML||PA|
|1||
|||
XELJANZ ORAL SOLUTION 1 MG/ML|1|PA|
Drug Name||Drug Tier|Requirements/Limits
XELJANZ ORAL TABLET 10 MG, 5 MG||1|PA
XELJANZ XR ORAL TABLET EXTENDEDRELEASE 24 HOUR 11 MG, 22 MG||PA|
||1|
|||
Immunostimulants|||
ACTIMMUNE SUBCUTANEOUS SOLUTION2000000 UNIT/0.5ML||PA|
|||
||1|
|||
INTRON A INJECTION SOLUTION 10000000UNIT/ML, 6000000 UNIT/ML||PA|
||1|
|||
INTRON A INJECTION SOLUTIONRECONSTITUTED 10000000 UNIT, 18000000UNIT, 50000000 UNIT||PA|
||1|
|||
PEGASYS SUBCUTANEOUS SOLUTION 180MCG/ML||PA|
||1|
|||
PEGASYS SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 180 MCG/0.5ML||PA|
||1|
|||
Immunosuppressants|||
ASTAGRAF XL ORAL CAPSULE EXTENDEDRELEASE 24 HOUR 0.5 MG, 1 MG, 5 MG||B/D|
|||
||1|
|||
azathioprine oral tablet 50 mg||1|B/D
CIMZIA STARTER KIT SUBCUTANEOUSPREFILLED SYRINGE KIT 6 X 200 MG/ML||PA|
||1|
|||
CIMZIA SUBCUTANEOUS KIT 2 X 200 MG||1|PA
CIMZIA SUBCUTANEOUS PREFILLEDSYRINGE KIT 2 X 200 MG/ML||PA|
||1|
|||
cyclosporine modified oral capsule 100 mg, 25mg, 50 mg||B/D|
||1|
|||
cyclosporine modified oral solution 100 mg/ml||1|B/D
cyclosporine oral capsule 100 mg, 25 mg||1|B/D
ENBREL MINI SUBCUTANEOUS SOLUTIONCARTRIDGE 50 MG/ML||PA|
||1|
|||
ENBREL SUBCUTANEOUS SOLUTION 25MG/0.5ML||PA|
||1|
|||
ENBREL SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 25 MG/0.5ML, 50MG/ML||PA|
||1|
|||
ENBREL SUBCUTANEOUS SOLUTIONRECONSTITUTED 25 MG||PA|
||1|
|||
ENBREL SURECLICK SUBCUTANEOUSSOLUTION AUTO-INJECTOR 50 MG/ML||PA|
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
ENVARSUS XR ORAL TABLET EXTENDEDRELEASE 24 HOUR 0.75 MG, 1 MG, 4 MG||B/D|
|1||
|||
everolimus oral tablet 0.25 mg, 0.5 mg, 0.75 mg,1 mg||B/D|
|1||
|||
gengraf oral capsule 100 mg, 25 mg|1|B/D|
gengraf oral solution 100 mg/ml|1|B/D|
HUMIRA PEDIATRIC CROHNS STARTSUBCUTANEOUS PREFILLED SYRINGE KIT80 MG/0.8ML, 80 MG/0.8ML & 40MG/0.4ML||PA|
|1||
|||
HUMIRA PEN SUBCUTANEOUS PEN-INJECTOR KIT 40 MG/0.4ML, 40 MG/0.8ML,80 MG/0.8ML||PA|
|1||
|||
HUMIRA PEN-CD/UC/HS STARTERSUBCUTANEOUS PEN-INJECTOR KIT 40MG/0.8ML, 80 MG/0.8ML||PA|
|1||
|||
HUMIRA PEN-PEDIATRIC UC STARTSUBCUTANEOUS PEN-INJECTOR KIT 80MG/0.8ML||PA|
|1||
|||
HUMIRA PEN-PS/UV/ADOL HS STARTSUBCUTANEOUS PEN-INJECTOR KIT 40MG/0.8ML||PA|
|1||
|||
HUMIRA PEN-PSOR/UVEIT STARTERSUBCUTANEOUS PEN-INJECTOR KIT 80MG/0.8ML & 40MG/0.4ML||PA|
|1||
|||
HUMIRA SUBCUTANEOUS PREFILLEDSYRINGE KIT 10 MG/0.1ML, 20 MG/0.2ML,40 MG/0.4ML, 40 MG/0.8ML||PA|
|1||
|||
leflunomide oral tablet 10 mg, 20 mg|1||
LUPKYNIS ORAL CAPSULE 7.9 MG|1|PA|
methotrexate oral tablet 2.5 mg|1||
methotrexate sodium (pf) injection solution 50mg/2ml|||
|1||
|||
methotrexate sodium injection solution 250mg/10ml, 50 mg/2ml|||
|1||
|||
methotrexate sodium oral tablet 2.5 mg|1||
mycophenolate mofetil oral capsule 250 mg|1|B/D|
mycophenolate mofetil oral suspensionreconstituted 200 mg/ml||B/D|
|1||
|||
mycophenolate mofetil oral tablet 500 mg|1|B/D|
Drug Name||Drug Tier|Requirements/Limits
mycophenolate sodium oral tablet delayed release180 mg, 360 mg||B/D|
||1|
|||
NULOJIX INTRAVENOUS SOLUTIONRECONSTITUTED 250 MG||B/D|
||1|
|||
PROGRAF INTRAVENOUS SOLUTION 5MG/ML||B/D|
||1|
|||
PROGRAF ORAL PACKET 0.2 MG, 1 MG||1|B/D
REZUROCK ORAL TABLET 200 MG||1|PA
SANDIMMUNE ORAL SOLUTION 100MG/ML||B/D|
||1|
|||
SIMPONI SUBCUTANEOUS SOLUTIONAUTO-INJECTOR 100 MG/ML, 50 MG/0.5ML||PA|
||1|
|||
SIMPONI SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 100 MG/ML, 50MG/0.5ML||PA|
||1|
|||
sirolimus oral solution 1 mg/ml||1|B/D
sirolimus oral tablet 0.5 mg, 1 mg, 2 mg||1|B/D
tacrolimus oral capsule 0.5 mg, 1 mg, 5 mg||1|B/D
Vaccines|||
ABRYSVO INTRAMUSCULAR SOLUTIONRECONSTITUTED 120 MCG/0.5ML|||
|||
||1|
|||
ACTHIB INTRAMUSCULAR SOLUTIONRECONSTITUTED|||
||1|
|||
ADACEL INTRAMUSCULAR SUSPENSION5-2-15.5  (PREFILLED SYRINGE), 5-2-15.5 LF-MCG/0.5|||
||1|
|||
AREXVY INTRAMUSCULAR SUSPENSIONRECONSTITUTED 120 MCG/0.5ML|||
||1|
|||
BCG VACCINE INJECTION SOLUTIONRECONSTITUTED 50 MG|||
||1|
|||
BEXSERO INTRAMUSCULAR SUSPENSIONPREFILLED SYRINGE|||
||1|
|||
BOOSTRIX INTRAMUSCULARSUSPENSION 5-2.5-18.5 LF-MCG/0.5|||
||1|
|||
BOOSTRIX INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 5-2.5-18.5 LF-MCG/0.5|||
||1|
|||
DAPTACEL INTRAMUSCULARSUSPENSION 23-15-5|||
|1.0||
|||
Drug Name|Drug Tier|Requirements/Limits|
DIPHTHERIA-TETANUS TOXOIDS DTINTRAMUSCULAR SUSPENSION 25-5LFU/0.5ML||B/D|
|1||
|||
ENGERIX-B INJECTION SUSPENSION 20MCG/ML||B/D|
|1||
|||
ENGERIX-B INJECTION SUSPENSIONPREFILLED SYRINGE 10 MCG/0.5ML, 20MCG/ML||B/D|
|1||
|||
GARDASIL 9 INTRAMUSCULARSUSPENSION|||
|1||
|||
GARDASIL 9 INTRAMUSCULARSUSPENSION PREFILLED SYRINGE|||
|1||
|||
HAVRIX INTRAMUSCULAR SUSPENSION1440 EL U/ML, 720 EL U/0.5ML|||
|1||
|||
HEPLISAV-B INTRAMUSCULAR SOLUTIONPREFILLED SYRINGE 20 MCG/0.5ML||B/D|
|1||
|||
HIBERIX INJECTION SOLUTIONRECONSTITUTED 10 MCG|||
|1||
|||
IMOVAX RABIES INTRAMUSCULARSUSPENSION RECONSTITUTED 2.5UNIT/ML||B/D|
|1||
|||
INFANRIX INTRAMUSCULAR SUSPENSION25-58-10|||
|1||
|||
IPOL INJECTION INJECTABLE|1||
IXIARO INTRAMUSCULAR SUSPENSION|1||
JYNNEOS SUBCUTANEOUS SUSPENSION0.5 ML|||
|1||
|||
KINRIX INTRAMUSCULAR SUSPENSIONPREFILLED SYRINGE 0.5 ML|||
|1||
|||
MENACTRA INTRAMUSCULAR SOLUTION|1||
MENQUADFI INTRAMUSCULAR SOLUTION|1||
MENVEO INTRAMUSCULAR SOLUTION|1||
MENVEO INTRAMUSCULAR SOLUTIONRECONSTITUTED|||
|1||
|||
M-M-R II INJECTION SOLUTIONRECONSTITUTED|||
|1||
|||
PEDIARIX INTRAMUSCULAR SUSPENSIONPREFILLED SYRINGE|||
|1||
|||
PEDVAX HIB INTRAMUSCULARSUSPENSION 7.5 MCG/0.5ML|||
1|||
|||
Drug Name|Drug Tier|Requirements/Limits|
PENTACEL INTRAMUSCULARSUSPENSION RECONSTITUTED|||
|1||
|||
PREHEVBRIO INTRAMUSCULARSUSPENSION 10 MCG/ML||B/D|
|1||
|||
PRIORIX SUBCUTANEOUS SUSPENSIONRECONSTITUTED|||
|1||
|||
PROQUAD SUBCUTANEOUS SUSPENSIONRECONSTITUTED|||
|1||
|||
QUADRACEL INTRAMUSCULARSUSPENSION  ,   (58 UNT/ML)|||
|1||
|||
QUADRACEL INTRAMUSCULARSUSPENSION PREFILLED SYRINGE 0.5 ML|||
|1||
|||
RABAVERT INTRAMUSCULARSUSPENSION RECONSTITUTED||B/D|
|1||
|||
RECOMBIVAX HB INJECTION SUSPENSION10 MCG/ML, 40 MCG/ML, 5 MCG/0.5ML||B/D|
|1||
|||
RECOMBIVAX HB INJECTION SUSPENSIONPREFILLED SYRINGE 10 MCG/ML, 5MCG/0.5ML||B/D|
|1||
|||
ROTARIX ORAL SUSPENSION|1||
ROTARIX ORAL SUSPENSIONRECONSTITUTED|||
|1||
|||
ROTATEQ ORAL SOLUTION|1||
SHINGRIX INTRAMUSCULAR SUSPENSIONRECONSTITUTED 50 MCG/0.5ML||QL (2 EA per 999 days)|
|1||
|||
TDVAX INTRAMUSCULAR SUSPENSION 2-2 LF/0.5ML||B/D|
|1||
|||
TENIVAC INTRAMUSCULAR INJECTABLE5-2 LFU, 5-2 LFU (INJECTION)||B/D|
|1||
|||
TETANUS-DIPHTHERIA TOXOIDS TDINTRAMUSCULAR SUSPENSION 2-2LF/0.5ML||B/D|
|1||
|||
TICOVAC INTRAMUSCULAR SUSPENSIONPREFILLED SYRINGE 1.2 MCG/0.25ML, 2.4MCG/0.5ML|||
|1||
|||
TRUMENBA INTRAMUSCULARSUSPENSION PREFILLED SYRINGE|||
|1||
|||
TWINRIX INTRAMUSCULAR SUSPENSIONPREFILLED SYRINGE 720-20 ELU-MCG/ML|||
1|||
|||
Drug Name||Drug Tier|Requirements/Limits
TYPHIM VI INTRAMUSCULAR SOLUTION25 MCG/0.5ML|||
||1|
|||
TYPHIM VI INTRAMUSCULAR SOLUTIONPREFILLED SYRINGE 25 MCG/0.5ML|||
||1|
|||
VAQTA INTRAMUSCULAR SUSPENSION 25UNIT/0.5ML, 25 UNIT/0.5ML 0.5 ML, 50UNIT/ML, 50 UNIT/ML 1 ML|||
||1|
|||
VARIVAX SUBCUTANEOUS INJECTABLE1350 PFU/0.5ML|||
||1|
|||
VARIZIG INTRAMUSCULAR SOLUTION 125UNIT/1.2ML|||
||1|
|||
VAXCHORA ORAL SUSPENSIONRECONSTITUTED|||
||1|
|||
VAXELIS INTRAMUSCULAR SUSPENSION||1|
VAXELIS INTRAMUSCULAR SUSPENSIONPREFILLED SYRINGE|||
||1|
|||
YF-VAX SUBCUTANEOUS INJECTABLE  ,(2.5 ML IN 1 VIAL, MULTI-DOSE)|||
||1|
|||
Inflammatory Bowel Disease Agents -|||
Treatment Of Ulcerative Colitis Or|||
Crohn's Disease|||
Aminosalicylates|||
balsalazide disodium oral capsule 750 mg|||
||1|
mesalamine oral capsule delayed release 400 mg||1|
mesalamine oral tablet delayed release 1.2 gm||1|
mesalamine rectal enema 4 gm||1|
mesalamine rectal suppository 1000 mg||1|
mesalamine-cleanser rectal kit 4 gm||1|
sulfasalazine oral tablet 500 mg||1|
sulfasalazine oral tablet delayed release 500 mg||1|
Glucocorticoids|||
budesonide er oral tablet extended release 24hour 9 mg||PA|
|||
||1|
|||
budesonide oral capsule delayed release particles3 mg|||
||1|
|||
dexamethasone intensol oral concentrate 1 mg/ml||1|
dexamethasone oral elixir 0.5 mg/5ml||1|
Drug Name||Drug Tier|Requirements/Limits
dexamethasone sodium phosphate injectionsolution 120 mg/30ml, 20 mg/5ml, 4 mg/ml|||
||1|
|||
hydrocortisone rectal enema 100 mg/60ml||1|
methylprednisolone acetate injection suspension40 mg/ml, 80 mg/ml|||
||1|
|||
prednisolone sodium phosphate oral solution 15mg/5ml|||
||1|
|||
prednisone intensol oral concentrate 5 mg/ml||1|
prednisone oral solution 5 mg/5ml||1|
prednisone oral tablet 1 mg, 10 mg, 2.5 mg, 20mg, 5 mg, 50 mg|||
||1|
|||
prednisone oral tablet therapy pack 10 mg (21),10 mg (48), 5 mg (21), 5 mg (48)|||
||1|
|||
Metabolic Bone Disease Agents -|||
Treatment Of Bone Diseases Including|||
Osteoporosis|||
Metabolic Bone Disease Agents|||
alendronate sodium oral tablet 10 mg, 35 mg, 5mg, 70 mg|||
|||
||1|
|||
calcitonin (salmon) nasal solution 200 unit/act||1|
calcitriol oral capsule 0.25 mcg, 0.5 mcg||1|
calcitriol oral solution 1 mcg/ml||1|
cinacalcet hcl oral tablet 30 mg, 60 mg||1|QL (60 EA per 30 days)
cinacalcet hcl oral tablet 90 mg||1|QL (120 EA per 30 days)
doxercalciferol oral capsule 0.5 mcg, 1 mcg, 2.5mcg|||
||1|
|||
ibandronate sodium oral tablet 150 mg||1|
NATPARA SUBCUTANEOUS CARTRIDGE100 MCG, 25 MCG, 50 MCG, 75 MCG||PA|
||1|
|||
paricalcitol oral capsule 1 mcg, 2 mcg, 4 mcg||1|
PROLIA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 60 MG/ML||PA|
||1|
|||
risedronate sodium oral tablet 150 mg, 30 mg, 35mg, 35 mg (12 pack), 35 mg (4 pack), 5 mg|||
||1|
|||
TERIPARATIDE (RECOMBINANT)SUBCUTANEOUS SOLUTION PEN-INJECTOR 620 MCG/2.48ML||PA|
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
TYMLOS SUBCUTANEOUS SOLUTION PEN-INJECTOR 3120 MCG/1.56ML||PA|
||1|
|||
XGEVA SUBCUTANEOUS SOLUTION 120MG/1.7ML||PA|
||1|
|||
Ophthalmic Agents - Treatment Of Eye|||
Conditions|||
Ophthalmic Agents, Other|||
atropine sulfate ophthalmic solution 1 %|||
||1|
bevacizumab intravitreal solution prefilledsyringe 2.5 mg/0.1ml, 3 mg/0.12ml, 3.25mg/0.13ml, 3.75 mg/0.15ml|||
||1|
|||
brimonidine tartrate-timolol ophthalmic solution0.2-0.5 %|||
||1|
|||
cyclosporine ophthalmic emulsion 0.05 %||1|QL (60 EA per 30 days)
CYSTARAN OPHTHALMIC SOLUTION 0.44%||PA|
||1|
|||
dorzolamide hcl-timolol mal ophthalmic solution2-0.5 %|||
||1|
|||
neomycin-polymyxin-dexameth ophthalmicointment 3.5-10000-0.1|||
||1|
|||
neomycin-polymyxin-dexameth ophthalmicsuspension 3.5-10000-0.1|||
||1|
|||
neomycin-polymyxin-gramicidin ophthalmicsolution 1.75-10000-.025|||
||1|
|||
OXERVATE OPHTHALMIC SOLUTION 0.002%||PA|
||1|
|||
proparacaine hcl ophthalmic solution 0.5 %||1|
sulfacetamide-prednisolone ophthalmic solution10-0.23 %|||
||1|
|||
tobramycin-dexamethasone ophthalmicsuspension 0.3-0.1 %|||
||1|
|||
Ophthalmic Anti-Allergy Agents|||
azelastine hcl ophthalmic solution 0.05 %|||
||1|
cromolyn sodium ophthalmic solution 4 %||1|
olopatadine hcl ophthalmic solution 0.1 %||1|
Ophthalmic Anti-Infectives|||
ak-poly-bac ophthalmic ointment 500-10000unit/gm|||
|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
bacitracin ophthalmic ointment 500 unit/gm||1|
bacitracin-polymyxin b ophthalmic ointment 500-10000 unit/gm|||
||1|
|||
ciprofloxacin hcl ophthalmic solution 0.3 %||1|
erythromycin ophthalmic ointment 5 mg/gm||1|
gentamicin sulfate ophthalmic solution 0.3 %||1|
moxifloxacin hcl ophthalmic solution 0.5 %||1|
NATACYN OPHTHALMIC SUSPENSION 5 %||1|
ofloxacin ophthalmic solution 0.3 %||1|
polymyxin b-trimethoprim ophthalmic solution10000-0.1 unit/ml-%|||
||1|
|||
sulfacetamide sodium ophthalmic ointment 10 %||1|
sulfacetamide sodium ophthalmic solution 10 %||1|
tobramycin ophthalmic solution 0.3 %||1|
Ophthalmic Anti-Inflammatories|||
dexamethasone sodium phosphate ophthalmicsolution 0.1 %|||
|||
||1|
|||
diclofenac sodium ophthalmic solution 0.1 %||1|
difluprednate ophthalmic emulsion 0.05 %||1|
fluorometholone ophthalmic suspension 0.1 %||1|
flurbiprofen sodium ophthalmic solution 0.03 %||1|
ketorolac tromethamine ophthalmic solution 0.4%, 0.5 %|||
||1|
|||
prednisolone acetate ophthalmic suspension 1 %||1|
prednisolone sodium phosphate ophthalmicsolution 1 %|||
||1|
|||
Ophthalmic Beta-Adrenergic Blocking|||
Agents|||
carteolol hcl ophthalmic solution 1 %||1|
levobunolol hcl ophthalmic solution 0.5 %||1|
timolol maleate ophthalmic solution 0.25 %, 0.5%|||
||1|
|||
Ophthalmic Intraocular Pressure|||
Lowering Agents, Other|||
acetazolamide er oral capsule extended release12 hour 500 mg|||
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
ALPHAGAN P OPHTHALMIC SOLUTION 0.1%|||
||1|
|||
brimonidine tartrate ophthalmic solution 0.2 %||1|
brinzolamide ophthalmic suspension 1 %||1|ST
dorzolamide hcl ophthalmic solution 2 %||1|
methazolamide oral tablet 25 mg, 50 mg||1|
pilocarpine hcl ophthalmic solution 1 %, 2 %, 4%|||
||1|
|||
RHOPRESSA OPHTHALMIC SOLUTION 0.02%||ST|
||1|
|||
ROCKLATAN OPHTHALMIC SOLUTION0.02-0.005 %||ST|
||1|
|||
SIMBRINZA OPHTHALMIC SUSPENSION 1-0.2 %|||
||1|
|||
Ophthalmic Prostaglandin And|||
Prostamide Analogs|||
latanoprost ophthalmic solution 0.005 %||1|
LUMIGAN OPHTHALMIC SOLUTION 0.01 %||1|
travoprost (bak free) ophthalmic solution 0.004 %||1|
Otic Agents - Treatment Of Ear|||
Conditions|||
Otic Agents|||
acetic acid otic solution 2 %|||
||1|
hydrocortisone-acetic acid otic solution 1-2 %||1|
neomycin-polymyxin-hc otic solution 1 %, 3.5-10000-1|||
||1|
|||
neomycin-polymyxin-hc otic suspension 3.5-10000-1|||
||1|
|||
ofloxacin otic solution 0.3 %||1|
Respiratory Tract/ Pulmonary Agents -|||
Treatment Of Breathing Conditions|||
Antihistamines|||
azelastine hcl nasal solution 0.1 %, 0.15 %, 137mcg/spray|||
|||
||1|
|||
cetirizine hcl oral solution 1 mg/ml, 5 mg/5ml||1|
clemastine fumarate oral tablet 2.68 mg||1|PA
cyproheptadine hcl oral syrup 2 mg/5ml||1|PA
Drug Name||Drug Tier|Requirements/Limits
cyproheptadine hcl oral tablet 4 mg||1|PA
hydroxyzine hcl oral syrup 10 mg/5ml||1|PA
hydroxyzine hcl oral tablet 10 mg||1|
hydroxyzine hcl oral tablet 25 mg, 50 mg||1|PA
levocetirizine dihydrochloride oral solution 2.5mg/5ml|||
||1|
|||
levocetirizine dihydrochloride oral tablet 5 mg||1|
promethazine hcl oral solution 6.25 mg/5ml||1|PA
Anti-Inflammatories, Inhaled|||
Corticosteroids|||
ARNUITY ELLIPTA INHALATION AEROSOLPOWDER BREATH ACTIVATED 100MCG/ACT, 200 MCG/ACT, 50 MCG/ACT|||
||1|
|||
budesonide inhalation suspension 0.25 mg/2ml,0.5 mg/2ml, 1 mg/2ml||B/D|
||1|
|||
flunisolide nasal solution 25 mcg/act (0.025%)||1|
fluticasone propionate hfa inhalation aerosol 110mcg/act, 220 mcg/act, 44 mcg/act|||
||1|
|||
fluticasone propionate nasal suspension 50mcg/act|||
||1|
|||
mometasone furoate nasal suspension 50 mcg/act||1|
Bronchodilators, Anticholinergic|||
ATROVENT HFA INHALATION AEROSOLSOLUTION 17 MCG/ACT|||
|||
||1|
|||
INCRUSE ELLIPTA INHALATION AEROSOLPOWDER BREATH ACTIVATED 62.5MCG/ACT|||
||1|
|||
ipratropium bromide inhalation solution 0.02 %||1|B/D
ipratropium bromide nasal solution 0.03 %, 0.06%|||
||1|
|||
SPIRIVA RESPIMAT INHALATIONAEROSOL SOLUTION 1.25 MCG/ACT, 2.5MCG/ACT|||
||1|
|||
tiotropium bromide monohydrate inhalationcapsule 18 mcg|||
||1|
|||
Bronchodilators, Sympathomimetic|||
Drug Name||Drug Tier|Requirements/Limits
albuterol sulfate hfa inhalation aerosol solution108 (90 base) mcg/act, 108 (90 base) mcg/act(nda020503), 108 (90 base) mcg/act (nda020983)|||
||1|
|||
albuterol sulfate inhalation nebulization solution(2.5 mg/3ml) 0.083%, (5 mg/ml) 0.5%, 0.63mg/3ml, 1.25 mg/3ml, 2.5 mg/0.5ml||B/D|
||1|
|||
albuterol sulfate oral syrup 2 mg/5ml||1|
albuterol sulfate oral tablet 2 mg, 4 mg||1|
epinephrine injection solution 0.3 mg/0.3ml||1|QL (2 EA per 30 days)
epinephrine injection solution auto-injector 0.15mg/0.15ml, 0.15 mg/0.3ml, 0.3 mg/0.3ml||QL (2 EA per 30 days)|
||1|
|||
formoterol fumarate inhalation nebulizationsolution 20 mcg/2ml||B/D|
||1|
|||
levalbuterol hcl inhalation nebulization solution0.31 mg/3ml, 0.63 mg/3ml, 1.25 mg/3ml||B/D|
||1|
|||
SEREVENT DISKUS INHALATIONAEROSOL POWDER BREATH ACTIVATED50 MCG/ACT|||
||1|
|||
STRIVERDI RESPIMAT INHALATIONAEROSOL SOLUTION 2.5 MCG/ACT|||
||1|
|||
terbutaline sulfate oral tablet 2.5 mg, 5 mg||1|
VENTOLIN HFA INHALATION AEROSOLSOLUTION 108 (90 BASE) MCG/ACT|||
||1|
|||
Cystic Fibrosis Agents|||
BRONCHITOL INHALATION CAPSULE 40MG||PA|
|||
||1|
|||
CAYSTON INHALATION SOLUTIONRECONSTITUTED 75 MG||PA|
||1|
|||
KALYDECO ORAL PACKET 13.4 MG, 25 MG,50 MG, 75 MG||PA|
||1|
|||
KALYDECO ORAL TABLET 150 MG||1|PA
ORKAMBI ORAL PACKET 100-125 MG, 150-188 MG, 75-94 MG||PA|
||1|
|||
ORKAMBI ORAL TABLET 100-125 MG, 200-125 MG||PA|
||1|
|||
PULMOZYME INHALATION SOLUTION 2.5MG/2.5ML||B/D|
||1|
|||
SYMDEKO ORAL TABLET THERAPY PACK100-150 & 150 MG, 50-75 & 75 MG||PA|
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
tobramycin inhalation nebulization solution 300mg/5ml||B/D; QL (280 ML per 56 days)|
||1|
|||
TRIKAFTA ORAL TABLET THERAPY PACK100-50-75 & 150 MG, 50-25-37.5 & 75 MG||PA|
||1|
|||
TRIKAFTA ORAL THERAPY PACK 100-50-75& 75 MG, 80-40-60 & 59.5 MG||PA|
||1|
|||
Mast Cell Stabilizers|||
cromolyn sodium inhalation nebulization solution20 mg/2ml||B/D|
|||
||1|
|||
cromolyn sodium oral concentrate 100 mg/5ml||1|
Phosphodiesterase Inhibitors, Airways|||
Disease|||
roflumilast oral tablet 250 mcg, 500 mcg||1|
theophylline er oral tablet extended release 12hour 300 mg, 450 mg|||
||1|
|||
theophylline er oral tablet extended release 24hour 400 mg, 600 mg|||
||1|
|||
theophylline oral elixir 80 mg/15ml||1|
theophylline oral solution 80 mg/15ml||1|
Pulmonary Antihypertensives|||
ADEMPAS ORAL TABLET 0.5 MG, 1 MG, 1.5MG, 2 MG, 2.5 MG||PA|
|||
||1|
|||
ambrisentan oral tablet 10 mg, 5 mg||1|PA
bosentan oral tablet 125 mg, 62.5 mg||1|PA
sildenafil citrate oral suspension reconstituted 10mg/ml||PA|
||1|
|||
sildenafil citrate oral tablet 20 mg||1|PA
tadalafil (pah) oral tablet 20 mg||1|PA
TADLIQ ORAL SUSPENSION 20 MG/5ML||1|PA
TYVASO DPI MAINTENANCE KITINHALATION POWDER 112 X 32MCG & 112X48MCG, 16 MCG, 32 MCG, 48 MCG, 64 MCG||PA|
||1|
|||
TYVASO DPI TITRATION KIT INHALATIONPOWDER 112 X 16MCG & 84 X 32MCG, 16 &32 & 48 MCG||PA|
||1|
|||
UPTRAVI ORAL TABLET 1000 MCG, 1200MCG, 1400 MCG, 1600 MCG, 200 MCG, 400MCG, 600 MCG, 800 MCG||PA|
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
UPTRAVI ORAL TABLET THERAPY PACK200 & 800 MCG||PA|
||1|
|||
VENTAVIS INHALATION SOLUTION 10MCG/ML, 20 MCG/ML||PA|
||1|
|||
Pulmonary Fibrosis Agents|||
OFEV ORAL CAPSULE 100 MG, 150 MG||PA|
||1|
pirfenidone oral capsule 267 mg||1|PA
pirfenidone oral tablet 267 mg, 534 mg, 801 mg||1|PA
Respiratory Tract Agents, Other|||
acetylcysteine inhalation solution 10 %, 20 %||B/D|
||1|
ADVAIR HFA INHALATION AEROSOL 115-21 MCG/ACT, 230-21 MCG/ACT, 45-21MCG/ACT|||
||1|
|||
ANORO ELLIPTA INHALATION AEROSOLPOWDER BREATH ACTIVATED 62.5-25MCG/ACT|||
||1|
|||
BEVESPI AEROSPHERE INHALATIONAEROSOL 9-4.8 MCG/ACT|||
||1|
|||
BREO ELLIPTA INHALATION AEROSOLPOWDER BREATH ACTIVATED 100-25MCG/ACT, 200-25 MCG/ACT|||
||1|
|||
BREZTRI AEROSPHERE INHALATIONAEROSOL 160-9-4.8 MCG/ACT|||
||1|
|||
BUDESONIDE-FORMOTEROL FUMARATEINHALATION AEROSOL 160-4.5 MCG/ACT,80-4.5 MCG/ACT|||
||1|
|||
COMBIVENT RESPIMAT INHALATIONAEROSOL SOLUTION 20-100 MCG/ACT|||
||1|
|||
DUPIXENT SUBCUTANEOUS SOLUTIONPEN-INJECTOR 200 MG/1.14ML, 300MG/2ML||PA|
||1|
|||
DUPIXENT SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 100 MG/0.67ML, 200MG/1.14ML, 300 MG/2ML||PA|
||1|
|||
FASENRA PEN SUBCUTANEOUSSOLUTION AUTO-INJECTOR 30 MG/ML||PA|
||1|
|||
FASENRA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 30 MG/ML||PA|
|1.0||
|||
Drug Name||Drug Tier|Requirements/Limits
fluticasone-salmeterol inhalation aerosol powderbreath activated 100-50 mcg/act, 113-14 mcg/act,232-14 mcg/act, 250-50 mcg/act, 500-50 mcg/act,55-14 mcg/act|||
||1|
|||
ipratropium-albuterol inhalation solution 0.5-2.5(3) mg/3ml||B/D|
||1|
|||
montelukast sodium oral packet 4 mg||1|
montelukast sodium oral tablet 10 mg||1|
montelukast sodium oral tablet chewable 4 mg, 5mg|||
||1|
|||
NUCALA SUBCUTANEOUS SOLUTIONAUTO-INJECTOR 100 MG/ML||PA|
||1|
|||
NUCALA SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 100 MG/ML, 40MG/0.4ML||PA|
||1|
|||
NUCALA SUBCUTANEOUS SOLUTIONRECONSTITUTED 100 MG||PA|
||1|
|||
promethazine vc oral syrup 6.25-5 mg/5ml||1|PA
promethazine-phenylephrine oral syrup 6.25-5mg/5ml||PA|
||1|
|||
STIOLTO RESPIMAT INHALATIONAEROSOL SOLUTION 2.5-2.5 MCG/ACT|||
||1|
|||
TRELEGY ELLIPTA INHALATIONAEROSOL POWDER BREATH ACTIVATED100-62.5-25 MCG/ACT, 200-62.5-25 MCG/ACT|||
||1|
|||
wixela inhub inhalation aerosol powder breathactivated 100-50 mcg/act, 250-50 mcg/act, 500-50 mcg/act|||
||1|
|||
XOLAIR SUBCUTANEOUS SOLUTIONPREFILLED SYRINGE 150 MG/ML, 75MG/0.5ML||PA|
||1|
|||
XOLAIR SUBCUTANEOUS SOLUTIONRECONSTITUTED 150 MG||PA|
||1|
|||
Skeletal Muscle Relaxants - Treatment|||
Of Muscle Tightness|||
Skeletal Muscle Relaxants|||
carisoprodol oral tablet 250 mg, 350 mg||PA; QL (90 EA per 30 days)|
||1|
chlorzoxazone oral tablet 500 mg||1|PA; QL (180 EA per 30 days)
cyclobenzaprine hcl oral tablet 10 mg, 5 mg||1|PA; QL (90 EA per 30 days)
Drug Name||Drug Tier|Requirements/Limits
metaxalone oral tablet 800 mg||1|PA; QL (120 EA per 30 days)
methocarbamol oral tablet 500 mg, 750 mg||1|PA
orphenadrine citrate er oral tablet extendedrelease 12 hour 100 mg||PA|
||1|
|||
Sleep Disorder Agents - Treatment Of|||
Insomnia|||
Sleep Promoting Agents|||
doxepin hcl oral tablet 3 mg, 6 mg||QL (30 EA per 30 days)|
||1|
eszopiclone oral tablet 1 mg, 2 mg, 3 mg||1|PA; QL (30 EA per 30 days)
HETLIOZ LQ ORAL SUSPENSION 4 MG/ML||1|PA
ramelteon oral tablet 8 mg||1|QL (30 EA per 30 days)
tasimelteon oral capsule 20 mg||1|PA
temazepam oral capsule 15 mg, 22.5 mg, 30 mg,7.5 mg||PA; QL (30 EA per 30 days)|
||1|
|||
zaleplon oral capsule 10 mg, 5 mg||1|PA; QL (30 EA per 30 days)
zolpidem tartrate er oral tablet extended release12.5 mg, 6.25 mg||PA; QL (30 EA per 30 days)|
||1|
|||
zolpidem tartrate oral tablet 10 mg||1|PA; QL (30 EA per 30 days)
zolpidem tartrate oral tablet 5 mg||1|QL (30 EA per 30 days)
Wakefulness Promoting Agents|||
armodafinil oral tablet 150 mg, 200 mg, 250 mg,50 mg||PA|
|||
||1|
|||
modafinil oral tablet 100 mg, 200 mg||1|PA
sodium oxybate oral solution 500 mg/ml||1|PA
XYREM ORAL SOLUTION 500 MG/ML||1|PA
XYWAV ORAL SOLUTION 500 MG/ML||1|PA
|||
|||
|||
|||
